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ABSTRACT 
STABILITY ANALYSIS OF IMMUNOGENIC GLIADIN ACCUMULATION 
IN HARD RED SPRING WHEAT (TRITICUM AESTIVUM L.) 
STACY LINDBLOM-DREIS 
2018 
Misconceptions regarding plant breeding objectives have led to speculation 
regarding the increasing prevalence of gluten intolerance, wheat allergy, and celiac 
disease. It is thought that contemporary wheat cultivars accumulate more immunogenic 
proteins than older cultivars because of supposed genetic changes effected through plant 
breeding strategies. This study evaluated the stability of gliadin accumulation in 191 hard 
red spring wheat cultivars grown in 12 location-years. Two enzyme-linked 
immunosorbent assays (ELISAs) were developed. A paired t test (N = 34) failed to find a 
statistically significant difference between the experimental ELISAs and the commercial 
R5 assay measures of mean gliadin (t = 0.37, p = 0.7). A Bland-Altman analysis indicated 
sufficient agreement between the assays, despite a low proportion of shared variance (R2 
= 0.29) and moderate correlation (r = 0.446). The experimental ELISAs overestimated 
gliadin by 0.412 g kg-1 flour (CI95 = -12.52, 13.34) relative to the commercial assay. 
Agronomic, milling quality, gluten, and baking quality traits were assessed for 154 
cultivars. Correlation between gliadin and the expected predictors whole-grain protein, 
flour protein, and dry gluten was not significant at the α = 0.05 level. Weak correlations 
were observed with Falling Number score (r = 0.32), test weight (r = 0.36), shorts (r = 
0.43), and flour yield (r = -0.36). Nonparametric stability analysis indicated that 
genotype-by-environment interaction was significant at a critical value of χ2 = 36.41 with 
xviii 
 
one degree of freedom. Nonparametric stability and genotype and genotype-by-
environment (GGE) analysis identified SD4416 as one of the three the most broadly 
adapted cultivars. A two-sample t test of gliadin accumulated by old and new cultivars 
grown in the same environments did not identify statistically significant differences in 
gliadin accumulation. Ten D genome-specific point mutation markers were used to screen 
40 cultivars chosen by rank and assigned to either the low- or high-gliadin accumulation 
groups. The cultivars screened showed little to no genotypic polymorphism for these 
markers. No conclusive evidence was found to support the hypothesis that plant breeding 
selection practices have increased gliadin accumulation in contemporary wheat cultivars. 
Environment exerted the greatest influence on gliadin accumulation in the 191 cultivars. 
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CHAPTER 1. INTRODUCTION 
BACKGROUND 
Recent popular opinion has condemned modern wheat (Triticum aestivum L.) 
cultivars as “toxic” (CBS News 7 Jan 2013), with some scientific inquiry as support (van 
den Broeck et al 2010). Celiac disease, a condition that reportedly affects 0.8-1.0% of 
people worldwide, is a Type IV delayed hypersensitivity to prolamin seed storage 
proteins of rye (Secale cereale), barley (Hordeum vulgare), and, most notably, wheat 
(Gujral et al 2012). Research exploring variations in wheat gliadin genes and peptides has 
identified specific motifs that stimulate an antibody-based immune response (i.e., the 
peptides are immunogenic) in people with specific human leukocyte antigen (HLA) 
genotypes (Mitea et al 2010; Salentijn et al 2012; Sollid et al 2012). Conversely, in vitro 
studies using synthetic peptides to antagonize gliadin-activated T cells have identified 
specific peptide sequences that modulated celiac-type immune responses to immunogenic 
peptides (Silano et al 2008). Evaluations of older wheat accessions, such as a relict durum 
landrace said to be derived from an Egyptian tomb find, found legacy cultivars to contain 
a greater proportion of immunogenic gliadin relative to total protein when compared with 
modern varieties (Weiser 2000; Gregorini et al 2009; Colomba and Gregorini 2012). 
Homologous gliadin alleles from alternative species, such as T. aestivum ssp. spelta, have 
also been compared for immunogenic potential and have been found to contain celiac-
reactive epitopes (Kasarda and D’Ovidio 1999; Molberg et al 2005). The α-gliadin 
subfraction of the prolamin family, expressed by genes located on all three genomes, has 
been implicated as the most-immunogenic of these storage proteins (van Herpen et al 
2006). Van Herpen et al determined that the gliadins expressed by genes located on the D 
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genome of bread wheat and Aegilops tauschii elicited greater immunogenicity than those 
of the A or B genomes; the D-genome proteins contain the majority of the T-cell 
epitopes.  
The physiological role of gliadins has not been clearly defined. Given their 
relative abundance in the protein profile (Anderson et al 1997; Zilic et al 2011; Qi et al 
2012) and accumulation in vacuoles near the aleurone layer in wheat endosperm 
(Levonony et al 1992; Tosi et al 2009), this protein family may participate in redox 
reactions in the maturing caryopsis. The low lysine content (< 1%) and conserved internal 
cysteines (Gasteiger et al 2005) of α-gliadin parallel properties of seed storage proteins in 
other species, such as pea albumin, that have been reported to scavenge reactive oxygen 
species (ROS) generated during germination (El Maarouf-Bateau et al 2013). Hurkman 
and Tanaka (2007), while examining the role of endosperm thioredoxin in seed storage 
protein mobilization and proteolysis, described changes in solubility as gliadin fractions 
became increasingly reduced. Li et al (2009) further described the changes in gliadin 
properties induced by thioredoxin during germination.  
Uhlmann and Beckles (2010) determined that expression of α-gliadin was limited 
to developing seeds, as hypermethylated promoter sequences may suppress expression in 
other tissues (Morton et al 1995; Phillips 2008; Wen et al 2012a). Evidence that seed 
storage protein gene expression occurs after promoter demethylation in endosperm cells 
has been described in wheat (Wen et al 2012a, b). Wen et al. used RNA interference 
methods to demonstrate that the quantity of 5-methylcytosine DNA glycosylase 
(DEMETER) transcript controlled prolamin promoter demethylation, and therefore 
gliadin accumulation, in the wheat caryopsis. Accumulation of α-gliadin transcripts has 
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been described to reach detectable levels at 9 days post-anthesis (dpa) with continued 
expression throughout caryopsis development (van Herpen et al 2008), indicating that α-
gliadin activity may be required through seed maturity. Oxidation of mRNA, another 
regulatory mechanism described in seed maturation, may end gliadin protein 
accumulation and ROS scavenging activity. The oxidized gliadins would then be recycled 
via the 20S proteasome to provide amino acids for seedling development as has been 
described in other species (El Maarouf-Bateau et al 2013). A comparison between wild 
wheat relatives Ae. tauschii and Ae. crassa and hexaploid cultivars demonstrated that 
expression levels of storage product genes were generally higher in the wild relatives, 
with the exception of one α-gliadin gene and one amylase gene (Uhlmann and Beckles 
2010). This would indicate that overall protein function is conserved, with the observed 
differences in expression level symptomatic of selective forces acting on cultivar 
development. Redundancy in the metabolic network would permit reduced α-gliadin 
accumulation if another seed storage protein could fulfill the same role. A change in in 
the relative proportions of each protein in the total protein profile would be expected, 
similar to that described by Choi et al (2002) in Arabidopsis thaliana and Wen et al 
(2012a, b) in wheat.  
 Attempts to modify or totally eliminate α-gliadin and its homologs from cereals 
have been confounded by gene copy numbers, as reported estimates vary between a few 
dozen to hundreds (Salentijn et al 2009). Undesired changes in end-use quality have also 
been described (Mondal et al 2009; van den Broeck et al 2009). Genome-specific gene 
sequences have been identified (van Herpen et al 2006), making it possible to design 
DNA markers to assay for specific genotypes (Qi et al 2012). Most antigenic gliadins 
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have been assigned to the Gli-D2 locus found on chromosome 6D (Salentijn et al 2009). 
Natural variation in wild-type bread wheat gliadin genes has been described (Xie et al 
2010; Sanchez-Leon et al 2017), mostly in the form of single nucleotide polymorphisms 
(Okita et al. 1985; Qi et al 2010). Once phenotypes have been accurately assayed, 
marker-assisted selection (MAS) could probably be used to identify less-immunogenic 
natural variants for use in breeding programs (Spaenij-Dekking et al 2005; Salentijn et al 
2009). 
STATEMENT OF THE PROBLEM 
Prolamin seed storage proteins containing the peptide sequence [PFPQPQLPY], 
where the underlined glutamine residue may be deaminated to glutamic acid during 
digestion, or similar peptides pose a health risk to people with HLA-DQ2 and -DQ8 
haplotypes (Sollid 2012). All current wheat cultivars possess immunogenic gliadins, but 
specific peptides have been found to stimulate T cell response more strongly than others 
(Salentijn et al 2012). Studies investigating gliadin properties and accumulation 
collectively indicate that gliadins are essential participants in germination; efforts to 
completely eliminate gliadins from wheat may be impossible if wheat is to remain a 
viable crop. Natural variation has been reported for gliadin fraction patterns (Metakovsky 
et al 1998; Salentijn et al 2012) as well as epitope content patterns in cultivars analyzed 
by PAGE and fluorescent Western blotting (Tosi et al 2011). Progressive annotation of 
the extent of gliadin gene variation has been slow, but the current understanding of the 
regulatory control of gene expression in wheat is improving. The role of environmental 
factors such as nitrogen fertilization and temperature have been investigated, but more 
information is needed to design a breeding plan to decrease immunogenic gliadin content 
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in wheat. 
AIMS AND OBJECTIVES 
This project was conducted to screen for natural variation in the available hard red 
spring wheat (HRSW) germplasm that may be used to develop cultivars with lower 
immunogenic gliadin. In the interim, the results of this study can be used to formulate 
production strategies that match less-immunogenic varieties to environmental conditions 
conducive to high protein deposition. The aims of this project were as follows: 
Aim 1: To quantify gliadin accumulation in 200 wheat cultivars. 
The first objective of this project was to identify a suitably-sized population of 
divergent phenotypes for further evaluation. Because the initial screening process was 
performed in a breeding program, the cultivars screened were expected to show less 
variation in phenotype than completely unrelated cultivars. Approximately 200 HRSW 
cultivars were evaluated to identify high- and low-gliadin phenotypes for this reason. 
Thirty-seven of these cultivars were obtained from the National Genetic Resources 
Program (NGRP) National Small Grains Collection (Aberdeen, ID) and included named 
cultivars released between the late 1800s and 1980s and six breeding cultivars. This 
group was chosen specifically to include related cultivars (e.g., ‘Red Fife’ and ‘Marquis’; 
Clark 1922), cultivars with emmer introgressions (‘Hope’), one cultivar from Europe 
(‘B775’), and cultivars with known low protein accumulation, such as ‘Rescue’ (Bayles 
and Clark 1954), or specific resistance traits. The remaining cultivars represent 
homozygous breeding lines developed and tested in the South Dakota State University 
Spring Wheat Breeding Program yield trials.  
Total gliadin accumulations in 191 cultivars were quantified using enzyme-linked 
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immunosorbent assay (ELISA) methods developed as part of this study. Twenty cultivars 
were selected for inclusion in each of the low- and high-gliadin groups, and further 
characterization in Aim 2. Antigenic gliadin accumulations in these 40 selected cultivars 
were quantified using a commercially-available, gliadin-specific ELISA. This assay was 
based on the R5 monoclonal antibody, which preferentially detects the non-hydrolyzed 
DQ2-Glia-α-2 epitope (Thompson and Mendez 2008; Mujico et al 2012; Khoeler 2013).  
Aim 2: To characterize genetic polymorphism in the selected cultivars. 
Ten functional DNA markers were chosen from the work of Qi et al (2012) for 
genotypic analysis. These authors recently described the development of D genome-
specific point mutation (PM) markers for the Gli-D2 locus. Primer mismatch and 
subsequent PCR amplification failure was used to identify cultivars with mutations. Two 
accessions of ‘Chinese Spring’ were chosen for controls, as Qi et al (2012) used variants 
of this cultivar to validate the PM markers.  
Aim 3: To examine genotype-by-environment interactions that influence gliadin 
accumulation. 
Effects of environment on gliadin accumulation were assessed using principal 
component analysis (PCA), and the genotype and genotype-by-environment interactions 
(GGE) analysis method developed by Yan and Kang (2003; Yan and Tinker 2006).  
RATIONALE AND SIGNIFICANCE 
Celiac disease is a valid health concern for approximately 1% of the world 
population. The Codex Alimentarius Commission delineates the maximum gluten 
(gliadin and glutenin) content of “gluten-free” foods made from cereals as 20 ppm, or 
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200 mg kg-1 (Codex Alimentarius Commission 2008). Despite implementation of stricter 
food standards, recent popular opinion has condemned modern wheat cultivars as “toxic” 
and other research has explored genetic modifications to reduce the quantity of 
immunogenic gliadin in wheat. However, genetically-engineered wheat is unlikely to be 
welcomed by the public and may be unsustainable by use of current methodologies 
(Schoft et al 2011). Furthermore, complete elimination of gliadin may not be desirable 
because of potential adverse effects on some wheat end-uses (Mondal et al 2009; Barak et 
al 2013; Barak 2015). 
Given previous reports of differences in proportions of immunogenic proteins 
versus total protein content between legacy and modern wheat cultivars (Ribeiro et al 
2016), the working hypothesis for this study was that fortuitous selection against 
antigenic proteins has occurred during modern cultivar development. This accidental 
reduction may be enhanced in future crosses by marker-assisted selection (MAS) of 
gliadin gene sequences to facilitate directed elimination of specific antigenic epitopes 
from this protein fraction. This must be accomplished without impairing seed 
germination, other agronomic traits, or end-use quality traits. An alternative interpretation 
is that changes in production practices and global weather patterns, and redistribution of 
wheat production areas may have precipitated differential expression of gliadin genes that 
have not undergone selection pressure and therefore remain in Hardy-Weinberg 
equilibrium. Since development of a cultivar can span a decade, supplementing current 
understanding of gene expression will enable producers to choose appropriate released 
cultivars to grow in environments conducive to high protein deposition until suitable low-
gliadin cultivars are developed. 
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EXPECTED OUTCOMES 
Gluten content is an important aspect of end-use quality, and gliadins are a subset 
of gluten proteins. High correlations between gliadin, gluten, and total protein contents 
were expected (Kulkarni et al 1987; Gomez-Beccera et al 2010). Since gliadin is 
hydrolyzed by cysteine proteases during germination (Bottari et al 1996), strong 
correlation with Falling Number value was also expected. Total gliadin accumulation was 
expected to exhibit genotype- and location-specific differences, as measured by ELISA. 
Anticipated problems with the phenotyping procedure were expected to be a consequence 
of the sample preparation and ELISA detection antibodies used. Genotype was also 
expected to influence gliadin accumulation as measured by the different ELISAs. Point 
mutation markers are not codominant, however, so heterozygosity was not expected as 
the population evaluated was theoretically homozygous. 
Due to the structure of the anticipated yield trial population, QTL or association 
mapping was not considered for characterizing gliadin allele differences in this study. 
Furthermore, impact of climate or weather on plant development may complicate QTL 
analysis (Verhoeven et al 2010). Other researchers have specifically investigated the 
effect of temperature on α-gliadin accumulation in winter wheat (Blumenthal et al 1993; 
Daniel and Triboi 2000). Heat stress has been implicated in increased chromosome 6D-
encoded α-gliadin accumulation under field and controlled conditions (Blumenthal et al 
1993). Daniel and Triboi (2000) also determined that variation in the gliadin fractions 
was influenced by nitrogen application. Neither of these studies incorporated other 
factors such as wind or day/night differentials; including these variables could have 
improved the statistical analysis.  
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CONTEXT  
Public discussion regarding the effects of wheat gliadin tend to focus on either the 
human health or plant breeding perspectives. Little attention has been given to the effects 
of human genotype-by-environment interactions (GEI), such as food culture/preparation 
and medical practices. Genetic modification of wheat has been advocated, with cursory 
acknowledgement of the genetic redundancy underlying gliadin accumulation. The 
question currently posed by society is “Can we do this?”, and not “Should we do this?”. 
This dissertation does, admittedly, examine the former question, and by necessity from a 
plant breeding perspective. As noted by Pauli et al (2000) in their discussion of medical 
research and education, prevailing theories are replaced as new data are acquired, because 
the old model can no longer explain the current body of evidence.  
The work presented in this dissertation is intended to guide decisions in crossing 
and selection practices with the intent to reduce the immunogenic protein accumulation in 
bread wheat following conventional breeding and cultivation practices. These approaches 
were chosen for their relevance, given that seed chemical composition is influenced by 
genetics, cultivation practices, and environmental factors. Recommendations for 
cultivation were based on current food culture and preparation of wheat products. 
Discussion regarding the physiological function of gliadin in the life cycle of wheat, and 
possible effects of altering this protein fraction on wheat development, was supported 
with existing literature. The proposed recommendations take both human health and 
viability of wheat as a crop into consideration.  
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CHAPTER 2. LITERATURE REVIEW 
ABSTRACT 
Historical plant breeding efforts have focused on increasing yields to secure food 
supplies in both Western and developing countries. Improved disease and pest resistance, 
increased abiotic stressor resistance, and expansion of production areas all contributed to 
production gains. As worldwide consumption of wheat (Triticum aestivum L.) has 
increased, so has prevalence of human health conditions such as wheat allergy, celiac 
disease, non-celiac gluten sensitivity, and other health conditions. The wheat seed storage 
proteins that compose gluten have been implicated in the development of wheat allergy 
and celiac disease. The prolamins, a protein family that has been evolutionarily conserved 
across the Triticeae, has been implicated as the most-immunogenic of the cereal seed 
storage proteins. Recent efforts to study these proteins have focused on their genetic 
origin, translation, and potential for genetic modification. Given the genetic redundancy 
of the prolamins, these seed storage proteins probably serve an important physiological 
function in the life of cereal caryopses. Further investigation into correlations between 
plant breeding targets, gliadin accumulation, and the life events of cereals is warranted.  
GLUTEN AND HUMAN HEALTH 
Wheat (Triticum aestivum L.) is consumed worldwide. The FAO estimated 
worldwide wheat use during the 2015/2016 reporting period at 711.8 million metric tons. 
Approximately 31.94 million metric tons were used during that same period in the United 
States. Worldwide use is projected to increase to an estimated 734 million tons during the 
2017/2018 reporting period, partly due to a 1.1% increase over 2016/2017 consumption 
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levels (FAO 05 October 2017). This outstrips the expected 2017/2018 world consumption 
of rice (480.48 million metric tons) and maize (650.48 million metric tons; USDA 12 
October 2017). As with the other cereals, whole wheat is an excellent source of protein, 
minerals, and B vitamins (Belitz et al 2004). Despite expressing proteins that perform 
similar functions in plant development, non-wheat cereals do not produce expansive, 
elastic gluten. The conserved sequences and structures of cereal seed storage proteins 
indicate a common evolutionary relationship among species. Sequence similarity is 
greatest among the seed storage proteins of the members of the Triticeae: hexaploid 
bread and spelt wheats (Triticum aestivum subsp. aestivum and T. aestivum subsp. 
spelta), durum wheat (T. turgidum subsp. durum), emmer (T. turgidum subsp. dicoccum), 
einkorn (T. monococcum), barley (Hordeum vulgare L.), rye (Secale cereale L.), and the 
wild relatives of these crops. These proteins have been implicated in certain human health 
conditions, most notably celiac disease (CD) and wheat sensitivities. 
Historical milestones in diagnosis of celiac disease 
Celiac disease was first described circa 200 A. D. by Arataeus the Cappadocian 
(Adams 1856; Tekiner 2015). Perhaps a contemporary of Galen, Arataeus produced a 
body of detailed manuals that he based on the best practices of the available medical 
literature and his own experiences (Laios et al 2012; Tekiner 2015). Arataeus wrote a 
terse description of the ‘celiac affectation’ of adults in The Causes and Symptoms of 
Chronic Disease (Adams 1856), which was lost to the medical profession until the Italian 
Renaissance. During the centuries following the rediscovery of the manual, physicians 
struggled to accurately diagnose celiac disease in their patients. Dr. Samuel Gee studied 
this problem in the late 19th century (Dowd and Walker-Smith 1974). Gee expanded the 
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patient demographic to include children and advocated dietary intervention as treatment. 
Unfortunately, he erred in recommending that patients consume toasted bread. Gee made 
no mention of the characteristic lesions used in current diagnostic practice, perhaps 
because he performed microscopy only on blood samples (Gee 1888). Dr. Willem Dicke 
realized a correlation with wheat consumption as early as 1941, and published his 1950 
thesis on the outcomes of dietary interventions in juvenile patients during the Dutch 
famine of 1944-45 (Dicke et al 1953; van Berge-Henegouwen and Mulder 1993). He 
implicated wheat flour as the trigger of the celiac reaction, and noted similar reactions 
upon rye flour consumption. Diagnosis improved upon the discovery of antibodies 
against tissue transglutaminase, an endogenous enzyme that crosslinks proteins via amine 
groups, and endomysial (muscle) tissues (Schuppan and Zimmer 2013).  
Incidence of celiac disease and causal factors 
Much of this discussion will focus on α-gliadin, as this is the most-immunogenic 
fraction of prolamins. The immunogenicity of gliadins was studied during the early 20th 
century (Lake et al 1914), even though the connection between wheat and CD was still 
not formally identified at the time of Osborne’s work with wheat proteins.  
A review by Sollid (2017) outlined the association between the HLA locus and 
CD. This author and collaborators expanded on reports published in the 1980s that 
described associations between the HLA locus and CD, and contributed to early 
understanding of genotypic correlations between human haplotypes and CD (Sollid et al 
1989). Sollid et al (1989) genotyped 94 Norwegian CD patients and 56 control subjects 
for both haplotype and specific alleles at the HLA locus, and identified the antigen D 
Related (DR) 3 haplotype in 90 of the 94 CD patients. The DR4 haplotype was also 
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identified in one CD patient. These authors observed that HLA-DQA1/HLA-DQB1 
encoded heterodimers prevailed in CD-positive patients; DNA probe hybridization 
identified both of these genotypes in 93 of 94 CD patients. Conversely, homozygous 
HLA-DQA1 and -DQB1 genes were found at a rate of 30.4% and 37.5%, respectively, in 
the control group. The rate of heterozygotes in the control group was 25%. Three CD 
patients whose haplotype differed from the DR3 and DR4 haplotype patients possessed 
the HLA-DQA1 and -DQB1 genes, indicating that HLA-DQ genotype was the 
predisposing genetic factor for CD. Sollid and Thorsby (1993) later reviewed genetic 
mapping efforts motivated by the associations between HLA genotypes and celiac 
disease, which were observed as early as the 1970s. These authors expressed their 
opinion that HLA-DQ2 was a predisposing, but not the deciding, factor for development 
of CD. Ricano-Ponce et al (2015) reported an approximate 41% of CD heritability was 
attributable to HLA haplotype, which left gene interactions and environmental effects as 
additional contributors to the development of CD. The associations of other HLA 
genotypes with CD left unexplained by Sollid and Thorsby in 1993 were later determined 
to be a consequence of linkage disequilibrium and high genetic similarities between 
alleles of different haplotypes (Sollid 2017).  
Genetic variation at loci within predisposing haplotypes do not adequately explain 
variance of CD development in the human population, prompting designs of genome-
wide association studies (GWAS) to assess the variation in genes contributing to CD. In 
their review on published GWAS, Ricano-Ponce et al (2015) noted that increased 
samples sizes in successive studies permitted identification of approximately 40 loci 
associated with CD, an estimate which has since been increased to 43 loci (Withoff et al 
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2016). The estimate of 40 loci was published by Trynka et al in 2012, who evaluated 
single nucleotide polymorphisms (SNPs) in 183 non-HLA loci. Thirty-six non-HLA loci 
were and four HLA loci were determined to have statistically significant association with 
CD (p < 5.0 x 10-8), and 13 were considered to be CD risk loci. The non-HLA genes 
included transcription factors and cytokine target genes activated in the T helper cell 1 
(TH1) differentiation pathway. Trynka et al fine-mapped the loci to identify a set of SNPs 
that might be used in place of haplotypes to assess risk of CD. Other studies evaluated of 
13 autoimmune diseases in addition to CD, seeking to identify loci common to multiple 
diseases in addition to associations between genetic loci and individual diseases (Ricano-
Ponce et al 2015). Ricano-Ponce et al attributed the associations between uncommon 
SNPs and CD in GWAS to sample size, although the authors admitted that the functions 
of the SNPs were unknown. Other authors have identified CD-associated SNPs in 
regulatory regions of the genome (Kumar et al 2012; Withoff et al 2016). Withoff et al 
proposed that context-specific expression of early immune response events in CD could 
be controlled by noncoding RNAs, and noted the superficial treatment of regulatory 
elements in evaluations of genetic determinants of CD. These authors cited studies that 
identified regulatory genes associated with CD that controlled immune cell differentiation 
in mice, such as Bach2 on the long arm of human chromosome 6 (Dubois et al 2010). 
The suite of physiological changes that accompanies CD, such as changes in the passive 
barrier and shifts of T helper cell populations, are probably the result of altered gene 
expression rather than gene product variants. 
Celiac disease has been diagnosed with increasing frequency worldwide (Catassi 
and Fasano 2008; Gujral et al 2012). Additional evidence of the genotypes HLA-DQ2 and 
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-DQ8 as predisposing factors in CD was inferred by Sollid (2017) after an examination of 
conserved loci within CD-associated haplotypes in different human populations. The 
major predisposing HLA genotypes, HLA-DQ2 and -DQ8, are present in the human 
population at frequencies that differ by geographic region. In Japanese and Philippine 
populations, the frequency of HLA-DQ2 is five percent or less, while German, Greek, 
Italian, Ethiopian, and the United States populations exhibit a frequency of up to 20% 
(Gujral et al 2012). The secondary genotype HLA-DQ8 is found most frequently in South 
American populations. GWAS have identified genetic variants that may confer higher 
risk to specific populations, such as a SNP mapped to the long arm of human 
chromosome 6 (Ricano-Ponce et al 2015). This SNP is encoded in the human Tumor 
Necrosis Factor (TNF) gene at position 6q23.3, and has been proposed to increase risk of 
CD in populations of African descent (Trynka et al 2012; Ricano-Ponce et al 2015). 
These genotypes are not recent mutations; the most predominant HLA genotype 
conferring susceptibility to CD has been present in the human population for many 
generations. The HLA-DQ2 genotype was identified in an approximately 1800-year-old 
inhumation find. Pathological examination determined that the 18 to 20-year-old woman 
from the modern Tuscany region had suffered from chronic malnutrition despite obvious 
socioeconomic security. The authors proposed that she was a possible CD patient 
(Gasbarrini et al 2012), although confirmation of diagnosis was impossible given the lack 
of soft tissues available to conduct a biopsy.  
The CDC calculation for the prevalence of a disease ([the number of cases 
identified in a timeframe / the number in the total population] x 100) is expressed as 
percentage. Gujral et al (2012) estimated that the genetic risk of developing CD to be 
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between 30 and 50%. Studies investigating human diseases have shown that the common 
disease, common variant (CDCV) model does not explain the variance of disease risk for 
different types of cancers (Moore and Williams 2009); therefore, it is reasonable to 
assume that risk factors beyond the HLA-DQ genotype underlying CD are largely 
unknown. In fact, evaluations of SNPs associated with any human disease have indicated 
that only rarely do the odds ratios of individual SNPs meet or exceed 1.5 (Moore and 
Williams 2009). Genome-wide association studies highlight how unaccounted genetic 
interactions and nonlinear relationships between genetic variants and traits lower 
heritability estimates (Zuk et al 2012). More investigation into human genetic 
interactions, including genotype-by-environment interactions (GEI), and revisions to 
current quantitative models are needed to establish the true genetic effect on CD 
pathogenesis. Without this basic knowledge, manipulation of the 17 Gbp wheat genome 
(Brenchley et al 2012) to address the needs of celiac patients will be difficult at best. 
The immune response underlies celiac disease pathology 
The interactions between antigen-presenting cells (APCs) and T helper (TH) cells 
direct the immune pathways that control development of CD, other autoimmune diseases, 
parasite infection, and allergies (Abbas et al 2007; Nemoto and Watanabe 2012; Abbas et 
al 2015). As described by Abbas et al (2007, 2015), the lives of TH cells begin in the bone 
marrow. Marrow-derived naïve TH cells complete their maturation process in the thymus 
and migrate to the lymph nodes to undergo two selection steps. T helper cells that express 
the correct T cell receptors (TCR) that recognize HLA with acceptable affinity, or 
restriction, are positively selected for continued maturation. This calibration, or HLA 
restriction, is necessary for naïve TH cells to discriminate between self- and nonself 
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molecules before participating in a subsequent immune response. Mature naïve TH cells 
that express the coreceptor CD4 later enter the TH cell pathways when nonself molecules 
are detected by APCs that live in the protective epithelial barrier of the skin or digestive 
tract. (Please note that the abbreviation ‘CD’ means ‘Cluster of Differentiation’ in the 
context of conventional nomenclature for cell phenotyping, and refer to the Glossary for 
more information. See also Abcam 2017). The nonself molecules recognized by APCs 
stimulate a specific immune reaction, and are called antigens. Antigenic molecules are 
engulfed by APCs, which process the antigens into fragments through enzymatic 
degradation in acidic endosomes and deposit the fragments on cell surface receptors such 
as the HLA. Protein fragments are specifically displayed on the HLA. Some antigen-
bearing APCs express a receptor that detects cytokines released from lymph nodes, then 
detach from their home tissue to migrate into a nearby node. In the lymph node, naïve 
CD4+ TH cells are activated to recognize the antigen. Other APCs remain in place and 
initiate the innate immune response by expressing cytokines that induce local 
inflammation. Cytokine markers of inflammation, such as interleukin 12 (IL-12) and 
interferon γ (IFN-γ), are released by APCs that recruit activated CD4+ cells to the site 
where the antigen was encountered. The CD4+ TH cells, now trained to recognize the 
antigen, follow the chemical gradient to the site of inflammation. Interaction with the 
stationary APCs displaying the HLA-antigen complex occurs via the TH cells’ TCRs and 
CD4 coreceptors. The adaptive immune response commences following commitment of 
the CD4+ cells to one of the TH pathways.  
 The type of nonself antigen dictates the development of adaptive TH cell 
populations (Nemoto and Watanabe 2012; Abbas et al 2015). The first two development 
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pathways described were the TH1 and TH2 (Abbas et al 2007), both of which have been 
described in the context of CD, wheat allergy, and other wheat sensitivities. As described 
by Abbas et al (2015), each TH pathway and cell population is characterized by the signal 
cascade leading to epigenetic modifications of different cytokine gene loci. Occasionally 
some variations in cytokine expression are observed, or a conversion between TH 
pathways may occur early in the immune response as the host immune system determines 
the best defensive action. These factors can complicate the classification of a TH cell 
population. Once the TH cell population has committed to a pathway, however, the 
epigenetic modifications of the chromatin and histones surrounding the cytokine gene 
promoter regions serve to amplify the chosen pathway through a positive feedback loop 
while simultaneously antagonizing the events of alternate TH pathways. The upregulation 
of inflammatory cytokine production has two consequences: 1) activated CD4+ TH cells 
and other leukocytes are recruited to the site of antigen encounter, and 2) damage of the 
surrounding tissues ensues. 
The activated leukocyte populations and mechanisms of tissue damage differ 
between the TH pathways. In the TH1 pathway, which is followed when APCs encounter 
intracellular pathogens such as bacteria or viruses, the APCs process protein antigens for 
display on HLA. The APCs release cytokines to indicate the type of pathogen 
encountered. Of these cytokines, IL-12 is most commonly expressed in the early innate 
immune response. This interleukin antagonizes the early signal events of other TH 
pathways and induces differentiation of naïve CD4+ T cells into TH1 cells. Other 
cytokines that may initiate the TH1 pathway include IL-8 and IFN-γ (Abbas et al 2015). 
Expression of IL-12 is notably absent from the CD immune response, which indicates 
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that alternative cytokines mediate the response (Bethune and Khosla 2008). Decreased 
expression of IL-12 in CD patients probably indicates that the adaptive immune response 
recognizes gliadin as neither microbial nor viral in origin, and therefore does not merit 
activation of the leukocytes charged with destroying these pathogens. The textbook TH1 
pathway continues when CD4+ T leukocytes interact with antigen-HLA complexes 
displayed by APCs. Recognition of the antigen is restricted by HLA and the coreceptor 
CD4 in the presence of the expressed cytokines. Conversion of the CD4+ T cells to TH1 
cells commences with expression of the transcriptional factor T-bet. The conversion 
process is protected by the initiating cytokine (e.g., IL-12) until epigenetic commitment 
to the TH1 cell pathway is complete. The committed TH1 cells then recruit 
macrophages—the ‘help’ to which TH refers—to the site of antigen encounter by 
inducing progressive inflammation. These events compose the delayed-type 
hypersensitive response whereby progressive inflammation is achieved through release of 
reactive oxygen species (ROS), nitric oxide (NO), and enzymatic degradation. Production 
of IgG characterizes the humoral response of the TH1 pathway (Abbas et al 2015). 
The TH2 pathway diverges from the TH1 pathway at the antigen-HLA presentation 
step. CD4+ T leukocytes encounter APCs presenting antigens of an intercellular 
pathogen. Recognition of the antigen is restricted by HLA and the coreceptor CD4 in the 
presence of IL-4 produced from an as-yet unidentified exogenous source (Abbas et al 
2015; Yamanishi and Karasuyama 2016). Conversion of the CD4+ T cells to TH2 cells 
commences with expression of the transcriptional factors STAT-6 and GATA-3. The 
activated CD4+ T cells express IL-4, IL-5, and IL-13 themselves (Abbas et al 2015). 
These cytokines initiate and amplify anti-parasite and allergy signal cascades, 
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culminating in the production of IgE by antibody-producing leukocytes and the activation 
of three granular leukocyte cell types: basophils, mast cells, and eosinophils. Activated 
basophils can produce IL-4 that drives TH2 differentiation and stimulate Ig production 
from antibody-producing leukocytes (Yamanishi and Karasuyama 2016). Basophils and 
mast cells have surface receptors that enable them to detect IgE bound to the surface of a 
parasite or allergen. Recognition of IgE initiates a signal cascade that causes the 
basophils and mast cells to rupture, or degranulate, and release inflammatory factors such 
as histamines that cause immediate damage to surrounding tissues. The immediate 
reaction is insufficient to kill a multicellular parasite, but anticoagulants and vasodilators 
increase fluid movement through the inflamed site and act to physically remove the 
invader or allergen from the tissue. Eosinophils are recruited by the TH2 cell-expressed 
cytokines to degranulate in a late-phase reaction. Peroxidases, nucleases, and enzymes 
released during eosinophil degranulation inflict oxidative stress on the invader and 
surrounding host tissues. Upregulation of the passive barrier defenses helps ensure the 
invader cannot cross the protective epithelial layer of the gastrointestinal tract. The 
bolstered passive barrier activated by the TH2 pathway differs from the progressive 
breakdown of the epithelial barrier described in CD. Expression of IgE characterizes the 
humoral response of the TH2 pathway (Abbas et al 2007; 2015). 
The TH pathway events that contribute to the clinical presentation of CD were 
examined in a study by Black et al (2002). These authors studied transgenic “humanized” 
mouse models that implicated the HLA-DQ genotype in the celiac response to wheat. 
While intestinal cross-sections revealed no gross histological changes in the immunized -
DQ8 mice, these subjects exhibited a malnourished phenotype and a potential T cell 
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response to a wheat-based diet relative to rice-fed controls. Intestine-derived T cells were 
used in proliferation assays that implicated CD4+ HLA-DQ-restricted T cells. Black et al 
observed that the cytokines upregulated in response to the gluten diet included IL-6, IL-
10, and transforming growth factor β (TGF-β). Interleukin-6 can either induce or repress 
inflammatory processes (Abbas et al 2007; Scheller et al 2011), and is the primary 
cytokine to which certain leukocytes respond as the innate immune response shifts to 
either an adaptive or regulatory response (Scheller et al 2011). IL-10 inhibits the 
expression of IL-12 and interferon gamma (IFG-γ). This downregulates CD4+ T cell 
differentiation in the TH1 pathway and inhibits expression of HLA on the surface of APC. 
IL-10 itself is an anti-inflammatory cytokine, and deactivates participant cells of the 
adaptive immune response (Abbas et al 2007). TGF-β has both inflammatory and anti-
inflammatory functions. Like IL-10, TFG-β also deactivates participant cells of the 
adaptive immune response. This cytokine induces tissue repair mechanisms and IgA 
expression (Abbas et al 2007). Black et al (2002) interpreted the observed upregulation of 
IL-6, IL-10, and TGF-β as a regulatory profile that differs from the human CD 
inflammatory response. Humoral anti-gliadin IgG was expressed by the immunized -DQ8 
mice, but not IgA—another difference between the transgenic mouse and human CD 
responses. The authors noted that natural peptides induced immune responses from the 
immunized mice as well as gliadin fragments deamidated by tissue transglutaminase. 
Black et al (2002) concluded that factors aside from HLA-DQ genotype probably 
contributed to manifestation of a CD response in humans, and proposed that commensal 
microbial populations or dietary conventions might contribute to the soft tissue damage 
observed in human celiac patients (Black et al 2002). Comparison of the events reported 
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by Black et al and the events of the textbook TH1 pathway illustrates how the variation in 
cytokine expression and downstream events can complicate classification of the immune 
response.  
A review by Bethune and Khosla (2008) discussed the roles of other cytokines 
and leukocyte populations in the development of CD. These authors proposed that 
upregulation of IL-15 was the result of an innate immune response triggered by the 12-
residue core peptide of gliadin. Bethune and Khosla cited studies that had identified a cell 
population acting in CD pathogenesis independently of the TH pathways: the 
intraepithelial lymphocytes (IELs), which are residents of gut-associated lymphoid tissue. 
Intraepithelial lymphocytes have been implicated in allergic and parasite responses 
(Yamanishi and Karasuyama 2016). These cells are able to independently recognize a 
repertoire of antigens, even in native state, and destroy nonself molecules while the 
adaptive immune response activates (Abbas et al 2007). Han et al (2013) examined the 
effect of oral gluten challenge on proliferation of circulating gluten-activated CD4+ T 
cells, and found a parallel increase in circulating T cells that expressed IEL phenotypes 
and TCRs that were reproducible with subsequent challenge. The authors observed cell 
surface markers on the IELs associated with tissue-specific migration to the 
gastrointestinal tract, although they admitted that gluten epitope recognition was probably 
mediated by CD4+ T leukocytes and not by IELs. Expression of IL-15 was not measured 
by Han et al (2013). In summary, CD pathogenesis is mediated by components of both 
innate and adaptive immune responses. The TH mechanisms that underlie CD 
pathogenesis demonstrate unique features that complicate precise classification of the TH 
pathway responsible for the CD immune response. Current understanding regarding 
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cytokine signaling and leukocyte participation in CD pathogenesis is incomplete. 
Celiac disease differs from other wheat sensitivities 
The symptoms of CD overlap with those described for other wheat sensitivities 
and gastrointestinal disorders, which often leads to some confusion over diagnosis and 
identification of the underlying cause of disease (Dewar and Ciclitira 2005; Freeman 
2008). Presentation of CD symptoms can differ between affected individuals. Early 
diagnosticians identified ‘the celiac affectation’ as a sporadic or a seasonal affliction, 
primarily of mature women (Arataeus the Cappadocian, via Adams 1856). Later 
physicians extended the patient demographic to include children (Gee 1888) and 
elucidated the connection between dietary components and disease (van Berge-
Henegouwen and Mulder 1993). Serological tests for humoral immunoglobulin markers 
may present false-positive diagnoses (Freeman 2015a), leaving intestinal endoscopy and 
duodenal biopsy as diagnostic standards for confirmation of CD (Dewar and Ciclitira 
2005; Atlas et al 2011; Freeman 2015a). Comorbidities include anemia, B12 deficiency, 
osteomalacea (softening of the bones), and other symptoms of malnutrition despite an 
adequate diet (Dewar and Ciclitira 2005). Advanced cases manifest extreme 
morphological changes in the colon. The characteristic features of advanced CD include 
truncated villi and hypoplasia of the crypts, which leads to fissuring of the mucosa 
(Dewar and Ciclitira 2005; Atlas et al 2011). Escalation to an autoimmune response is 
possible when an endogenous protein-crosslinking enzyme, transglutaminase 2, interacts 
with gliadin peptides presented on the surface of cells beyond the epithelial barrier of the 
intestinal mucosa (Tonutti and Bizzaro 2014). The foremost difference between CD and 
other wheat sensitivities is that nearly all CD patients have one of two genotypes that 
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have confirmed correlation with CD: the HLA genetic variants HLA-DQ2 and -DQ8 
(Sollid and Thorsby 1993; Gujral et al 2012; Sollid 2017). The association between CD 
and the HLA haplotype DR3 was first described in the 1970s (Sollid 2017) and was later 
traced to the DQA1and DQB1 genes frequently associated with this haplotype (Sollid et 
al 1989). The relationship between HLA and CD was discussed in greater detail in the 
“Incidence of celiac disease and causal factors” section. 
 Non-celiac gluten sensitivity (NCGS) patients may also carry the CD-susceptible 
HLA-DQ2 or -DQ8 genotypes, but at lower frequency than that observed in celiac 
patients. Sapone et al (2010) reported that four of 11 subjects diagnosed with NCGS had 
the HLA-DQ2 or -DQ8 genotype as compared to 12 of 13 CD patients. A larger study 
conducted by Carroccio et al (2012) reported that just over half of the patients diagnosed 
with wheat sensitivity (146/276) carried the HLA-DQ2 or -DQ8 genotypes, as compared 
to 100% of the CD patients. The Carroccio 2012 study noted that a moderate proportion 
of the wheat-sensitive patients tested positive for antigliadin IgA and IgG (40-55%) as 
compared to CD patients (72-78%). The authors performed a retrospective study and 
defined two NCGS groups: 1) non-allergic wheat sensitivity, with no reaction to other 
foods; and 2) allergic-type wheat sensitivity, with concurrent sensitivities to other foods, 
such as dairy and eggs (Carroccio et al 2012). They identified distinct serological markers 
(i.e., serum IgG and IgA) against gliadin and increased basophil activation in non-allergic 
wheat sensitivity sufferers. The authors also observed eosinophil infiltration of the colon 
and duodenum mucosa, events that serve as histological markers of inflammation, in the 
NCGS groups. This differs from the celiac response, where CD4+ T leukocytes are 
activated in the TH1 pathway after encountering gliadin peptides in complex with HLA 
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expressed on the surface of APCs. The TH2 immune cell pathway followed in NCGS 
starts when circulating eosinophils encounter gradients of chemotactic cytokines released 
by distressed cells or leukotrienes released by white blood cells. The eosinophils follow 
the signal gradient to sites of inflammation, infiltrate the tissue, and participate in the TH2 
pathway of the active immune response. The TH2 pathway is typically involved in 
parasite defense but can also activate in immediate hypersensitivity reactions, which may 
be identified by serological tests for humoral IgE (Abbas et al 2014).  
Carroccio et al (2012) reported that none of the allergy-type wheat sensitivity 
patients evaluated in their study expressed IgE in response to the allergen challenge tests. 
The authors did not report observations of mast cells, which differentiate within tissue, 
bind IgE, and activate in allergic responses to secrete inflammatory cytokines (Abbas et 
al 2015), in their histological specimens. Mast cells and eosinophils are easily 
distinguished by morphology, despite each cell type possessing a granular cytoplasm. 
Eosinophils have a two-lobed nucleus while mast cells have a round or ovoid nucleus 
(Kindt et al 2007). The eosin staining procedure used by Carroccio et al (2012) would 
have clearly differentiated the two cell types. Reporting mast cell activation would have 
improved the authors’ discrimination between the allergic-type wheat sensitivity and true 
allergy. Carroccio et al (2017) later established that NCGS, like CD, is a lifelong 
condition with symptoms differing among those who experience the condition. 
The NCGS pathway diverges from the both the allergy and celiac pathways 
through the upregulation of the innate immune response Toll-like Receptor-2 (TLR-2), 
while CD events diverge from NCGS through upregulation of the adaptive immune 
response signal IL-17 (Sapone et al 2010; 2011) and the master regulatory pathway of the 
37 
 
regulatory T cell (Treg) population, forkhead box P3 (FOXP3; Sapone et al 2011).  
Celiac disease differs from allergies and food intolerances  
Celiac disease is neither an allergy nor an intolerance. Originally applied to only 
allergies, the Gell and Coombs classification scheme (1968) differentiates four types of 
hypersensitive responses: Type I, humoral IgE-mediated hypersensitivity, with combined 
interactions of the humoral and granular cell responses; Type II, humoral IgG- or IgM-
mediated cytotoxic hypersensitivity; Type III, humoral immune complex-mediated 
hypersensitivity; and Type IV, T lymphocyte-mediated hypersensitivity (Kindt et al 
2007; Busse 2013). The Gell-Coombs classification scheme has more recently been used 
to categorize non-allergic immune responses that result in disease (Rajan 2003; Busse 
2013).  
‘Classical’ allergies are categorized as Type I hypersensitive responses (Janeway 
et al 2001; Busse 2013). A food allergy is a non-typical, inappropriate, adaptive immune 
response to one or more components of a food that gives rise to inflammation of the skin 
or mucous membranes, such as those of the respiratory or gastrointestinal tracts. An 
extreme allergic response (hypersensitive response) may result in anaphylaxis, a life-
threatening systemic condition that requires medical intervention (Asthma and Allergy 
Foundation of America 2017; Mayo Clinic 2017). The CD4+ T leukocyte populations 
differentiated to act in either allergic or celiac responses reactions are derived from the 
same population of naïve CD4+ T leukocytes (Abbas et al 2014). Differentiation of the 
subpopulations of CD4+ T leukocytes hinges on the type of antigen presented to them and 
the intercellular signals (cytokines) secreted by other immune cell populations. Type I 
hypersensitivity/allergy is therefore associated with a TH2 cell response. In summary, 
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though the same population of naïve immune cells is recruited in both CD and the 
allergic response, divergent signal pathways lead to the differentiation of activated 
immune cell populations and associated humoral markers specific to each condition.  
Palosuo et al (2001) reported a humoral IgE response to purified wheat ω-gliadin 
administered by skin prick in children who exhibited wheat allergy symptoms. Battais et 
al (2005) reported a detailed analysis of allergenic epitopes present in gliadin sequences. 
These authors found distinct differences in the allergenic motifs, expressed in the ω-
gliadins, versus the celiac epitopes expressed in all gliadins. They concluded that wheat 
allergy and CD did not share a common trigger, despite the proximity of the epitopes 
within the protein structure. The authors also proposed that variation in pathology 
manifestation arose from the conformational presentation of the immunogenic motif to 
the immune system. This could reflect the unique genetic and environmental factors that 
influence the interaction between human immune cells and gliadin fragments. Tatham 
and Shewry (2008) reviewed literature describing various immunogenic factors present in 
cereals and concluded that gluten components are one of several types of immunogenic 
proteins in wheat and related species. Some α-amylase inhibitors, lipid transfer proteins, 
peroxidases, thioredoxins, and wheat germ agglutinins have also been implicated in 
human immune reactions to cereals (Tatham and Shewry 2008). These authors also noted 
that post-translational modifications of proteins (e.g., glycosylation) can influence 
immunogenic potential in susceptible people. Glycosylation creates a larger target for the 
immune system to ‘see’. The additional carbohydrate moiety can improve specificity of 
antibody recognition, and can stabilize proteins against proteolysis through the 26S 
proteasome and downstream enzymes (Rudd et al 2001).  
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Carroccio et al (2012) suggested the possibility of a non-IgE mediated allergic 
response as the cause of allergy-type wheat sensitivities. Non-IgE mediated food allergies 
were the subject of a 2015 review by Nowak-Wegrzyn et al, who determined that this 
class of gastrointestinal tract syndromes was poorly characterized due to the lack of 
serological diagnostic criteria. These authors cited only a few studies in which elevated 
levels inflammatory cytokines were observed in patients, and noted that typical markers 
of active immune responses to food allergens (i.e., IgA, IgG, and IgE) were largely 
absent from the patient cohorts.  
Food intolerances arise when insufficient or deficient enzyme activity causes 
illness in an individual after consuming a specific foodstuff. A well-described example of 
food intolerance, favism is an X-linked deficiency of glucose-6-phosphate dehydrogenase 
(G6PD), an important enzyme in the pentose phosphate pathway. Mehta (1994) reported 
G6PD-deficiency prevalence to fall between 5 and 25% worldwide. More-recent reports 
indicate that local prevalence for G6PD-deficiency approaches 40% in some Middle 
Eastern countries (Alabdulaali et al 2010; Doss et al 2016). These rates exceed the rate of 
celiac disease prevalence. Exposure to certain compounds—including the seed storage 
proteins in fava beans—leads to accumulation of free radicals within and subsequent 
oxidative damage to red blood cells in susceptible people. Extreme hemolysis can lead to 
anemia and death (Mehta 1994). Inhalation of fava pollen is also reported to induce a 
crisis event, although the mechanism of reaction differs from inhaled allergens (Mager et 
al 1969; Perlman 1969) and is quite rare, if reports are reliable (Simoons 1998).  
Favism parallels CD in that exposure to seed storage proteins induces illness and 
that genetic predisposition does not guarantee illness will develop. The cell-mediated 
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immune response is not activated in favism, as in allergies and CD, with pathology 
occurring almost entirely within the vasculature (Mehta 1994). This contrasts with the 
gastrointestinal lesions characteristic of CD. 
Finally, concomitant factors can aggravate wheat intolerance and allergy. Aspirin 
use, flour conditioning enzymes, and food preparation practices have been implicated as 
aggravating factors in the literature (Tatham and Shewry 2008). This does not appear to 
be the case with CD, where the distinctive properties of the gliadin protein are 
responsible for activation of the immune response. Aggregation of the water-insoluble 
monomers, transport across the epithelial barrier of the intestinal mucosa, and 
deamidation-conversion of glutamine to glutamic acid lead to association of gliadin with 
HLA (Bethune and Khosla 2008).  
MISCONCEPTIONS REGARDING GLUTEN AND HUMAN DISEASES 
Advances in diagnostic methods have led to increased rates of CD diagnosis. This 
in turn has promoted public awareness of CD, and has introduced beneficial changes in 
the lives of celiac patients by expanding the range of gluten-free products commercially 
available. Unfortunately, misunderstanding of wheat breeding targets has led to 
misconceptions regarding the role of plant breeding methods in the increasing prevalence 
of CD diagnoses. Selection for height, yield, and gluten strength have been maligned as 
sources of “mutant” or “new” proteins. These “toxic” proteins have been proposed to be 
the cause of autoimmune, inflammatory, and neurological conditions in an increasing 
proportion of the population. The following sections briefly discuss some selected claims 
and the literature (or lack thereof) that supports them.  
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Historical plant breeding targets 
Early efforts to organize plant breeding focused on competent inquiry through 
identification/cataloging of observations, followed by formal assessment backed by 
theory—the first stages of any scientific discipline (National Research Council 2002). 
This can be seen in Worzella’s (1941) outline of what he considered the most important 
goals for plant breeding in the 20th century. He advocated plant breeders to 1) compile a 
comprehensive, organized inventory of the extant wheats and their traits; 2) analyze those 
traits, to develop a plan for development of improved varieties; 3) develop specific tests 
to systematically analyze the inventoried wheat traits; 4) search for new and superior 
germplasm for use in varietal improvement; and 5) promote fundamental research into 
the behavior of the tested traits. Note the implication in Worzella’s outline: plant breeders 
must adopt a collaborative approach in formulating a long-term strategy to crop 
improvement through multiple approaches that link theory to empirical investigation. 
Over 75 years later, the modern plant breeding community has successfully integrated the 
first three goals into their programs and has more freedom to focus on the last two goals 
than their predecessors.  
Wheat breeding targets can be broadly classified as either performance or quality 
traits. Performance in the field, including disease resistance, yield, abiotic stress 
resistance, and pest resistance are often cited as plant breeding objectives. These foci aim 
to reduce production inputs, such as application of chemical protectants, and to secure 
food production in the face of climate change and production area expansion, while 
maintaining soil and water quality (Reynolds and Borlaug 2006; Mergoum et al 2009; 
Carter et al 2015). Various improvements have been made through conventional breeding 
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activities, with the introgression of the semi-dwarf trait performed by Inazuka and Vogel 
and rust resistance by McFadden, cited as famous examples (Clark and Ausemus 1928; 
Reynolds and Borlaug 2006; Schindler 2016). The emphasis on performance has been 
driven by the efforts of the Consultative Group for International Agricultural Research 
(CGIAR) and its member commodity research centers, such as the International Maize 
and Wheat Improvement Center (CIMMYT, Mexico), with the intent to make formerly 
import-dependent countries self-sufficient in the production of staple crops like wheat. 
Performance quality also includes seed quality (Wrigley 2017). The storability and 
germinability of the seed are critical to establish uniform stands under challenging 
production conditions, such as deep planting to compensate for low soil surface moisture. 
High-quality seed needs adequate nutritional reserves to drive normal seedling 
development, including reserves such as starch and protein.  
The focus on wheat quality goes further than simple protein accumulation 
(Deckard et al 1987; Graham et al 1999; Mergoum et al 2009). The overall nutritional 
profile of a crop includes the quantity and type of starch, oil or lipid content, mineral and 
vitamin composition, the quantity and type of antimetabolites, and protein amino acid 
content (Wrigley 2017).  
The general composition of an average intact caryopsis is approximately 85% 
carbohydrate, with a range of starch between 60-80% (Slade et al 2012; Uthayakumaran 
and Wrigley 2017). This means that starch granule composition has great impact on the 
milling and end-use properties of wheat, and therefore is a reasonable breeding target. 
Milling efficiency and consistency are economically important to commercial mills 
(Evers and Millar 2002; Wrigley 2017), which blend flours from different sources to 
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achieve a grist of specific rheological properties (Mergoum et al 2009). Lipids can have 
an adverse effect on loaf volume, but in proper proportion can maintain gas bubbles 
introduced into machined dough and improve crumb of the finished loaf (Gan et al 1995; 
Goesaert 2005; Uthayakumaran and Wrigley 2017). Mineral and vitamin deposition is 
most closely associated with the germ and bran. Phytate also associates with the germ 
and bran, and can reduce bioavailability of iron and calcium although it is a source of 
phosphorus (Belitz et al 2004; Alldrick 2017; Uthayakumaran and Wrigley 2017). Protein 
quality has been a longtime breeding target. Assessment of protein quality is based on 
amino acid content, particularly lysine and sulfur-containing amino acids (Belitz et al 
2004; Shewry et al 2009), and its strength under extension during machining and baking 
(Hoseney 1986). Baking quality is mostly assessed and demanded by consumers, with 
loaf volume touted as a primary quality parameter.  
Progress in wheat quality improvement has largely been the product of captured 
genetic gain and attempted moderation of GEI through production management practices 
(Wrigley 2017). Wheat breeders apply standardized assessments of quality, such as those 
curated by the American Association of Cereal Chemists (AACC International, 
aaccnet.org) to assess their success in capturing genetic gains and inform subsequent 
selections.  
As noted by Balyan et al (2013), genetic improvement of wheat protein content is 
constrained by yield. The well-described inverse relationship between protein content and 
yield has been the bane of wheat breeding efforts to improve both yield and end-use 
quality (Deckard et al 1987; Graham et al 1999), as has the strong GEIs that influence 
protein accumulation (Shewry et al 2009). Selections made on yield or protein 
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accumulation alone are ineffective when the magnitude of the genotypic response to the 
environment is unpredictable or nonlinear (Graham et al 1999; Hallauer and Carena 
2009). Furthermore, plant breeding selections are often made on several traits 
simultaneously using an index that may incorporate the summed ranks of the traits under 
selection or heritability estimates (Hallauer and Carena 2009). This means that changes in 
the mean of one trait will be slow if the summed ranks of the other traits are sufficient to 
warrant selection of a cultivar for advancement to the next generation.  
Genetic engineering versus transgenic introgression and selection 
Desired traits can be conventionally introgressed from wild species to cultivars 
through hybridization of genetically-compatible species. The wheat gene pool includes 
the A genome diploids (2n = 2x = 14) Triticum urartu (Au) and T. monococcum ssp. 
monococcum or einkorn (Ab); the BA genome tetraploids (2n = 4x = 28) T. turgidum ssp. 
dicoccum or cultivated emmer, T. turgidum ssp. dicoccoides or wild emmer, T. turgidum 
ssp. durum, T. turgidum ssp. polonicum or mirabile wheat; and GA genome tetraploid T. 
turgidum ssp. timopheevii. The hexaploid (2n = 6x = 42) wheats include the ABD 
genome group of T. aestivum ssp. aestivum or common wheat, T. aestivum ssp. spelta or 
spelt, T. aestivum ssp. compactum or club wheat, T. aestivum ssp. sphaerococcum or shot 
wheat, and the ABG genome T. zhukovskyi or Zhukovsky’s wheat (WGRC, www.k-
state.edu/wgrc). The D genome originates from the Aegilops genus, with Ae. tauschii or 
Tausch’s goat grass (2n = 2x = 14) as the most likely donor (Vasil and Vasil 1999). This 
non-exhaustive list indicates the complexity of the wheat gene pool. When a desired trait 
is missing from the cultivated gene pool, the wild wheat relatives often can be used as a 
source for the missing trait (Reynolds and Borlaug 2006; Mergoum et al 2009; 
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Ogbonnaya et al 2013).  
Transgenic wheat development has been fraught with challenges, some biological 
(e.g., off-target effects and transgene instability) and some political (Vasil and Vasil 
1999). Mutant breeding with or without concurrent doubled haploid (DH) production is 
another option. Transgenic cultivars are strictly defined as those that have received one or 
more genes through a transfer agent such as Agrobacterium or biolistic methods. The 
worldwide Mutant Variety Database (MVD), jointly maintained by the Foreign 
Agriculture Office (FAO) and International Atomic Energy Agency (IAEA), lists 225 
hexaploid wheat varieties that have been voluntarily registered (mvd.iaea.org). The 
majority originate from China (164 varieties). Only four mutant varieties have been 
developed in the U.S. This registration is not required, so the MVD is not a 
comprehensive list. The improved traits listed for the registered U.S. varieties and others 
in the scientific literature include early maturity, lodging resistance, disease resistance, 
and imidazolinone tolerance (mvd.iaea.org; Maluszynski et al 1995). No comments 
regarding quality traits are included in the MVD. Transgenic and mutation breeding 
methods are often used with wheat only if conventional breeding practices have not 
successfully transferred a trait (Mergoum et al 2009).  
Dwarfing genes and protein accumulation 
Some popular press concerning introgression of the semi dwarf trait into bread 
wheat would have readers believe that dwarfing genes have somehow led to changes in 
gluten and nutritional value. Introgression of dwarfing genes into standard height 
cultivars, while cited as a source of increased immunogenic protein, is unlikely to have 
caused a change in ‘modern’ wheat relative to legacy cultivars. Cutler (1919) wrote a 
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short piece describing his work with Canadian wheat germplasm, during which he 
observed fully-dwarf ‘Marquis’ wheat variants in a field plot. He noted the height (~23 
cm) was strikingly shorter than the standard height (~100 cm). Cutler conducted an 
experiment in 1913 in which he selected 200 heads from “normal” plants to plant head 
rows of 20 individuals each. His assessment of the natural variation within ‘Marquis’ was 
represented by a range of phenotypes that included those that differed for height and 
spike characteristics. Subsequent selections made between 1915 and 1916 demonstrated 
Mendelian segregation for height. Cutler noted that the pedigree of ‘Marquis’ (‘Hard Red 
Calcutta’/‘Red Fife’) contained Indian cultivars, and he posited that the dwarfing trait 
was either a characteristic of Indian wheats or perhaps a result of a natural cross in the 
experiment block. If Vogel’s introgression of ‘Daruma’ dwarfing genes into North 
American germplasm (Reynolds and Borlaug 2006; Lumpkin 2015) caused an increase of 
immunogenic protein, comparison of unselected ‘Marquis’ to ‘Norin-10’ and 
‘Akakomugi’ descendants should prove enlightening.  
The various dwarfing genes induce changes in physiology and morphology 
through different mechanisms. Only a handful of reduced height (Rht) genes have been 
deployed on a commercial scale. ‘Norin-10’-derived Rht1 and Rht2, prevalent in North 
American germplasm, are recessive genes located on chromosomes 4A and 4D, 
respectively (Gale and Marshall 1976). These dwarfing genes mediate the elongation of 
cells in vegetative, but not reproductive, tissues in response to GA1 (Flintham et al 1997; 
Gale and Youssefian 1985). Developing caryopsis tissues take up a different form of 
gibberellic acid, GA54 (Gale and Youssefian 1985). Rht1 and Rht2 are not limited to the 
North American germplasm, as they were introgressed into European cultivars in the 
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mid-20th century and were distributed worldwide via CIMMYT breeding programs (Gale 
and Youssefian 1985; Borojevic and Borojevic 2005). ‘Akakomugi’-derived Rht8, the 
most common dwarfing gene in Europe, confers photoperiod insensitivity (Gale and 
Youssefian 1985; Borojevic and Borojevic 2005). Rht8 is located on the short arm of 
chromosome 2D (Worland et al 1998). Rht8 was introgressed into Italian wheats as early 
as 1918 and distributed for production in southern Europe during the early 20th century 
(Worland et al 1998; Borojevic and Borojevic 2005). Increased grain yields in semi-
dwarf cultivars arises from a larger number of tillers and reduced floret abortion.  
Gibberellic acid-insensitive dwarfing genes have been implicated in slight 
reductions in wheat test weight and protein content (Gale and Youssefian 1985). In their 
1998 review, Gent and Kiyomoto noted that kernel size and protein correlate with plant 
height. These authors speculated that the increased tiller number of semi- and fully-dwarf 
plants led to competition for photosynthates and nitrogen among the spikes. Flintham et 
al (1997) observed that expression of the dwarf phenotype depended on the genetic 
background into which it was introduced. Cultivars carrying these genes tended to 
respond more than their standard height counterparts to abiotic stress factors. The 
cumulative effect of dwarfing may not affect protein or nutritional value, but could result 
in altered stability for other traits.  
Older cultivars are “healthier” than new cultivars of wheat 
Reports of immunogenic potential in contemporary and legacy wheat cultivars 
offer a mixed view on the impact of plant breeding as it influenced durum and bread 
wheat traits (Molberg et al 2005; Gregorini et al 2009; Pizzuti et al 2009; van den Broeck 
et al 2010; Colomba and Gregorini 2012; Kasarda 2013; Malalgoda 2016; Ribeiro et al 
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2016; de Santis et al 2017). The relative immunogenicity of gliadin proteins encoded by 
each genome is predicted to be D > A > B, with some genetic variation among the wheat 
species (Molberg et al 2005; Spaenij-Dekking et al 2005; van Herpen et al 2006). Spelt, a 
subspecies of common wheat, also expresses immunogenic gliadin. Kasarda and 
D’Ovidio (1999) evaluated the sequence of an α-gliadin gene from spelt, and found 
potential celiac epitopes within the protein sequence. These authors published the 
alignment with little comment beyond the 98.5% similarity with wheat gliadin over 285 
amino acid residues and an opinion on the immunogenicity of spelt gliadin. Van den 
Broeck et al (2010) observed no differences in mAb reactivity to gliadin between winter 
and spring cultivars. A concise summary of these works is that old and new wheat 
cultivars possess immunogenic gliadins, and the strength of immunogenicity is more 
dependent on the source genome. 
WHEAT HAS BEEN IMPLICATED IN NON-CELIAC HEALTH CONDITIONS 
Claims supported by evidence  
The Celiac Disease Foundation (2017) has compiled a list of comorbidities 
commonly reported with CD for which evidence has been collected. Anemia 
(approaching 69%), lymphocytic colitis (15-27%), thyroid disease (26%), and dermatitis 
herpetiformis (25%) are reported most often in celiac patients. Iron deficiency anemia has 
multiple causes, but in the case of CD is a symptom of chronic inflammation that 
damages the epithelial cells responsible for nutrient transport (Freeman 2015b). Case 
reports have noted that anemic celiac patients did not always complain of the classical 
celiac symptoms (Meseeha et al 2016). Carroccio et al (2017) noted that sufferers of non-
allergy type NCGS also demonstrated iron-deficiency anemia.  
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A growing body of literature discusses behavioral conditions concomitant with 
CD. Behavioral changes in response to chronic health conditions is a topic of widespread 
interest that exceeds the scope of this literature review. Studies that explicitly examine 
comorbidities with CD will be discussed briefly in an effort to address public 
misconceptions regarding the role of gluten on human health.  
Development of an eating disorder is a reasonably-expected consequence of a 
disease caused by food ingestion. A news summary published on BeyondCeliac.org 
(published 21 April 2017; accessed 30 June 2017) discussed a study conducted by Marild 
et al (2017) that found an increased risk of anorexia nervosa was associated with CD. 
Patients who focused excessively on diet developed disordered eating patterns at a higher 
rate than matched controls. The Marild study must not be considered a definitive work, as 
the cross-section experimental design was suitable for correlation analysis but not for 
causal factor analysis. Other authors have admitted that misdiagnosis of anorexia in place 
of CD is possible, since the physical symptoms appear similar between the two 
conditions (Leffler et al 2007; Golden and Park 2017). In fact, Dicke described anorexia 
as a symptom of CD (Dicke et al 1953). While the Marild study did not ascertain the 
precise relationship between CD and anorexia, the acumen of caregivers could explain 
one reason that celiac diagnosis is becoming more prevalent.  
A specific case of misdiagnosis was published by Yucel et al (2006) in which a 
patient admitted for psychological concerns surrounding eating was later diagnosed with 
CD. The 31-year-old woman’s counselor fortuitously chose a medical exam to address 
the patient’s report of gastrointestinal complaints. The authors explained that eating 
disorders, such as anorexia nervosa, can cause patients to report nausea, vomiting, and 
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abdominal pain similar to that reported by CD patients. Yucel et al (2006) recommended 
that caregivers pay special attention to nontypical eating patterns and single-nutrient 
deficiencies despite an otherwise-normal medical workup when making diagnoses. A 
review by Leffler et al (2007) determined that more investigation into the overlapping 
symptoms of eating and gastrointestinal disorders (specifically CD) was warranted. 
Golden and Park (2017) opined that testing all suspected anorexic patients for CD should 
be the subject of a future study. Addolorato et al (2008) discussed how chronic conditions 
like CD can cause anxiety and depression to develop.  
Genome-wide association studies have been conducted to search for genetic 
variation contributing to development of autoimmune diseases, including CD. Reports 
indicated that these diseases share associations with predisposing genetic variants that 
control regulation of immune response pathways, such as transcription factors and non-
coding RNAs (Kumar et al 2012; Withoff et al 2016). While associations do not imply 
causation, GWAS can identify candidate loci for fine mapping and expression studies. A 
review by Kumar et al (2012) cited the study conducted by Dubois et al (2010) in CD 
patients of European descent, which confirmed previously identified associations of 14 
loci with CD and identified 13 additional loci. Associated loci included HLA and non-
HLA loci Bach2 (a cytokine transcriptional enhancer), CCR4 (a cytokine receptor on 
CD4+ T leukocytes), THEMIS (a T cell selection-associated regulatory gene), and 
RUNX3 (a transcriptional regulator) genes. The Bach2 locus was also identified as one of 
several CD-associated loci in a GWAS conducted by Garner et al (2014), and may confer 
increased risk of developing autoimmune disease or allergy (NIH 2013; Roychoudhuri et 
al 2013). The gene product of Bach2 binds to a transcription factor locus and redirects the 
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inflammatory TH pathways to develop an induced regulatory T cell (iTreg) population that 
mitigates the adaptive immune response. Roychoudhuri et al (2013) cited studies that 
have implicated this locus in various autoimmune diseases. The CCR4, THEMIS, 
RUNX3, and other genes identified in GWAS have been implicated in T leukocyte 
development and function, highlighting the common origin of adaptive immune 
responses. Other CD- and autoimmune disease-associated genes may control the 
differentiation of other leukocyte populations (Kumar et al 2012). 
Claims unsupported by evidence 
Some popular press writers assert that rheumatoid arthritis, diabetes mellitus, 
Hashimoto’s thyroiditis, and other chronic inflammatory conditions are “associated with 
wheat,” and are triggered by the immunogenic epitopes that induce celiac disease. No 
evidence corroborates these claims (Brouns et al 2013), which has prompted researchers 
(Freed 1999; van Buul and Brouns 2014) to investigate other molecules such as lectins in 
wheat germ agglutinin (WGA). Claims that WGA could be a causal factor of celiac or 
other inflammatory diseases was reviewed by van Buul and Brouns (2014) and found to 
be largely unsubstantiated. Overlap between CD and other autoimmune disease 
pathologies can be explained by the common adaptive immune response pathways 
discussed in the previous section. Investigation into other reports of behavioral and other 
health conditions is ongoing. 
GLUTEN AND WHEAT HEALTH 
Discussions of gluten’s impact on human health often superficially address the 
physiological role of gluten in the life cycle of wheat, if at all. The body of plant 
physiology literature offers some explanations for the general utility of seed storage 
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proteins to cereals.  
Seed storage proteins of grains 
Two literature reviews (Shewry et al 1995; Dieckert and Dieckert 1976) regarding 
seed storage proteins in several major crops established the common features of seed 
storage proteins (i.e., tissue-specific expression and storage, nutritional status effects on 
synthesis, and polymorphism within protein families) before discussing their biochemical 
and physiological functions. Although understanding of the biological activity of storage 
proteins has advanced in recent years, it is not as complete as that of ‘housekeeping’ 
proteins such as enzymes and structural proteins.  
The biochemical classification of seed protein fractions was carried out by 
Osborne in the early 20th century (Osborne 1907). His classifications were based upon 
the principle of solvent-based extraction of these protein fractions, although more 
sophisticated methods to classify proteins have since been developed (Huebner and Bietz 
1993; Lookhart and Bean 1995; Mandal and Mandal 2000; Belitz et al 2004). The four 
Osborne fractions are albumins, globulins, glutelins, and prolamins (Mandal and Mandal 
2000; Belitz et al 2004; Shewry et al 2009).  
The albumin fraction comprises small water-soluble proteins primarily derived 
from the cytoplasm (Belitz et al 2004) with sedimentation coefficients ranging between 
1.6-2.0 S. Albumins are typically heterodimers linked by disulfide bonds (Pantoja-Uceda 
et al 2004a; Moreno et al 2005; Lehmann et al 2006) and are most abundant in dicots 
(Shewry and Pandya 1999). The albumin protein fraction includes several described 
allergens in tree nuts (Robotham et al 2002, 2005), peanuts (Arachis hypogaea L.; 
Lehmann et al 2006), and oilseeds (Bashir et al 1998; Pantoja-Uceda et al 2004a, 2004b; 
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Moreno et al 2005) that are grouped with the prolamin superfamily on the basis of 
structure. Other albumins that function as enzymes are not storage proteins. Of the 
cereals, rye and oats (Avena sativa) contain the greatest amounts of albumins (Belitz et al 
2004).  
Globulins are soluble in weak saline solutions, small (7 to 13 S), and the 
predominant storage proteins of legumes. Often isolated from the cytoplasm, some 
globulins are enzymes and not storage proteins. Wheat and oats contain small quantities 
of globulins called edestin and avenalin (Belitz et al 2004).  
Prolamins are the major seed storage protein family found in the dry single seed 
(properly termed caryopsis) of grasses. Soluble in alcohol, the prolamins form aggregates 
in protein bodies and contain proline- and glutamine-rich regions for which the protein 
family is named. Wheat and maize (Zea mays) accumulate the greatest amounts of 
prolamin of all the cereals (Belitz et al 2004). Dieckert and Dieckert (1976), who studied 
the seed storage proteins deposited in single-layered intracellular organelles in shepherd’s 
purse (Capsella bursa-pastoris L. Medik.), cotton (Gossypium hirsutum L.), peanut, and 
coconut (Cocos nucifera L.), proposed that a deletion of a major globulin locus may have 
occurred in an early monocot ancestor. Their comparisons between coconut and wheat 
endosperm storage protein bodies identified motifs conserved between the 
cocosin/concocosin (globulin) and glutelin (prolamin) protein families support their 
proposed evolutionary origin of prolamins. 
Glutelins were classified as insoluble by Osborne (Shewry et al 2009) but may be 
extracted using acidic or basic solutions (Mandal and Mandal 2000; Weiser 2007; 
Shewry et al 2009). Glutelins are a heterogenous class of storage proteins that can be 
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found in both monocot and dicot species (Mandal and Mandal 2000). Oats and rice 
contain the greatest amount of this protein class, relative to the other cereals (Belitz et al 
2004). Gluten is an umbrella term for the seed storage proteins that form complexes 
during water absorption and mixing of wheat flour dough. These proteins are the 
glutenins (wheat glutelins) and gliadins (wheat prolamins), found in an approximate 1:1 
ratio (Belitz et al 2004). 
The origin and fate of seed storage proteins in wheat 
Gliadins are evolutionarily conserved across the Triticum tribe. A bootstrapped 
consensus tree (Figure 2.1) illustrates the phylogenetic relationship of the gliadin protein 
and homologous proteins in 22 wheat and wheat-related species. Species relationships 
can be identified by the proportion of conserved versus non-conserved bases in a given 
sequence as DNA base substitution occurs at a generally consistent rate. The genes 
encoding the prolamin seed storage proteins are clustered in blocks on the homologous A, 
B, and D genomes. Researchers have reported varied numbers of genes (up to 150 α-, 11 
to 40 γ-, 5 to 18 ω-, and 3 δ-gliadin) and varied numbers of pseudogenes clustered at six 
major gliadin loci present on the A, B, and D genomes, but especially the Gli-D1 and Gli-
D2 groups (Okita et al 1985; Sumner-Smith et al 1985; Anderson and Greene 1997; 
Anderson et al 1997; Anderson et al 2009; Mitea et al 2010; Qi et al 2010; Anderson et al 
2012; Anderson et al 2013). Prolamins exhibit a high degree of conservation not only 
within the Triticum genera and closely-related cereals, but also in the wild wheat relatives 
with some paralogs in other grasses (Spaenij-Dekking et al 2005; Silano et al 2008; 
Gregorini et al 2009; Salentijn et al 2009; Xie et al 2010). Some gene groups are the 
result of genome duplication (Goryunova et al 2012; Rasheed et al 2014), but analyses of 
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gene number have been confounded by conversions to pseudogenes and by the nature of 
the repeat motifs within the proteins (Anderson et al 2009). 
Gene expression 
In wheat, seed storage protein gene expression begins during endosperm 
development (Reeves et al 1986). Progressive shifts in gene expression during the stages 
of development drive accumulation of seed components. Wheat caryopses develop to 
maturity over approximately 40 days (Reeves et al 1986; Shewry et al 2012) in three 
distinct phases. The early phase (1 to 9 dpa) follows the double fertilization event and is 
marked by rapid mitotic divisions within the triploid endosperm nucleus (Bechtel et al 
2009). Expression of α-gliadin is limited to developing seeds (Uhlmann and Beckles 
2010), as hypermethylated promoter sequences are thought to suppress expression in 
other tissues (Wen et al 2012a; Morton et al 1995; Phillips 2008). Transcript 
accumulation reaches detectable levels at 9 dpa with continued expression throughout 
caryopsis development (van Herpen et al 2008), which indicated that gliadin activity may 
be required during seed maturation.  
Transport and storage 
Prolamins, including gliadins, start their life on the membrane of the rough 
endoplasmic reticulum, then are transferred to their target storage vacuole by the Golgi 
transport system (Shewry and Halford 2002). Prolamins are trafficked to protein bodies 
in the subaleurone layer of the seed (Levanony et al 1992; Tosi et al 2009; Uhlmann and 
Beckles 2010; Francin-Allami et al 2013). Two categories of protein bodies have been 
described: the PB-I body, formed while the prolamins still reside at the ER membrane, 
and PB-II, which contains aggregates of glutelins after transport to the vacuole.  
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Physiological functions of gliadin in wheat 
The physiological role of gliadin has not been clearly defined, but its genetic 
redundancy indicates that gliadins fulfill an essential biological function. The energetic 
investment in their synthesis certainly indicates so. The production value for gliadin, 
using nitrate (NO3) as the conversion substrate, was calculated by Penning de Vries et al 
(1974) to be 0.638 g of gliadin produced per 1 g of glucose. Compare this to the 
production values for washed gluten (0.664 g), whole-grain protein (0.478 g), and the 
enzyme ribulose-1,5-bisphosphate carboxylase/oxygenase (RuBisCO; ~0.390 g). Much 
of gliadins’ value stems from the more-expensive glutamine and cysteine residues 
incorporated into their primary sequence (Penning de Vries et al 1974; Mitra and Bhatia 
2008). 
Gliadins are relatively abundant in the grain protein fraction. The α-gliadins 
compose between 15 to 30% of the total protein (Anderson et al 1997; Zilic et al 2011) 
and may participate in redox reactions in the maturing caryopsis. The α-gliadins 
accumulate in vacuoles near the aleurone layer in wheat endosperm (Levanony et al 
1992; Tosi et al 2009). The low lysine content (<1%) and conserved internal cysteines 
(Gasteiger et al 2005) of gliadins parallel the properties of seed storage proteins in other 
species, such as pea (Pisum sativum L.) albumin, that have been reported to scavenge 
reactive oxygen species (ROS) generated during germination (El Maarouf-Bateau et al 
2013).  
El Maarouf-Bateau et al (2013) reviewed studies on the balance of reactive 
oxygen species (ROS) as oxidative metabolites and as second messengers in intercellular 
signaling during germination. Low water activity in a desiccated seed effectively 
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deactivates the antioxidant enzymes of the cell, leaving the mRNA that regulates 
germination transcriptional activity unprotected. The oxidative damage by ROS is 
mitigated by accumulated seed storage proteins, which may sacrifice acyl moieties on 
lysine or proline residues, an electron from a cysteine or methionine residue, or both.  
 Prolamins may be highly expressed to protect the mRNA from extensive 
oxidative damage under desiccation and to help stabilize their own structures within 
protein bodies inside the aqueous cell cytoplasm. Gliadins suffer alterations in solubility 
and other properties as they become increasingly reduced by thioredoxins (Hurkman and 
Tanaka 2007; Li et al 2009). Once the seed imbibes water, the protein bodies 
disaggregate and the proteins are hydrolyzed. El Maarouf-Bateau’s model concludes with 
the oxidized seed storage proteins recycled via the 20S proteasome to provide amino 
acids for seedling development (El Maarouf-Bateau et al 2013). Investigations are needed 
to confirm these processes in wheat.  
The pathway is robust and dynamic 
Uhlmann and Beckles (2010) conducted a comparison between wild wheat 
relatives Ae. tauschii and Ae. crassa and hexaploid cultivars to demonstrate that 
expression levels of storage product genes were generally higher in the wild relatives, 
with the exception of one α-gliadin gene and one amylase gene. Overall protein function 
was probably conserved; the observed differences in expression levels may have reflected 
the selection practices used during cultivar development. Redundancy in the metabolic 
network would permit reduced α-gliadin accumulation if another seed storage protein 
could fulfill the same role. A change in in the relative proportions of each protein in the 
total protein profile would be expected, similar to that described in mutant Arabidopsis 
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thaliana L. Heynh. and transformed wheat (Choi et al 2002; Wen et al 2012b). The 
authors interpreted the observed differences to be a consequence of unused amino acids 
being reallocated to a physiologically-equivalent protein fraction. If gliadin function 
parallels that of seed storage proteins in other plant species, then oxidation of mRNA, 
another regulatory mechanism described in seed maturation, may end gliadin protein 
accumulation and ROS scavenging activity.  
SEED STORAGE PROTEINS AND END-USE QUALITY OF WHEAT 
The factors responsible for end-use quality have been the subject of wheat 
research for centuries. In the 4th edition of Wheat: Chemistry and Technology, Shewry et 
al (2009) cited the historic investigation of Jacopo Beccari into the components of wheat 
flour fractions: the starches and proteins (termed amylaceum and glutinosum, 
respectively). Beccari introduced this research to his colleagues in 1745. Further 
investigations by other researchers led to the biochemical characterization of wheat 
proteins by Osborne (1907). Lake et al (1914) studied the immunological properties of 
wheat gliadin and edestin, rye secalin, and barley hordein, among other seed proteins.  
The properties of wheat seed storage proteins that undergo chemical reactions 
during the mixing baking processes are of special interest to plant breeders, bakers, and 
consumers. These proteins, known as gluten, are responsible for the elasticity, strength, 
viscosity, and spread of wheat dough. Gluten’s ability to form “foams” that trap air 
bubbles during the baking process contributes to the light and airy texture desired by 
consumers of breads and pastries. The other cereals express proteins that perform similar 
functions in plant development, but cannot form crosslinks like those formed between 
wheat gliadins and glutenins (Belitz et al 2004).  
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From the human perspective, gliadin is a useful accessory to glutenin for some 
products and necessary by itself for others. Absolute removal of gliadin would probably 
affect some wheat quality tests typically used to assess baking quality. Gliadins 
contribute to the viscosity and extensibility of bread doughs. Positive associations of 
gliadin with dough development time, dough extensibility, and Falling Number value 
have been reported (Gomez-Becerra et al 2010; Mondal et al 2009). The α- and γ-fraction 
gliadins interact covalently with glutenins during dough development, with higher 
proportions of gliadin contributing to less-stable doughs (Khatkar et al 2002a). Khatkar et 
al proposed that ω-gliadins may not associate with glutenins due to a lack of cysteine 
residues, or possibly interfere with gluten formation (Khatkar et al 2002b).  
Developing varieties suitable for cookies and biscuits would be a more difficult 
goal. Glutenins, positively associated with dough strength, reduce cookie spread (Barak 
et al 2013). Flour with less and weaker glutenin is more suitable for these products, and 
therefore have a greater percentage of extensibility-inducing gliadins. Gliadins are 
especially important to cookie quality in terms of spread ratio and softness (Barak et al 
2013; Barak 2015). The gliadin/glutenin ratio has been reported to have a strong 
correlation with cookie spread but a negative correlation with breaking force (Barak et al 
2013).  
CONCLUSION 
The information presented in the previous section could explain why the 
germination rate decreases in old seeds. Yet extensive search of the literature has given 
no indication of whether some important questions have been addressed: why does a gene 
with a high copy number have similar immunogenic motifs in nearly every copy, 
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including paralogs in other species (Mitea et al 2010; van den Broeck et al 2010; 
Salentijn et al 2012)? What physiological function do these protein motifs perform? 
Removing this motif or peptide from wheat may be possible, but is elimination of 
gliadins altogether advisable? 
The current body of work has identified differences in seed storage protein 
expression levels in response to nutritional management strategies. These proteins are 
responsible for wheat’s rheological properties, and are assayed extensively before 
selections are made in a breeding program. Evidence for potential to make direct 
selection on gliadin accumulation, and for the utility of the immunogenic motifs in 
making selections, is growing (Mitea et al 2010; Prandi et al 2014; Malalgoda 2016).   
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Figure 2.1. Maximum Parsimony analysis of 22 wheats and related grasses.  
Seventy-one gliadin protein sequences were obtained from NCBI. Triticum aestivum is 
represented by nine sequences, while the other species are represented by three. 
Evolutionary history was inferred using the Maximum Parsimony (MP) method. All 
positions containing gaps and missing data were eliminated. There were 63 total positions 
in the final dataset. The inferred bootstrap consensus tree was taken to represent the 
evolutionary history of the taxa analyzed. Branches corresponding to partitions 
reproduced in less than 70% bootstrap replicates are collapsed. The percentage of 
replicate trees in which the associated taxa clustered together in the bootstrap test (500 
replicates) are shown next to the branches. The MP tree was obtained using the Subtree-
Pruning-Regrafting (SPR) algorithm with search level 1 in which the initial trees were 
obtained by the random addition of sequences (5 replicates). Evolutionary analyses were 
conducted in MEGA7. 
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CHAPTER 3. PHENOTYPIC ASSAY OF GLIADIN ACCUMULATION 
ABSTRACT 
Two ELISAs were developed to assess gliadin accumulation in 52 hard red spring 
wheat (Triticum aestivum L.) cultivars. Both assays were sensitive enough to differentiate 
low concentrations of analyte from a sample blank. The indirect ELISA had a higher 
theoretical limit of quantitation (13.37 ng well-1) than did the direct ELISA (~6 ng well-1). 
Correlation between the two assays was weakly negative (r = -0.187) with no significant 
linear relationship. A Bland-Altman analysis of mean differences to determined that the 
indirect ELISA underestimated extracted gliadin relative to the direct ELISA by an 
average of -6.703 g kg-1 (SD = 12.29). The wide variation in relative standard deviations 
between paired samples made correction for bias impracticable. Correlation between 34 
paired measurements collected using the experimental ELISAs and a commercially 
available sandwich ELISA were compared was moderately positive (r = 0.446, df = 34, p 
= 0.0064), and analysis of mean differences indicated the experimental ELISAs 
overestimated gliadin by 0.412 g kg-1 (SD = 6.60) relative to the commercial assay. These 
results reflect the cumulative uncertainty inherent to each assay format, and suggest that 
ELISAs are poorly suited to measuring gliadin in raw wheat flour.  
INTRODUCTION 
In their brief reviews on the history and principles of the enzyme-linked 
immunosorbent assay (ELISA), Lequin (2005) and Aydin (2015) explained the derivation 
of the ELISA method from the radioimmunoassay (RIA). The two enzymes most 
commonly used in ELISAs, alkaline phosphatase (AP) and horseradish peroxidase 
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(HRP), were the basis of the conjugate immunoassays independently developed by 
Engvall and Perlmann in 1971 (Engvall 2010) and Van Weeman and Schuurs (1971), 
respectively. It was Engvall and Perlmann who chose microtiter plates instead of 
cellulose as the solid phase medium (Engvall 2010), which made standardization and 
automation of ELISAs possible. The wells of the microtiter plate may be coated with 
target or capture molecules, which contributed to the evolution of the primary ELISA 
formats: the direct, the indirect, the sandwich, and competitive ELISAs (Crowther 2001; 
Aydin 2015) discussed below. Derivations of these formats are discussed in detail by 
Crowther (2001).  
Detection of target molecules  
All ELISAs depend on immunoglobulin-antigen interactions. Immunoglobulins 
(Ig, also called antibodies) are symmetrical, Y-shaped proteins produced by vertebrate 
animals in response to exposure to nonself molecules, called immunogens or antigens, 
expressed by perceived pathogens. Antigens may be proteins, carbohydrates, lipids, 
nucleic acids, or metabolites (Abbas et al 2007b). Students of phytopathology might 
compare these molecule classes to elicitors. Antibodies interact with their antigens 
through conformational complementarity at sites called the complementarity-determining 
regions (CDR); immunoglobulins possess a total of six CDRs between the pair of heavy 
and light peptide chains that compose one antigen-binding site (Abbas et al 2007b). An 
antibody recognizes either a linear or conformational epitope (portion of the antigenic 
molecule) depending on the original presentation of the antigen by a professional antigen-
presenting cell (APC). Large antigens offer multiple epitopes for recognition by the 
animal immune system, as the arrangements of the individual hypervariable CDRs are 
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limited to 10 amino acids in length. The antigen-binding sites of an antibody are therefore 
often small in size relative to the antigen. This relationship is analogous to a lock-and-key 
set, where the epitope of the antigen fits into the pocketlike CDRs of the antibody’s 
antigen-binding site. Hydrophobic interactions, hydrogen bonding, and van der Waal’s 
forces between the antigen and the CDR residues, and some additional interactions with 
the amino acid residues surrounding the CDR also occur; together, these multiple 
interactions mediate the specificity and affinity of the antibody for an antigen (Abbas et 
al 2007b). Epitope site variation can lead to imperfect complementarity with an 
antibody’s CDRs and reduce the affinity of the antibody for the antigen (Lipman et al 
2005). Specificity in immunoassays also suffers when proteins with high sequence or 
structural similarity—for example, wheat gliadins and rye secalins—can be bound by the 
same antibody. This is the basis for cross-reactivity in ELISAs.  
ELISAs are suitable for detecting rare targets in a sample. Each N-terminal ‘arm’ 
of an Ig contains one antigen-binding site for a total of two per monomer. Two constant 
regions within the Ig heavy chains (domains CH1 and CH2) flank a peptide that ranges 
between 10 and 60 residues long called the hinge region. The hinge region permits the 
antigen-binding sites to flex and make contact with multiple epitopes within the same 
protein, such as the multiple epitopes found in gliadin, or in separate proteins (Abbas et al 
2007b). The C-terminal region of the Ig molecule, composed of the CH2 and CH3 heavy 
chain domains, can be noncovalently adsorbed to a solid substrate such as a microplate to 
orient the antigen-binding sites uniformly across a well. This permits enrichment of a rare 
target in a mixed sample and subsequent detection by a paired Ig conjugated to either AP 
or HRP. The enzyme is conjugated to the C-terminal region of the paired Ig, or detection 
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antibody (Crowther 2001). 
Commercially prepared antibodies are classified as monoclonal (mAb) or 
polyclonal (pAb). The distinction between mAb and pAb lies in the uniformity of the 
antibodies produced and has a critical impact on antigen detection by ELISA. 
Monoclonal antibodies are traditionally produced from clonal hybridized B lymphocyte 
populations derived from the spleens of immunized animals, often mice (Abbas et al 
2007b). B lymphocytes maintain the antibody repertoire of the mammalian immune 
system through somatic recombination of the V-D-J genes during B lymphocyte 
maturation. Each somatic recombination is a unique event. Once differentiated, a B 
lymphocyte produces only one form of antibody for the rest of its life. B lymphocyte 
lineages that target a particular pathogen will eventually decline if the challenge does not 
recur; a smaller population of ‘memory’ cells will remain after the adaptive immune 
response has been subdued. Antibody titers also decline over time. Circulating IgG has a 
half-life of less than one month (Hanly et al 1995; Simon et al 2015). Researchers need to 
perform somatic cell hybridization, a process also called immortalization, of mature B 
lymphocytes harvested from an immunized animal with aminopterin-treated myeloma 
cells to produce stable antibody-producing cell cultures. Aminopterin-induced mutations 
in the myeloma nucleotide synthesis pathways ensure only true somatic hybrid cells 
proliferate. The original B lymphocytes produce a mixture of antibodies, so a series of 
dilutions and subcultures in a growth medium supplemented with hypoxanthine and 
thymidine must be made to isolate monoclonal populations. The resulting hybridized B 
lymphocytes produce only one type of antibody that interacts with one specific epitope 
(National Research Council 1999; Abbas et al 2007b). After a monoclonal culture is 
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achieved, the expressed mAbs can be affinity purified. Evaluation of the purified mAb 
for use in detection of the specific epitope in specific applications is called validation. 
Production of a mAb can take several months. Monoclonal antibodies are homogenous 
and stable compared to pAb, but can suffer from contamination with serial propagation. 
Long-term storage of reserve cultures is a good cell culture practice (Hartung et al 2002). 
Thus, the cost of production and maintenance is much higher for a mAb than for a pAb. 
Minor fluctuations in pH or reagent concentrations can alter the activity of mAb in an 
assay (Lipman et al 2005). These issues may lead to greater between-assay variation 
where multiple researchers prepare reagents or perform ELISAs.  
Polyclonal antibodies are often isolated from immunized rabbits but can be 
developed in other laboratory and farm animal species. The rabbit germline V-D-J gene 
segment diversity is inherently low even in outcrossed genotypes (Janeway et al 2001), 
and rabbits produce a single IgG isotype (Hanly et al 1995). For these reasons, production 
and isolation of rabbit IgG are considered technically easy and of reasonably high titer 
(Stills 2012), especially when proteins are used as immunogens (Hanly et al 1995; Stills 
2012). As with the early stages of mAb production, an array of mature B lymphocytes 
differentiates and produces unique antibodies that recognize epitopes within the 
immunogen. The single-isotype IgG pAb can be affinity-purified using the antigen only. 
The pAb will still have affinity for the antigen even if there is natural variation in one 
epitope, since the pAb is a heterogenous mixture of antibodies that detect multiple 
epitopes throughout the entire antigen. In addition, the cost and development time of 
producing a pAb is less than that for a mAb. The primary disadvantage of pAb is non-
reproducibility. The immunized animal produces a unique repertoire of pAb, and lives for 
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a finite time (Lipman et al 2005).  
In summary, the decision to select a mAb or a pAb for use in an ELISA must 
consider the objective for the assay, the quantity and nature of the target analyte and 
detection reagents, assay reproducibility, and the cost of assay deployment.    
ELISA formats   
The factors described in the previous section also influence the selection of 
ELISA format. The direct ELISA format is useful for identifying the presence or absence 
of a target analyte, or for estimating the quantity of an abundant target. The indirect 
ELISA can amplify the signal from less-abundant target directly coated onto the 
microplate for estimation of quantity. A sandwich ELISA is useful for enrichment of rare 
targets within a sample matrix, and can quantify the amount of analyte due to a 
theoretical one-to-one relationship between capture antibody and target. The competitive 
ELISA estimates the quantity of a target in a sample matrix mixed with a pre-titrated 
detection antibody solution. The microtiter plate may be coated with the target of interest, 
or with another target that also binds the detection antibody (Crowther 2001; Aydin 
2015). The direct, indirect, and sandwich ELISA formats were used over the course of 
this study and will be described in greater detail.  
The direct and indirect ELISAs use a plate-coating approach (Crowther 2001). 
The nature of the target determines the choice of plate, as target molecules with different 
overall charges require an appropriately charged plastic surface for adsorption to occur. 
The sample extract is mixed with a coating buffer to a dilution factor that brings the 
solute within the adsorbance capacity of the well. A typical coating buffer contains 
sodium carbonate and sodium bicarbonate at alkaline pH (Crowther 2001), but the choice 
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of coating buffer is dictated by the properties of the target and the microtiter plate. 
Adsorbance is mediated by electrostatic interactions between the plastic and the target. 
Passive adsorption takes time, so the microtiter plate is incubated at a constant 
temperature. Overnight incubations at 4oC are common. The assay is resumed after 
washing the unadsorbed sample out of the wells using a wash buffer suitable for the 
chosen substrate system. Nonspecific binding of other ELISA components is prevented 
through a blocking step. A buffer containing a protein that will not react with the selected 
antibodies (e.g., bovine serum albumin, when an anti-rabbit secondary antibody is used in 
an indirect ELISA) is aliquoted into each well. The ELISA microtiter plate is then 
incubated at a constant temperature. No wash step is necessary after a blocking step; the 
next step can be performed after the blocking agent is removed.  
After blocking, the direct and indirect ELISAs vary slightly (Crowther 2001; 
Aydin 2015) Figure 3.1 illustrates the differences. The direct method uses a detection 
antibody conjugated to an enzyme while the indirect ELISA uses an unconjugated 
detection antibody. The relationship between the primary antibody of a direct ELISA and 
its antigen may not have a one-to-one relationship. The primary antibody of a direct 
ELISA may be able to bind one or two antigens per antibody, or an antigen with multiple 
epitopes may attract two or more antibodies. Steric hindrance of antibody binding may 
occur when epitopes are near each other. An extra step is included in the indirect ELISA 
as a conjugated antibody is used to bind the primary antibody (Voller et al 1978; 
Crowther 2001; Aydin 2015). The secondary antibody must be derived from an animal 
immunized against the source of the primary antibody (namely, an unconjugated rabbit 
pAb primary antibody would require a secondary antibody raised in another species, such 
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as a goat or donkey). To reduce risk of nonspecific interactions, the species of secondary 
antibody should neither be closely related to the source of the primary antibody nor the 
source of the analyzed sample (AbCam 2017a; AbCam 2017b; Crowther 2001; Jackson 
ImmunoResearch). The indirect ELISA can ‘amplify the signal’ of rare targets as more 
than one secondary antibody may bind to each primary antibody. As with the direct 
ELISA, steric hindrance of antibody binding may also occur. Unbound antibody is 
washed out of the well before proceeding with the next step. The absorbance (optical 
density) of the colorimetric reaction between the conjugated enzyme and its substrate is 
measured using a spectrophotometer and compared with the absorbance of a 
characterized calibration curve. The direct and indirect ELISAs are therefore suitable for 
detecting the presence or absence of an antigen, or for estimating antigen quantities when 
an appropriate calibration curve is included in the assay. 
The sandwich ELISA is considered a quantitative assay. In contrast to the direct 
and indirect ELISAs, the solid phase is first coated with a capture antibody (Voller et al 
1978; Crowther 2001; Aydin 2015). The capture antibody may be applied to the 
microtiter plate, preserved, and stored for later use, or the plate may be coated and used 
immediately in the next step of the assay. The capture antibody-coated plate then receives 
an aliquot of sample diluted in a blocking buffer. This enriches for rare antigens, as the 
complex sample matrix encounters a ‘lawn’ of capture antibody and precludes 
nonspecific binding to the microtiter plate. After incubation, unbound antigen is washed 
away. The detection antibody is added to each well; it may be conjugated to an enzyme if 
the antigen capture is sufficient to obtain a measurable absorbance. Otherwise, the 
detection antibody may remain unconjugated and a conjugated secondary antibody may 
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be applied to increase the signal (Crowther 2001). Capture and detection antibodies are 
typically developed as pairs. Each antibody should detect a different epitope to avoid 
binding competition, which will reduce the sensitivity of the ELISA. Binding competition 
should be minimal between the capture and detection antibodies if the antigen contains 
multiple, non-overlapping epitopes. The theoretical relationship between the capture or 
detection antibody and antigen is 1:1, although this depends on the size of the antigen and 
number of epitopes available on it. The absorbance of the unknowns may be compared to 
a characterized calibration curve for quantification.  
The antigen-antibody interaction is visualized by a biochemical reaction between 
an enzyme and its substrate, with the concentration of reaction product reported as 
absorbance (Gibbs 2001). The enzymes most commonly used in ELISAs are AP and 
TMB, although β-D-galactosidase is sometimes used. Chemiluminescent and fluorescent 
substrates are alternative options to the traditional colorimetric reactions (Gibbs 2001; 
Thermo Scientific 2011). Voller and colleagues (1978) advocated using an inexpensive 
enzyme that catalyzes its reaction quickly. Gibbs (2001) noted that large enzymes were 
another source of steric hindrance when conjugated to antibodies. When HRP, AP, and 
the tetrameric β-D-galactosidase (~ 44, 140-160, and 465 kDa, respectively) are judged 
solely on size, HRP and AP are considered preferable to β-D-galactosidase. Minor cost 
differences between the two enzymes aside, sample preparation needs to be considered 
when choosing between HRP and AP. Reagents commonly used in sample extraction and 
storage, such as sodium azide and PBS, can inhibit HRP or AP activity, respectively 
(Gibbs 2001).  
Several substrates are available for use with AP and HRP in ELISAs, and the 
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deciding factor for choosing one is the quantity of antigen expected in the sample. When 
the range of antigen is unknown or expected to be wide, the slower-acting substrates can 
produce more intense color in strongly-positive samples without overdeveloping wells 
containing lower concentrations of antigen. A 15- to 30-minute development time is 
usually more convenient for busy laboratory workers performing end-point 
measurements. Alkaline phosphatase may be coupled with p-nitrophenylphosphate (p-
NPP) in an ELISA in a long incubation (30 to 60 minutes) to develop low-concentration 
samples. This reaction is stopped with 1N NaOH, and the absorbance measured at 405 
nm. Perhaps the most common substrate used with HRP, 3,3’,5,5’ tetramethylbenzidine 
(TMB) is catalyzed more quickly than the alternatives, 2,2’-azino-di[3-ethyl-
benzthiazoline] sulfate (ABTS) and o-phenylenediamine (OPD). A lower concentration 
of antigen will be detected by the faster-acting TMB within minutes. The absorbance of 
the TMB reaction can also be measured with a spectrophotometer while in progress at 
650 nm, making this substrate convenient for kinetic assays, or at 450 nm after stopping 
the reaction with a 1M solution of either phosphoric or sulfuric acid (Gibbs 2001). The 
absorbance of the slower-acting ABTS is measured at 405 nm, and uses a safer stopping 
solution (1% SDS) than TMB. 
Special considerations 
Development of ELISAs for food testing, especially for allergens, has been a 
challenge. Developing antibodies against plant targets is especially challenging, as the 
animals used to create antibodies are typically herbivores. Lake et al (1914) described 
their own difficulties in immunizing rabbits with wheat extracts. Many plant target 
proteins are too small to be detected by the immune system without conjugation to a 
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carrier molecule (Knudsen, personal communications). Abbot et al (2010) discussed in 
detail the lack of suitable food allergen standards, couched in terms of 1) unique, 
individual reactions to the same immunogen or allergen, and 2) the effects of the food 
matrix and preparation or treatment. Van Eckert et al (2006) developed a standardized 
gliadin reference material derived from European wheat cultivars and tested it against 
other references available with reversed-phase HPLC, mass spectroscopy, PAGE, and 
several ELISAs including the commercially available Rida assay. The work of van Eckert 
and colleagues demonstrated the intensity of effort required to produce a suitable 
reference material with a response curve that parallels those of the samples to be analyzed 
(Plikaytis et al 1994; van Eckert et al 2006). Unfortunately, agreement of assay results 
between different laboratories has been another challenge (Wright et al 1993; Rzychon et 
al 2017). Correlations between assay results are inconsistent despite the 
commercialization of references and antibodies. Hayashi et al (2004a) proposed that 
modeling the error that propagates with each step of an assay during preparation could 
mitigate the reported variability in measurements. 
METHODS 
Plant materials 
Fifty-two hard red spring wheat (Triticum aestivum L.) cultivars were grown in 
the South Dakota State University Spring Wheat Breeding Program yield trials between 
2013 and 2016. These locations included four sites in South Dakota: Brookings (lat. 
44.31, lon. -96.67), Groton (45.49, -100.01), Selby (45.108, -97.103), and Watertown 
(45.42, -97.91). All plant materials were planted in a randomized block design with three 
replicates at the three locations. Due to hail damage at the Groton location in 2015, a 
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location substitution (Watertown) was made to balance the dataset. 
ELISA development 
Estimation of gliadin accumulation in the composited milled flour samples was 
performed using the ELISA method. Two ELISAs were developed over the course of this 
study following recommended procedures (Sasaki and Mitchell, 1997; Crowther, 2001; 
Abbot et al 2010), as a change in vendor offerings required redevelopment and validation 
of the assay. Both used a direct-coating approach; the Immobulon 2HB plate (Thermo-
Fisher Scientific, Waltham, MA) was coated with an appropriate dilution of ethanol-
soluble proteins extracted as described by Garcia et al (2005) with modification. The 
standard curve was extracted by the same method from the performance check cultivar 
samples from the preceding year. Expected concentrations of the standard curve were 
first calibrated using the gliadin-specific specific R5 ELISA (R-biopharm # R7001), 
which is the Codex Alimentarius-approved gliadin assay. 
Ethanol-soluble proteins were extracted from 125 mg sifted flour in 15 mL 
centrifuge tubes. Aliquots of 1.25 mL extraction buffer (250 mM β-mercapto ethanol and 
2 M guanidine hydrochloride in ultrapure water) were added to each tube, and were 
vortexed until the sample was fully suspended. Samples were incubated at 50 oC for 40 
minutes with shaking, and allowed to cool before 80% ethanol in ultrapure water was 
added (q.s. to 5 mL per tube). The tubes were vortexed to mix thoroughly and incubated 
for one hour at room temperature on an orbital shaker. Insoluble protein and starch were 
pelleted by centrifugation at 2500 x g for 10 minutes at room temperature. The room-
temperature supernatants were transferred to microcentrifuge tubes and diluted to 0.1 mg 
mL-1 immediately. Surplus supernatant was stored at -20 oC. Extracted samples were 
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further diluted by appropriate dilution factors during assay setup to obtain sample 
absorbances within the dynamic range of the ELISA standard curves. 
Gluten-free, single-variety rice flour processed in a rice-only facility was obtained 
from a grocer for use as a negative control. The rice flour control was subjected to the 
same extraction procedure as the samples, and diluted to the same factor as the samples 
before coating on the plate. 
Sample preparation 
Purified gliadin was purchased from Sigma (St. Louis, MO). A spike-and-
recovery assay using the purchased gliadin was performed to assess the discrimination of 
the ELISA under development (Thermo Scientific 2007). The purchased gliadin was 
subjected to the same extraction treatment as the unknowns, but solubility was poor. The 
dilution curve of this material did not parallel that of the extracted unknown samples. For 
this reason, composited performance check cultivar samples were extracted for use as a 
standard curve instead of the purchased gliadin. The instability of the ethanol-soluble 
proteins required fresh extractions of check cultivars before performing the ELISAs each 
year. The ethanol-soluble protein was measured by Bradford assay (BioRad #5000002, 
Hercules, CA), and gliadin concentration was measured using the R5 assay. The standard 
curve was then diluted to coat the wells of the ELISA plate with 125, 100, 75, 50, 37.5, 
25, and 12.5 ng of ethanol-soluble protein. The expected concentration of gliadin in the 
standards therefore varied by year, leading to the need for re-validation of the standard 
curve for each year. Chessboard titration was performed to optimize each assay format, 
and to re-validate the assay after changes in plate, coating buffer, or antibody lots 
(Crowther, 2001).  
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Indirect ELISA for quantifying total gliadin 
ELISA-1 was developed as an indirect ELISA. Extracted gliadin was further 
diluted in bicarbonate coating buffer, pH 9.6, to coat the well of each ELISA plate with 
100 or 250 ng of flour equivalent. This format used an unconjugated primary (rabbit pAb; 
Abcam ab50602, Cambridge, MA) to detect the full-length gliadin directly coated on the 
plate. A secondary antibody (Invitrogen G-21040, Grand Island, NY) conjugated to 
horseradish peroxidase and TMB (Pierce 34021) were used to develop the assay. The 
reaction was stopped by the addition of 100 ul 1N H2SO4. Absorbance was measured at 
450 nm with a FilterMaxF5 plate reader and SoftMax Pro software (Molecular Devices, 
Sunnyvale, CA). 
Direct ELISA for quantifying total gliadin 
ELISA-2 was developed as a direct ELISA. Extracted gliadin was further diluted 
in bicarbonate coating buffer, pH 9.6, to coat the well of each plate with 250 or 500 ng of 
flour equivalent. This format used a primary antibody conjugated to horseradish 
peroxidase (rabbit pAb; Abcam ab49713, Cambridge, MA) to detect the full-length 
gliadin directly coated on the plate. The rest of the assay followed the procedure outlined 
in Appendix B, with the absorbance at 450 nm read by a BioTek H1 plate reader and 
Gen5 software (BioTek Instruments, Winooski, VT). 
Assay parameters and criteria 
Absorbance at 450 nm was plotted against back-calculated concentrations and fit 
with the 4-parameter fit equation: 
y = D * [(A – D) / (1 +(x/C)B] 
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where x = the observed measurement; A = minimum asymptote; B = slope of the 
curve; C = effective concentration 50%, or the inflection point of the curve; and D = 
maximum asymptote. Interassay reliability was evaluated using the coefficient of 
variation (CV) of the standards (Reed et al 2002). Signal-to-noise ratios were calculated 
by dividing the mean value of replicate standards by the standard deviation of the 
replicates. Ratios equal to or greater than 10 were considered excellent; ratios as low as 5 
were still considered acceptable (R&D Systems). The limits of detection were calculated 
using the equations (Armbruster and Pry 2008):  
Limit of blank (LoB) = meanblank + 1.645 SDblank 
Limit of detection (LoD) = LoB + 1.645 SDlowest concentration standard 
Limits of quantitation (LoQ) were defined as a concentration equal to or greater 
than the LoD, with an interassay CV of <20%. Armbruster and Pry (2008) recommended 
a minimum of 20 replicates be used to determine these limits. Considerable variation 
between technical replicates was observed, perhaps due to the behavior of the ethanol-
soluble gliadin in the aqueous coating buffer. Acceptance criteria for both assays were set 
as follows: unknown sample absorbances at 450 nm with CVs greater than 15% were 
rejected and re-run; assays with more than 20% rejected unknowns were rejected; and 
assays with more than two standard curve points with back-calculated concentrations that 
differed from expected concentrations by more than 20% or more than one point with an 
absorbance CV greater than 15% were rejected. 
Commercial ELISA 
The R5 sandwich ELISA from R-biopharm (R-7001) was performed following 
the manufacturer’s recommendations. The extracted flour samples were diluted by 
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appropriate dilution factors to obtain optical densities within the functional range of the 
assay standard curve. 
Protein analysis 
Whole-grain and flour protein of composited samples were measured by near-
infrared spectroscopy (Foss 1229 Infratec Grain Analyzer, Hilleröd, Denmark). The ratio 
of ELISA-estimated gliadin accumulation to whole-grain protein was determined. If the 
percentage of measured gliadin exceeded 50% of flour protein, the sample was repeated.  
Statistical analysis 
All statistical analyses were performed using R version 3.3.2 (The R Core Team 
2016) and the packages named hereafter. The two assays were evaluated for agreement 
with the Bland-Altman plot method (Bland and Altman 1986; Giavarina 2015). No 
acceptance limits were set for agreement between the two assays, as replacement of the 
indirect ELISA-1 with the direct ELISA-2 was unavoidable.  
The Grubb’s test for outliers in the full dataset was conducted using the library 
‘outliers’ (Komsta 2011). Normality was assessed using the Anderson-Darling test from 
the library ‘nortest’ (Gross and Ligges 2015) and the Shaprio-Wilk test (The R Core 
Team 2016). The package ‘moments’ (Komsta and Novomestky 2015) was also used. 
Levene’s test from the package ‘lawstat’ (Gastwirth et al 2015) was applied to evaluate 
homoscedasticity of variance. Pairwise t tests were used to compare the means of the 
assay results (library ‘stats’; The R Core Team 2016). Correlation between whole-grain 
protein, flour protein, and gliadin was determined using base R and the library ‘corrplot’ 
(Wei and Simko 2016). 
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RESULTS  
ELISA development 
The LoB, LoD, and LoQ for the two ELISA formats developed in this study are 
summarized in Table 3.1. Assay limits were determined using the methods outlined in 
Armbruster and Pry (2008). The zero standard (0 ng ml-1) was used to determine the LoB, 
which was determined by the formula LoB = meanblank + 1.645*SDblank. The LoD, the 
lowest concentration discernable from the blank, was determined from standard point 7 
(STD7; 60 ng ml-1) following the form LoD = LoB + 1.645*SDSTD7. As the coefficient of 
variation between STD7 back-calculated concentrations (ELISA-1 = 10.03%, ELISA-2 = 
9.88%) was less than the 20% guideline discussed by Armbruster and Pry, the theoretical 
LoQ of each format was determined to be the same as the LoD. The curve fit for both 
ELISA-1 and ELISA-2 followed a four-parameter fit model, therefore no extrapolation 
beyond the upper and lower standard concentrations could be made. The theoretical LoQ 
for ELISA-2 fell between the two lowest points on the standard curve (3 ng and 7 ng 
well-1; Table 3.1). The 4-parameter fit of the standard curves for 2014 and 2015 are 
summarized in Figure 3.2 and Table 3.2.  
Bland-Altman analysis of ELISA-1 and ELISA-2 
Twenty-three 2014 yield trial cultivars were used in the assessment of the indirect 
assay, ELISA-1, versus the direct assay, ELISA-2. Two performance check varieties 
were grown in two nurseries at the same location. These observations were treated as 
unique, bringing the total to 25 paired observations. Descriptive statistics for the gliadin 
measurements for ELISA-1 and ELISA-2 are summarized in Table 3.3. Correlation 
between gliadin measurements from ELISA-1 and ELISA-2 was weakly negative (r = -
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0.19) with no significant linear relationship (t = -0.91, CI95 = -0.54, 0.23). Simple 
regression indicated that the two ELISAs shared a low proportion of variance (adjusted 
R2 = 0.19). Normality of the observations was not rejected by the Anderson-Darling test 
for ELISA-1 (A = 0. 0.54, p = 0.15) or ELISA-2 (A = 0.59, p = 0.11) for Case 0 where the 
critical value A = 1.93 at a significance level of α = 0.10. The classical Levene’s test 
applied to gliadin measurements grouped by assay format rejected the assumption of 
equal variance (W = 4.50, p = 0.04, upper critical value F(1, 48) = 4.04) at the significance 
level of α = 0.05. 
 The Bland-Altman analysis of mean differences, conducted to determine the 
degree of agreement and bias between the two ELISA procedures, is depicted in Figure 
3.3. The mean of differences between the two assays was -6.70 g kg-1 of flour (SD = 
12.29), indicating that gliadin measurements of ELISA-1 were lower than those of 
ELISA-2. Qualitative assessment of Figure 3.2 did not reveal any obvious bias that might 
relate to quantity of gliadin, and illustrated that the two ELISAs shared a low proportion 
of variance (R2 = 0.22). The observed differences of assay means were negatively skewed 
(-0.83), but normality of the observations was not rejected by the Shapiro-Wilk test (W = 
0.92, p = 0.05) at the significance level of α = 0.05. Despite the small sample size, 
potential deviations from normal distribution did not appear serious enough to negatively 
impact subsequent analyses.  
A paired t test of means failed to accept the null hypothesis that the mean 
observed results of ELISA-1 and ELISA-2 were equal (t = -2.73, 24 degrees of freedom, 
p = 0.01) at a 95% confidence level (CI95 = -11.78, -1.63). The percent difference 
between paired observations is summarized in Table 3.3. The power of the two-sided 
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paired t test (0.74) was determined using the calculated difference in assay means (-6.70), 
the standard deviation of differences in paired assay means (12.29), and the significance 
level of α = 0.05.  
The limits of agreement were calculated as recommended by Giavarina (2015). 
The difference between assay means (͞d) and the standard deviation (s) were entered into 
the formula [ ͞d ± 1.96*s] to determine the lower and upper limits of agreement (-30.79, 
17.38) at a confidence level of 95%. Estimates of gliadin accumulation obtained using 
ELISA-1 may have been -30.79 g kg-1 lower or 17.38 g kg
-1 higher than estimates 
obtained using ELISA-2. The range of percent differences (Table 3.3) demonstrated that 
bias was present between the two assays, but was inconsistent across the range of 
measurements. This inconsistency would have complicated adjustment of the ELISA-1 
measurements, so the original 2013 and 2014 observations were compared directly with 
later observations. 
The results described previously were compared to results obtained from the 
commercial R5 sandwich ELISA, the functional limits of which have been described 
elsewhere. Forty cultivars were chosen by rank of mean gliadin accumulation across 
environments and years 2013 to 2015, then assigned to high- and low-gliadin groups. 
These cultivars were assayed with either ELISA-1 or ELISA-2, depending on the year 
harvested, and again with the R5 ELISA. No corrections were applied to the ELISA-1 
values for the reasons explained above. Three varieties were removed from each of the 
low and high groups due to unacceptable within-sample variance in the commercial assay 
results before comparison to the experimental assay results. Eleven of the 40 cultivars 
were subjected with all three ELISA formats; the mean gliadin accumulation and relative 
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standard deviation (RSD) for these cultivars are summarized in Table 3.4. After two 
cultivars with unacceptable within-sample variance in the commercial assay were 
removed from the dataset, the remaining nine were subjected to two-sided paired t tests 
(Table 3.5). The paired t tests failed to reject the null hypothesis of equal means at the 
95% confidence level. As the ELISA-1 and ELISA-2 gliadin measurements for the check 
cultivars were not conclusively equal, both observations were included in a paired t test 
for a total of 36 paired observations for the 34 cultivars. The null hypothesis of equal 
means (t = 0.38, df = 35, p = 0.71) was not rejected at a 95% confidence level (CI95 = -
1.82, 2.64). Results of the t tests of high- and low-gliadin cultivar groups are summarized 
in Tables 3.6 and 3.7.  
Bland-Altman analysis of ELISA-1, ELISA-2, and the commercial ELISA  
Correlation between gliadin measurements by the three ELISAs was determined 
to be moderately positive (r = 0.45 df = 34, p = 0.006) with no significant linear 
relationship (t = 2.91, CI95 = 0.19, 0.68). Simple regression indicated that the combined 
experimental ELISAs shared a low proportion of variance (adjusted R2 = 0.18) with the 
commercial assay. 
The Bland-Altman analysis of mean differences, conducted to determine the 
degree of agreement and bias between the combined experimental and commercial 
ELISA procedures, is depicted in Figure 3.4. The mean of differences between the 
combined ELISAs and the commercial ELISA was 0.41 g kg-1 of flour (SD = 6.60), 
indicating that gliadin measurements of the combined experimental ELISAs were higher 
than those of the commercial test. Figure 3.4 illustrates that all ELISAs shared a low 
proportion of variance (R2 = 0.22). The observed differences of all assay means were 
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negatively skewed (-0.12). The classical Levene’s test applied to gliadin measurements 
grouped by assay rejected the assumption of equal variance (W = 4.18, p = 0.045, upper 
critical value F(1, 70) = 3.98) at the significance level of α = 0.05. Bootstrap resampling (N 
= 1000) demonstrated that the correlation between the 34 paired assay results could be 
considered to have a moderate positive relationship (r0 = 0.45 compared to rresample = 0.43, 
t = 2.39, p = 0.02) at a 95% confidence level (CI95 = 0.09, 0.69) but not at the 99% level 
(-0.15, 0.79). The correlation coefficients of the resample demonstrated a clear leftward 
skew (-0.71; Figure 3.5). 
Protein trait analysis 
Whole-grain protein, flour total protein, and gliadin accumulation in 52 cultivars 
is summarized by location-year in Table 3.8. The probability density and distribution of 
each trait are illustrated in Figures 3.7-3.9. The correlations between gliadin and protein 
traits in nine cultivars assessed by all three ELISA formats are given in Table 3.9. 
DISCUSSION 
The ELISA method is a pragmatic, but not ideal, system for measuring 
immunogenic gliadin accumulation in flour samples. The high abundance of gliadin 
requires the extracted sample to be diluted to within the functional range of the assay 
system; this introduces greater uncertainty with each step. The indirect ELISA had an 
extra source of error relative to the direct ELISA due to the addition of a secondary 
antibody. Variability could also be attributed to variation in antibody lots from year to 
year, as the pAb used in this study were probably isolated from different rabbits. 
Polyclonal antibodies are a mixture of immunoglobulins that have specificities for 
different epitopes within the same target, as opposed to the single epitope targeted by 
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mAb. The varied reactivity of pAb lots obtained from different individual rabbits can 
arise from the complex genetic exchanges of the rearranged V-region genes that control 
light-chain antigen-binding specificity (Sehgal et al 1999; Janeway 2001). Even with the 
lower germline diversity in the V-gene segments found in rabbits (Janeway 2001), 
somatic gene rearrangements are non-heritable, unique events. Use of mAbs would 
mitigate potential variability, however, production of mAbs is more resource-intensive, 
as they are derived from clonal populations of hybridized cells. Few anti-gliadin mAbs 
appear to be commercially available outside of kits.  
Matched pairs of antibodies are typically used in sandwich ELISAs to avoid 
competition for specific epitopes, but the repeat motifs of gliadins permit use of a single 
antibody. For this reason, the R5 ELISA can use a single mAb in a sandwich format to 
detect the multiple epitopes present in gliadins. Antibody binding in the R5 assay would 
be limited by the proximity of the epitopes on the exposed protein surface.  
ELISAs are subject to compounded error due to variation in the reagents and 
disposables, sample preparation, pipetting, and incubation times and temperatures—
artifacts of methodological development—as well as the nature of the analyte itself 
(Hayashi et al 2004a, 2004b; Bugyi et al 2013). An assay needs to be revalidated before 
transitioning to a new reagent or plate lot, and micropipetters need to be calibrated 
regularly. Sources of error have been discussed at length for different ELISA formats, 
including ELISA microarrays, with the recommendation that uncertainty of measurement 
also be reported for the assay (Hayashi et al 2004a; Daly et al 2005; Toussaint et al 2007; 
Mati et al 2008; Biswas and Saha 2015; Codex Alimentarius 2015). The American 
Association for Laboratory Accreditation (AALA; 2014) outlined a list of 10 factors that 
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may contribute to uncertainty in measurements including: environmental conditions; 
methodological artifacts, accuracy, and precision; concentration of the analyte; and 
human error. Reports of uncertainty should follow the procedures detailed in the Guide to 
the Expression of Uncertainty in Measurement (GUM), and include a statement of the 
standard and nonsystematic uncertainties. Unfortunately, these statistics are difficult to 
implement if a traceable reference is unavailable, as is the case for many food-derived 
targets (Abbot et al 2010). Both procedural (CAC/GL 59-2006; Mati et al 2008) and 
statistical (Dumitriu et al 2010) workarounds have been devised to mitigate the lack of a 
widely available certified reference. The ELISAs developed for this study were 
performed by one worker in one laboratory, which precluded use of the procedural 
workarounds. 
Another challenge to reporting uncertainty of an assay is the linearity of response. 
Hayashi et al (2004a) discussed how the limits of detection and quantitation can be 
rendered inaccurate by non-linearity in the standard curve—as in the case of the 
experimental gliadin assays discussed in the previous sections. These authors published 
an equation to determine the approximate uncertainty of a competitive ELISA. 
Modification of this procedure to assess other formats would help explain in part the lack 
of concordance in ELISA measurements conducted by different researchers.  
Bootstrap resampling and confidence interval testing of the paired experimental 
and commercial R5 ELISA results showed that the experimental assays produced 
reasonably similar, although not perfectly equivalent, results despite the sources of 
cumulative error inherent to the ELISA formats. Bland and Altman (1986) pointed out 
that correlation and regression are commonly—and inappropriately—used to assess 
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agreement between two procedures. They discussed differences in measurement scales 
and the impact upon agreement between two methods (a factor that appeared between the 
assays used in this study) and that two procedures designed to measure a single trait 
could naturally show a high correlation regardless of agreement. The Bland-Altman test 
is usually performed to decide whether a new method should replace an established test, 
but the change in antibody supplied by the vendor required the use of a different method 
for part of this study. For this reason, the Bland-Altman test was used to concurrently 
assess the degree of bias and repeatability so comparisons could be made between the 
two ELISA formats (Giavarina 2015). The need for less-stringent acceptance criteria and 
observed percent difference between assay measurements may be ascribed to the nature 
of the protein measured. Gliadins are ethanol-soluble proteins that form aggregates in 
vivo. The biochemical properties of gliadin diluted into the aqueous ELISA coating 
buffer probably caused greater variability in dilutions and pipetting.  
Some challenges arose early in this study. Technical issues included quantitation 
of the ethanol-soluble proteins prior to use in the ELISAs. Quantitation by measuring 
absorbance at 280 nm returned unexpectedly low results (data not shown). The low 
aromatic content of gliadin likely resulted in underestimation of protein concentration in 
extracted samples measured by A280. The ProtParam application on ExPasy 
documentation warns of an approximate 10% error in concentrations obtained by this 
method. The bicinchoninic acid (BCA) method was then chosen to quantify the ethanol-
extracted protein because of its insensitivity to amino acid composition differences 
(Pierce). That starch can react with BCA was not mentioned in the Pierce assay 
literature—this assay is typically used to assay mammalian or bacterial proteins. Horn 
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and Eijsink (2004) described protein as an “interfering substance”, which explained 
detection of 80-112% of the unknown samples assayed using this method. Filtration with 
a 0.45 um syringe filter did not uniformly improve quantitation using the BCA method 
(data not shown). The ethanol-soluble proteins were measured using the Bradford assay 
to for these reasons.  
Estimation of protein concentration by the Bradford assay was performed three 
times with varied results, although the expected trend was observed. The amounts of 
potentially interfering reagents, such as β-mercaptoethanol, guanidium HCl, and ethanol, 
were diluted below concentrations expected to interfere with the assay. The Bradford 
assay is sensitive to a lack of aromatic residues and may also underestimate protein 
concentrations. The acid in the Bradford reagent may have slightly altered associations 
between acid- and ethanol-soluble proteins extracted by the Garcia et al (2005) method. 
The observed concentration of purchased gliadin also measured lower than expected after 
extraction using the Garcia et al method. Extracts of purchased gliadin filtered through a 
0.45 um syringe filter exhibited visible loss of particulate material. Two possible 
explanations for the lower observed concentration are: 1) the original isolation method of 
the purchased purified gliadin may have altered the protein properties slightly, causing a 
loss of material in the Garcia et al extraction procedure due to precipitation, or 2) the 
purchased gliadin may have contained some starch that was removed by the additional 
extraction procedure performed in this study.  
The ELISA development was complicated by the lack of commercially available 
mAb against gliadin. The single available mouse mAb, 14D5 (Santa Cruz Biotech), 
preferentially detects the deaminated epitope [PELPY] (personal communication, Haff). 
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Acid hydrolysis of samples with 0.15 N HCl was unsuccessful. The amount of either 
reducing agents or ethanol in the sample may have interfered with deamination. If 
deamination is required for future assays, guinea pig tissue transglutaminase may be used 
to expose the epitope (Skovbjerg et al 2004).  
Another concern regarding antibody specificity was addressed in a review by 
Bordeaux et al (2010). In multiple studies, unexpected or nonspecific interactions were 
exhibited by the antibodies under evaluation. These authors cited a lack of standardized 
best practices for ensuring an antibody is fit for its purpose, a concern that was discussed 
again in a 2015 Nature news article (Baker 2015). Poorly-characterized commercially 
available antibodies were implicated in an unreproducible pancreatic cancer biomarker 
study (Prassas et al 2014). Baker (2015) described problems with nonspecific detection 
by improperly validated antibodies in epigenetics studies. Bordeaux et al (2010) 
concluded that the burden of proof that an antibody detects its declared target lies on the 
investigator, not necessarily the lab that produced the antibody. Other investigators have 
tried to avoid these problems. Gliadin researchers Skovbjerg et al (2004) tested the mAbs 
they generated against synthetic peptide mixtures to ensure specificity. The developers of 
the Rida R5 sandwich ELISA documented their development process, and described the 
cross-reactivity of the R5 antibody with barley and rye prolamins (Thompson and 
Mendez 2008). Kahlenberg et al (2006) further evaluated the R5 antibody for specificity 
using synthetic peptides, and compared its performance with other anti-prolamin mAbs.  
The problem of gliadin quantitation has been the subject of much interest. The 
Mendez R5 sandwich ELISA and its competitive ELISA counterpart (Mujico et al 2012) 
were still under evaluation by the Prolamin Working Group while they were the assays 
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currently recommended by the Codex Alimentarius Commission (2004; 2008). Mujico et 
al (2012) criticized the Mendez R5 sandwich ELISA as lacking in reproducibility. The 
standard for this assay was supposedly derived from only 12 cultivars, and in the opinion 
of Mujico et al is not a reproducible reference. It is also not a pure protein, but a mixture 
of glutenins and gliadins extracted using 60% ethanol. Their other criticism addressed 
public availability of anti-gliadin mAbs—only as a component of a kit. Another assay 
using the G12 monoclonal antibody has been released (Moron et al 2008; Working Group 
on Prolamin Analysis and Toxicity 2013; Gell 2015).  
The pAb used in the development of the indirect ELISA was not entirely free of 
problems. As the sample matrix evaluated in this study was simply milled flour, 
theoretically there was no need to evaluate cross-reactivity with other substances such as 
milk, eggs, or shellfish. However, reports of endogenous anti-gliadin antibodies in lab 
rabbits fed commercial lab animal diets (March 2003) raised a concern regarding 
specificity of the pAb used in this study. Non-specific antibodies reacting to other flour 
components may result in overestimation of gliadin content. Affinity purification of the 
pAb using gliadin peptides characterized by mass spectroscopy or chromatography would 
increase confidence in the specificity of gliadin detection by the pAb used in this study. 
Availability of detection reagents is only one issue with gliadin quantitation. 
Taylor et al (2009) cited a general lack of acceptable reference materials for most 
allergens, which makes any declared reference subject to contention. Variability of 
gliadin isoforms has been described elsewhere, and can be used by seed testing 
laboratories to discriminate between cultivars. A suitable reference material would need 
to include many different cultivars to ensure it is representative of wheat in production. 
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The method by which a reference is isolated may also influence its utility for evaluating 
samples treated by a different method; Ellis et al (1998) encountered this problem while 
studying starch granule-bound gliadin. The authors found that repeated washing of wheat 
starch changed the gliadin profile in the final sample. The difference in solubility and 
lack of parallelism between the purchased and unknown sample dilution curves described 
in the previous sections was probably due to the differences in the extraction methods 
used to isolate the purchased gliadin and unknown samples.  
CONCLUSION 
This study indicated that the ELISA method was an inappropriate system to use 
for measuring gliadin accumulation in raw flour. The accumulation levels in flour 
exceeded the functional limits of the commercial assay, and required extensive serial 
dilution to bring extracts within the functional limits of the assay. Serial dilutions can be 
time-intensive and can lead to increased uncertainty in the measurement. The commercial 
sandwich ELISA was more appropriate for measuring trace amounts of gliadin in foods. 
High-throughput assessment of gliadin accumulation might be more accurately and 
quickly achieved through other methods such as NIR (Garcia-Molina et al 2016). 
Establishing an accurate system of assaying gliadin accumulation is crucial for 
developing criteria upon which to base selection decisions. Identification of low-gliadin 
cultivars might be confounded by direct selection on other target traits. Previous reports 
indicated that increased gliadin content tends to reduce dough strength (Blumenthal et al 
1993; Daniel and Troboi 2000). Dough rheology traits are often used as a basis for 
selection in wheat breeding programs, so differences in gliadin accumulation may not be 
evident in the advanced or released varieties as weak-doughed cultivars are discarded 
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during advanced trials. Selection for total protein or dry gluten content could indirectly 
influence gliadin accumulation. Preharvest sprouting susceptibility is another trait that 
could potentially confound selection on gliadin accumulation, as the measured seed 
storage proteins could either appear to increase when multiple epitopes become exposed 
through partial hydrolysis or decrease after complete hydrolysis of the proteins. The 
correlations between current wheat breeding target traits and gliadin accumulation need 
systematic investigation to determine if direct selection on gliadin traits is feasible.   
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Figure 3.1. Comparison of the ELISA formats used in this study. A) direct, B) 
indirect, and C) sandwich formats. In A and B, the target is directly adsorbed to the 
microtiter plate using a coating buffer suitable for the substrate system. After 
incubation, unbound sample is washed away. Non-specific binding is diminished by 
blocking with a solution containing a non-reactive protein (e.g., nonfat milk). The 
detection or primary antibody (dark gray) binds to the epitope (yellow). A) 
Horseradish peroxidase (HRP) is conjugated to the detection antibody. The 
chromogenic detection substrate TMB and peroxide are added. The HRP catalyzes 
hydrolysis of peroxide, generating free radicals that oxidize TMB. A blue precipitate 
develops. The reaction is stopped by addition of 1 N sulfuric acid (H2SO4). The 
optical density of the precipitate is measured at 450nm by a plate reader. B) The 
indirect ELISA differs from the direct by addition of a secondary antibody conjugated 
to HRP. C) In the sandwich ELISA, a capture antibody coats the plate. The target is 
then added and incubated. Excess sample is washed away. The detection antibody is 
conjugated to HRP. The remaining steps are the same as in A and B. 
A. B. C. 
H2SO4 stop 
TMB + H2O2 
HRP 
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  Figure 3.2. Comparison of the ELISA standard curves, 2014 indirect and 2015 
direct assay. The extracted standards were diluted to the same concentration of 
ethanol-soluble proteins as measured by Bradford assay to ensure the dilution steps 
remained consistent year-to-year. The standard curves were quantified with the R5 
commercial assay to ensure parallelism of responses.  
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Figure 3.3. Bland-Altman analysis of ELISA-1 and ELISA-2 mean differences. 
The mean of differences was calculated to determine the degree of bias between the 
two assay formats. The mean of differences in gliadin measurement was -6.703 g kg-1 
of flour.  
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Figure 3.4. Bland-Altman analysis of experimental versus commercial ELISA 
mean differences. The mean of differences in gliadin measurement was 0.412 g kg-1 
of flour.  
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Figure 3.5. Histogram of the bootstrapped resample of observed differences in 
assay means.  
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Table 3.1. Summary of ELISA functional limits.  
The limits are described in ng mL-1 of solution used to coat the plate, as dilution 
factors of the unknowns were adjusted to keep signal within the range of the standard 
curve. The functional sensitivity of the test, in bold text, is determined by the limit of 
detection and by the lowest standard concentration. The four-parameter fit model 
does not permit extrapolation beyond the lowest and highest concentrations of the 
standard points. 
  
Limit of Blank Limit of Detection Limit of Quantitation 
ng mL-1 coating solution ng mL-1 coating solution ng mL-1 coating solution 
(ng well-1) (ng well-1) (ng well-1) 
ELISA-1 
2.26 13.37 13.37 
-0.23 -1.33 -6.00 
        
ELISA-2 
4.44 5.81 5.81 
-0.44 -0.58 (6.00) 
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Table 3.2. Parameter estimates of the standard curves 
for ELISA-1 in 2014 and ELISA-2 in 2015. 
The ELISA-1 (12 assays) model had a residual error of 0.27 on 175 degrees of 
freedom, required six iterations to convergence, and achieved convergence tolerance 
at 1.578e-06. ELISA-2 (18 assays) had a residual standard error of 0.1442 on 250 
degrees of freedom, required three iterations to achieve convergence, and achieved 
convergence tolerance at 1.455e-07. 
Parameters Estimate SE t Pr(>|t|) 
ELISA-1     
A 0.12 0.24 2.15  0.0331 
B 1.54 0.24 6.30 <0.0001 
C 21.64 3.49 6.20 <0.0001 
D 2.37 0.24 10.02 <0.0001 
ELISA-2     
A 0.05 0.03 2.03  0.0436 
B 0.98 0.21 4.71 <0.0001 
C 20.46 11.71 1.75  0.0818 
D 1.41 0.37 3.82  0.0002 
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Table 3.3. Bland-Altman analysis table 
comparing ELISA-1 and ELISA-2 gliadin measurements. 
Cultivar Name ELISA-1 ELISA-2 Mean SD % Diff RSD 
1 FOREFRONT 22.083 23.437 22.76 0.957 -6.1 4.205 
1 FOREFRONT 28.182 23.179 25.68 3.538 17.8 13.777 
2 PREVAIL 22.553 21.944 22.248 0.431 2.7 1.937 
2 PREVAIL 27.572 18.689 23.13 6.281 32.2 27.155 
3 SD4552 21.768 24.737 23.252 2.099 -13.6 9.027 
4 SD4557 20.632 17.402 19.017 2.284 15.7 12.010 
5 SD4558 26.681 16.21 21.446 7.404 39.2 34.524 
6 SD4585 30.751 29.516 30.133 0.873 4 2.897 
7 SD4587 29.77 48.443 39.106 13.204 -62.7 33.765 
8 SD4589 31.761 28.153 29.957 2.551 11.4 8.516 
9 SD4594 31.093 30.475 30.784 0.437 2 1.420 
10 SD4493 14.03 33.419 23.724 13.71 -138.2 57.790 
11 SD4496 12.925 25.955 19.44 9.214 -100.8 47.397 
12 SD4501 13.579 32.756 23.168 13.56 -141.2 58.529 
13 SD4506 14.38 38.569 26.475 17.104 -168.2 64.604 
14 SD4511 20.567 35.114 27.84 10.286 -70.7 36.947 
15 SD4514 15.318 55.803 35.56 28.627 -264.3 80.503 
16 SD4515 13.341 33.333 23.337 14.136 -149.9 60.573 
17 SD4524 19.272 20.182 19.727 0.643 -4.7 3.259 
18 SD4529 19.691 20.159 19.925 0.331 -2.4 1.661 
19 SD4537 21.695 18.95 20.322 1.941 12.7 9.551 
20 SD4539 17.642 26.711 22.176 6.413 -51.4 28.919 
21 SD4546 22.002 32.948 27.475 7.74 -49.8 28.171 
22 SD4548 21.779 17.424 19.602 3.079 20 15.708 
23 FALLER 22.711 35.856 29.284 9.295 -57.9 31.741 
 Mean 21.671 28.375     
 Var 34.774 94.850     
 SD 5.897 9.739     
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Table 3.4. Bland-Altman comparison of the three ELISA formats. 
          Mean SD RSD 
Name Group ELISA1 ELISA2 R5 ELISA1+R5 ELISA2+R5 ELISA1+R5 ELISA2+R5 ELISA1+R5 ELISA2+R5 
SD4557 low 20.63 17.40 24.57 22.60 20.99 2.78 5.07 12.32 24.15 
SD4552 low 21.77 24.74 21.96 21.86 23.35 0.14 1.96 0.62 8.41 
PREVAIL low 25.06 20.32 29.51 27.29 24.91 3.14 6.50 11.53 26.09 
SD4493 low -- -- -- -- -- -- -- -- -- 
SD4514 high 15.32 55.80 37.97 26.64 46.88 16.02 12.61 60.11 26.90 
FOREFRONT high 25.13 23.31 25.50 25.32 24.40 0.26 1.55 1.02 6.35 
SD4529 high 19.69 20.16 27.33 23.51 23.75 5.40 5.07 22.98 21.36 
SD4506 high 14.38 38.57 30.36 22.37 34.46 11.30 5.81 50.50 16.85 
SD4587 high 29.77 48.44 20.33 25.05 34.39 6.68 19.88 26.65 57.81 
FALLER high -- -- -- -- -- -- -- -- -- 
SD4589 high 31.76 28.15 23.82 27.79 25.99 5.61 3.06 20.20 11.78 
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Table 3.5. Paired t test of nine HRSW cultivars  
measured with all three ELISA formats. 
A two-sided, paired t test was used to compare the means obtained by ELISA-1 and 
ELISA-2 to that of the R5 assay. The significance level was set at 0.05 prior to the 
analysis. 
  Mean Mean of 
differences 
t test CI95 
  (g kg-1) t df p-value LL UL 
ELISA-1 22.61 -4.20 -1.23 8 0.2573 -12.15 3.74 
ELISA-2 30.77 3.95 0.95 8 0.3717 -5.68 13.57 
Commercial 26.82 -- -- -- -- -- -- 
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Table 3.6. Comparison of low- and high-gliadin groups. 
A two-sample t test was used to compare the means of the low- and high-gliadin 
groups identified by ELISA-1 and ELISA-2 with the measurements acquired using 
the R5 assay. The significance level was set at 0.05 prior to the analysis. The 
commercial ELISA did not discriminate between the two groups identified by 
experimental ELISAs (p > 0.05). 
 Low High t test 
  mean mean t df p 
ELISA-1 and ELISA-2 23.092 27.653 -3.801 30.894 0.0006 
Commercial ELISA 23.54 26.381 -1.176 30.391 0.2488 
Mean of differences -0.448 1.272 -- -- -- 
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Table 3.7. Comparison of the ELISAs used to quantify gliadin in 34 HRSW 
cultivars. 
A paired t test was used to compare the means returned by the two tests. The 
significance level was set at 0.05 before performing the analysis. No significant 
differences (p > 0.05) were found between the two ELISA measurements. 
  Experimental ELISAs Commercial ELISA t test 
Group Mean Variance SD Mean Variance SD t df p 
Low 23.09 8.85 2.98 23.54 34.23 5.85 -0.30 17 0.7687 
High 27.65 17.07 4.13 26.38 75.65 8.41 0.78 17 0.4451 
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Table 3.8. Summary of protein traits by location-year in the 54 cultivars. 
Location-
year 
Whole-grain protein Flour protein Gliadin 
Mean 
Var SD 
Mean 
Var SD 
Mean 
Var SD 
(g kg-1) (g kg-1) (g kg-1) 
BRK2013 151.23 36.96 6.08 138.83 29.21 5.40 39.01 
108.0
7 
10.40 
BRK2014 148.34 40.07 6.33 136.27 63.42 7.96 24.95 36.20 6.01 
BRK2015 150.73 36.06 6.01 136.05 29.51 5.43 21.65 67.55 8.22 
BRK2016 138.72 48.66 6.98 126.13 29.81 5.46 37.16 61.58 7.85 
GRO2013 146.64 26.58 5.16 136.40 30.56 5.53 37.16 75.17 8.67 
GRO2014 145.01 43.17 6.57 130.54 83.52 9.14 24.31 37.45 6.12 
GRO2016 144.18 26.01 5.10 134.62 20.08 4.48 30.80 49.00 7.00 
SEL2013 159.06 43.74 6.61 147.56 46.17 6.80 41.53 
125.8
6 
11.22 
SEL2014 155.80 48.75 6.98 142.09 60.59 7.78 19.63 49.02 7.00 
SEL2015 154.30 32.64 5.71 141.22 28.28 5.31 29422 74.57 8.64 
SEL2016 156.72 78.46 8.89 145.69 70.54 8.40 39.84 33.17 5.76 
WAT2015 143.50 33.04 5.75 131.78 30.15 5.49 28.83 70.18 8.38 
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Table 3.9. Correlations between gliadin and protein traits in the nine cultivars 
measured with all three ELISA formats. 
Significant correlations (p ≤ 0.05) are highlighted in bold text. 
  ELISA1 ELISA2  R5 Whole-grain protein Flour protein 
ELISA1        1     
ELISA2 -0.19 1    
R5 -0.69 0.41 1   
Whole-grain protein -0.10 0.77 0.23 1  
Flour protein 0.04 0.69 0.05 0.92 1 
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CHAPTER 4. AGRONOMIC AND QUALITY TRAIT ANALYSIS 
ABSTRACT 
One hundred fifty-four hard red spring wheat (Triticum aestivum L.) cultivars 
were assessed for 14 agronomic and quality traits, with 80 cultivars further evaluated for 
baking traits. Spearman’s rank correlations between the 14 traits and gliadin 
accumulation indicated that relationships between gliadin and Hagberg Falling Number (r 
= 0.32), milling percent (r = -0.36) shorts (r = 0.43), and test weight (r = 0.36) were 
statistically significant (α = 0.05), while correlations with whole-grain protein, flour 
protein, and dry gluten were not significant for the 154 genotypes. Regression analysis 
identified growing environment as a strong influence on all protein traits (F(11, 684) = 
36.77, adjusted R2 = 0.36.15, p < 0.0001), even stronger than genotype for gliadin 
accumulation (F(138, 557) = 2.26, adjusted R
2 = 0.2000, p < 0.0001). Principal components 
analysis of the 80 quality-tested cutivars indicated that the first two dimensions of the 
model did not explain the variation observed in gliadin accumulation. Biplot analysis 
indicated that selection on the mixing and baking traits might effect a slight decrease in 
gliadin accumulation. Analysis of least significant differences indicated that gliadin 
accumulated in five of 12 environments was not significantly different (α = 0.05), unlike 
the trends exhibited by the other protein traits.  
INTRODUCTION 
Overview of plant breeding objectives 
Plant breeding objectives are driven by market demands, and the market demands 
light, fluffy bread with large loaf volume. Misconceptions about the effects of selection, 
144 
 
such as the assumption that breeders select only for high protein and have somehow 
created immunogenic wheats, have led to public condemnation of wheat (Triticum 
aestivum L.) and its effects on human health. If consumers are to understand how plant 
breeding influences wheat end-use and health benefits, they must first learn about some 
common plant breeding objectives, and the factors that drive plant breeding selections. 
 Yield 
Grain yield is an ancient plant breeding target. Domestication-related traits, such 
as seed retention (as opposed to shattering) and increased grain size, were early 
contributors to yield (Abbo 2014). This knowledge has survived to the modern era 
through surviving manuscripts of classical Roman-era authors who discussed the 
performance of their wheats. Cicero estimated returns of 8:1 and Varro of 10:1 in their 
respective regions, with a sowing rate of four to five modii per iugerum (or about one and 
a half to two bushels per one acre) on good soil (Green 1997; Erdkamp 2005).  
Protein quality 
Plant breeders aim to improve wheat protein quality, not simply quantity. Protein 
content largely dictates end-use quality of the grain. In terms of gluten, quality equals 
strength and extensibility for optimal gas-trapping capacity. These traits contribute to 
greater loaf volume and are the product of glutenin quality (Nelson et al 2006). Glutenins 
are the target, not gliadins, in bread wheat breeding. Absolute removal of gliadin would 
probably affect some wheat quality tests typically used to assess baking quality, as they 
do contribute to the viscosity and extensibility of bread doughs. Flours with less and 
weaker glutenin are more suitable for cookies and tortillas, and therefore have a greater 
percentage of extensibility-inducing gliadins relative to the total protein profile (Barak et 
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al 2013; Mondal et al 2009). Gliadins are especially important to cookie quality in terms 
of spread ratio and softness (Barak et al 2013; Barak 2015). The gliadin/glutenin ratio has 
been reported to have a strong correlation with cookie spread but a negative correlation 
with breaking force (Barak et al 2013). 
Several tests may be used to assess protein quality and strength, predictors of 
bread loaf volume. One is the alveograph (AACC Method 54-30.02, ICC Method 121). 
This test observes the tenacity (P) and extensibility (L) of dough, important traits for 
trapping gas bubbles within the bread loaf matrix (Bettge et al 1989; KSU 2008). High 
tenacity and extensibility predict more desirable gas cell formation in the final product. 
High values of L and deformation energy (W) correlate with greater loaf volume for hard 
wheat flours (Bettge et al 1989). Low values of W (~100 J) indicate cookie quality in soft 
wheat flour (Simsek 2015). Alveograph is the standard method used in some places, since 
Mixograph was not equally available in all countries until recently (Codina et al 2010; 
Mironeasa and Codina 2014).  
Kasarda (2013) noted that the domestication-related traits of wheat pertained to 
grain size and quantity, traits that are easily measured and have an inverse with protein 
accumulation. This problem complicates modern breeding efforts even with the advent of 
new and increasingly sophisticated protein analyses. The growing environment can also 
have profound effects on wheat protein (Graybosch et al 1995) and other traits. 
Sprouting damage 
Severe preharvest sprouting can incur discounts when the producer sells their 
grain. Starch debranching can make more simple sugars available to yeasts during 
fermentation, but can also reduce the consistency of batch-to-batch baking performance 
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(Hoseney 1986). The Hagberg Falling Number test is a measure of α-amylase activity, an 
indirect test of sprouting damage. Germination-induced expression of proteinases that 
hydrolyze storage proteins can change wheat flour end-use quality (Humphreys and Noll 
2002; Ganzle et al 2008). 
Baking volume/extensibility 
Consumer preference drives this breeding objective. The definition of ‘quality’ 
depends on the type of bread discussed. For example, hearth breads baked without the 
support of a pan require flour with high protein quality (not quantity) and non-endosperm 
components removed to achieve the form ratio characteristic of this bread family Aamodt 
et al (2005) proposed that gas-holding ability is responsible for the most desirable form 
ratios. Northern Chinese steamed breads also require high dough strength (Huang et al 
1996). Flatbreads, whether leavened or unleavened, depend on dough pasting quality and 
protein extensibility (Qarooni et al 1993; Pena 2008). Light-textured breads need strong, 
elastic proteins to hold the air bubbles that lead to fine crumb textures. Selections made 
on volume and extensibility traits can be made using molecular markers associated with 
these traits instead of relying on biochemical assays alone (Branlard et al 2001; Bedo et 
al 2017). The molecular markers ensure that favorable alleles are retained through the 
selection process even if environmental conditions do not induce expression of the 
desired trait. 
Milling yield 
Plant breeders must also keep the interests of millers in mind when making 
crosses and selections. Test weight and kernel size indicate potential milling yield—and 
therefore profitability—of wheat (Krishnan et al 2012). Grain batches with a large 
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percentage of small kernels would reduce the extraction efficiency through the first of the 
five breaks in the milling pipeline. Heterogeneity of kernel size would require 
adjustments of the commercial roller mill to extract flour from smaller kernels, adding to 
increased costs (Posner 2009). Kernel hardness, which can be measured either by the 
single kernel characterization system (SKCS, commonly used in the US) or the particle 
size index (PSI), is also a determinant of milling yield (Posner 2009), water absorption, 
and baking properties (Pena 2008).  
The plant breeder’s goal is to balance all these requirements while making 
selections to capture maximum genetic gain, and to ensure the traits remain stable 
regardless of production conditions. Furthermore, selection decisions consider the 
combined performance of several traits. The selective pressure on each trait is therefore 
lower than if selections are directly made on the individual traits, unless the traits are 
correlated. Correlation between directly-selected traits, especially protein traits, and 
gliadin could indicate potential indirect selection on gliadin. This study was designed to 
identify potential correlations between common wheat breeding target traits and gliadin 
accumulation.  Relationships between gliadin and other traits could also be used to 
predict the magnitude of potential indirect selection, and answer questions raised about 
unintended consequences of plant breeding activities (Kasarda 2013). 
MATERIALS AND METHODS 
Plant materials 
One hundred fifty-four hard red spring wheat cultivars were grown in the South 
Dakota State University Spring Wheat Breeding Program yield trials between 2013 and 
2016. Fifteen of these were performance check cultivars. These locations included four 
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sites in South Dakota: Brookings (lat. 44.31, long. -96.67), Groton (45.49, -100.01), 
Selby (45.108, -97.103), and Watertown (45.42, -97.91). All plant materials were planted 
in a randomized block design with three replicates at the three locations. Due to hail 
damage at the Groton location in 2015, a location substitution (Watertown) was made to 
balance the dataset. 
Assessment of traits 
Whole-grain protein was measured by near-infrared spectroscopy (NIR) at 570-
1050 nm and test weight was determined through use of a Foss 1229 Infratec Grain 
Analyzer (Hilleröd, Denmark). Hagberg Falling Number, milling yield, kernel trait, 
rheological, and baking trait analyses were conducted by the USDA Hard Red Spring and 
Durum Wheat Quality Laboratory (Fargo, ND). Replicate samples were composited 
before splitting into 500 g representative samples and milled at SDSU using a Brabender 
Quadrumatic® Jr mill (Duisberg, Germany). The flour was sifted using a # 60 sieve 
(Fisher Scientific). Flour samples were then subjected to the Perten Gluten Index (ICC 
Standard Method #155) analysis of washed gluten and to the ELISAs described in 
Chapter 3. 
Statistical analysis  
 All statistical analyses were performed using R version 3.3.2 (The R Core Team 
2016) and the packages named hereafter. The Grubb’s test for outliers in the full dataset 
was conducted using the library ‘outliers’ (Komsta 2011). Normality was assessed using 
the Anderson-Darling test from the library ‘nortest’ (Gross and Ligges, 2015) and the 
Shaprio-Wilk test (The R Core Team 2016). The package ‘moments’ (Komsta and 
Novomestky 2015) was also used. Levene’s test from the package ‘lawstat’ (Gastwirth et 
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al 2015) was applied to evaluate homoscedasticity of variance. Correlations between 
traits was determined using base R and the library ‘corrplot’ (Wei and Simko, 2016). 
Principal components analysis (PCA), k-means clustering, and biplot drawing were 
performed using base R functions and the package ‘factoextra’ (Kassambara and Mundt 
2017). 
RESULTS 
Grain traits 
Performance check cultivars and cultivars under development were compared on 
the basis on means per location-year, due to the breeding program workflow. The 
performance check cultivar annual mean test weight, kernel size, and sprouting damage 
are summarized in Tables 4.1 through 4.4. Note that performance check varieties are 
periodically updated in performance yield trials; in this study, replacements were made in 
2014, 2015, and 2016. The replacement varieties (‘Prevail’, ‘Focus’, and ‘Surpass’) were 
included in the previous years’ yield trials, and so were assessed as part of the 
performance check group for all years. These observations were included in the trait 
means summarized in Tables 4.1 through 4.4. The distribution of the cultivars under 
development was assessed by the Anderson-Darling test of normality (library ‘nortest’), 
as this method is more robust against outliers. The null hypothesis of normality was not 
rejected for test weight (A = 1.52, p = 0.0007) at a significance level of α = 0.05, for Case 
0 (Acritical = 2.492), but was rejected for large (A = 6.04, p < 0.0001) and small (14.58, p < 
0.0001) kernel size and, respectively, and Falling Number score (93.41, p < 0.0001). A 
rank-based Brown-Forsythe type Levene’s test on medians (package ‘lawstat’, trim = 
0.05, no correction, kruskall.test = TRUE) failed to accept the null hypothesis of 
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homogenous variance for all traits in the cultivars under development (Wcritical = 1.803, df 
= 11 and 690) at a significance level of α= 0.05. Examination of kurtosis and skew 
indicated that kurtosis exceeded [skewness2 + 1] for all traits (data not shown). A Welch 
two-sample t test comparing trait means between the cultivars under development and 
performance check cultivars indicated a difference in test weight (t = 3.98, df = 351.58, p 
< 0.0001) at a significance level of α = 0.05. The mean test weight of the 139 cultivars 
under development (59.78 lb bu-1) slightly outperformed the 15 performance check 
varieties (59.10 lb bu-1). The mean percentages of large kernels (t = -0.36, df = 363.14, p 
= 0.721), and small kernels (t = -0.66, df = 346.48, p = 0.4608) were not significantly 
different between the cultivars under development and performance check cultivars. 
The hypothesis of equal means in the cultivars under development was not 
rejected by one-way ANOVA at a significance level of a = 0.05 for test weight (F(138) = 
4.80, p < 0.0001), large and small kernel size (F(138) = 6.44 and F(138) = 6.16, respectively 
with p < 0.0001), and Falling Number (F(138) = 1.30, p = 0.0227). The package ‘agricolae’ 
(de Mendiburu 2016) was used to analyze Fisher’s least significant differences (LSD) for 
test weight and Falling Number score by location-year are summarized in Table 4.5. 
Significant differences were identified between the means of different location-years for 
kernel size traits (data not shown). Genotype and location-year were predictive for grain 
traits in the cultivars under development. Multiple regression analysis (y = m1x1 +m1x2 + 
b) was conducted for each trait. Test weight demonstrated the most predictable linearity, 
with a residual standard error (RSE) of 0.706 (df = 552) and an F-statistic of 43.30 (df = 
149 and 552, p < 0.0001). The adjusted R2 (0.8999) indicated that genotype and location-
year considered together may adequately predict test weight. Of the 122 genotypes with 
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significant effect (p ≤ 0.05), 15 cultivars under development produced at least 4 lb bu-1 
more than the population mean of 59.79 lb bu-1. SD4580 had the highest test weight 
(+5.25 relative to the mean). Five location-years were determined to exert a negative 
effect on test weight in the cultivars under development (Brookings 2014, Brookings 
2015, Selby 2014, Selby 2015, and Watertown 2015) at a significance level of α = 0.05. 
Groton had the most positive impact on test weight in 2013 (+2.71 lb bu-1) of the 
remaining seven environments.  
One-way ANOVA indicated that genotype had a statistically-significant influence 
on the percentage of large kernels produced (F(138) = 6.44, p < 0.0001). A high adjusted 
R2 (0.8209) and F-statistic (22.56, df = 149 and 552, p < 0.0001) obtained using multiple 
regression indicated that the combination of genotype and environment could be used to 
predict large kernel size (RSE = 6.47, df = 552). Most location-years had a positive 
influence on large kernel size, with two exceptions: Groton in 2013 and Selby in 2015. 
Simple regression suggested that these two locations may have produced fewer large 
kernels (-1.46 and -3.27%, respectively), although the null hypothesis of no effect was 
not rejected at a significance level of α = 0.05 (p = 0.5382 and 0.1524, respectively). 
Multiple regression indicated that small kernels could be adequately predicted using the 
modeled factors (R2 = 0.8187, F(149, 552) = 16.73, p < 0.0001). Comparison with multiple 
regression analysis conducted on the performance check cultivars (R2 = 0.7353, F(25, 184) 
= 20.45, p < 0.0001) supports this conclusion. A Welch two-sample t test of means (t = -
0.66, df = 344.98, p = 0.5072) indicated that the true difference between the released and 
developing cultivars was negligible (10.12% versus 10.36% small kernels). The four 
cultivars under development that produced the largest kernels (p < 0.0001) were SD4507 
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(32.0 %), and SD4489, SD4490, and SD4494 (tied at 30.0 %). All environments with 
statistically significant effect exerted a negative influence on small kernel size. Only 
Selby in 2015 failed to demonstrate a differentiable influence (p = 0.3763) in the cultivars 
under development.  
Environmental conditions influenced Falling Number score more strongly (R2 = 
0.6587, F(11, 690) = 121.10, p < 0.0001) than genotype (R
2 = 0.2410, F(138, 563) = 1.295, p = 
0.0227). Sprouting damage was observed after harvest-time rains in the Brookings and 
Selby locations in 2014, and at the Watertown location in 2015 (Figure 4.1). The 
combination of environmental conditions with genotype explained approximately 80.5 % 
of the variance in sprouting damage (adjusted R2 = 0.7518, F(149, 552) = 15.25, p < 0.0001). 
The cultivars under development suffered the worst sprouting damage at Selby 2014 (-
187.00 sec, p < 0.0001), followed by Brookings 2014 (-43.28 sec, p < 0.0001) and 
Watertown (-20.90 sec, p = 0.0055). One-way ANOVA indicated that both genotype 
(F(138) = 1.295, p < 0.0227) and location-year (F(11) = 121.06, p < 0.0001) contributed to 
Falling Number score at a significance level of α = 0.05. Simple regression analysis on 
the performance checks mirrored the results observed in the developing varieties in 2014 
(Selby = -206.37 sec, Brookings = -44.40 sec, p < 0.0001), with environment contributing 
to 76.16% of the observed variance in the trait. The effect of performance check genotype 
was minimal (R2 = 0.0599, F(14, 915) = 0.8881) by comparison. The Falling Number scores 
from the performance check grain harvested at Watertown in 2015 were not determined 
to be different between the damaged and undamaged samples (p = 0.6088). The means of 
the cultivars under development and of the performance checks were concluded to be 
different by a Welch two-sample t test (t = -0.83, df = 334.79, p = 0.4058). This probably 
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reflects the degree of selection already enacted upon each group. The greater proportion 
of variance described in the varieties under development was probably due to a small 
number of cultivars with greater-than-average susceptibility to sprouting damage 
included in the trial. Multiple regression identified six of the 139 cultivars under 
development that exhibited a significant resistance or susceptibility to sprouting damage 
(p < 0.05). SD4511 retained grain integrity best, with a Falling Number score of ~73 
seconds (p = 0.0085) greater than the population mean (411.99 seconds). SD4552 
demonstrated the greatest susceptibility with a score of ~90 seconds lower than the mean 
(p = 0.0002). The cultivars with significant resistance or susceptibility are summarized in 
Table 4.6.  
Milling quality traits 
The performance check cultivar annual mean bran, shorts, and flour yield are 
summarized in Tables 4.7 through 4.10. The null hypothesis of normality was not 
accepted for any of the milling quality traits at a significance level of α = 0.05, for Case 0 
(Acritical = 2.492). A rank-based Brown-Forsythe type Levene’s test on location-year 
medians failed to accept the null hypothesis of homogenous variance for all traits (Wcritical 
= 1.803, df = 11 and 684).  
The hypothesis of equal means in the 139 cultivars under development was not 
rejected by one-way ANOVA at a significance level of α = 0.05 for bran (F(138) = 7.91, p 
< 0.0001), shorts (F(138) = 4.16, p < 0.0001), milling percentage (F(138) = 5.78, p < 
0.0001), and flour yield (F(138) = 6.74, p < 0.0001). Equivalence of means in response to 
location-year was also not rejected for bran (F(11) = 12.81), shorts (F(11) = 100.82), 
milling percentage (F(11) = 36.74), and flour yield (F(11) = 42.31, p < 0.0001). Fisher’s 
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least significant differences for bran and shorts are summarized in Table 4.11. The means 
of bran (t = 3.88, df = 309.92), shorts (t = 3.21, df = 430.51), milling percentage (t = -
4.67, df = 347.04), and flour yield (t = -4.34, df = 330.66) were concluded to be different 
by a Welch two-sample t test (p < 0.0001) comparing the performance of check and 
developing cultivars at a significance level of α = 0.05. Multiple regression analysis 
indicated that the combination of genotype and location-year had strong predictive power 
for all milling quality traits (Tables 4.12-4.15). The high R2 (0.8285) and low RSE (1.70, 
df = 552) indicated that genotype and location-year considered together may adequately 
predict bran, with other unmodeled factors influencing this trait (F(149, 552) = 17.89, p < 
0.0001). Less than half of the cultivars under development with statistically significant 
effect produced lower percentages of bran relative to the average of the population (Table 
4.12). The greatest genotypic contribution to bran development was exhibited by SD4477 
(+19.62%) and SD4313 (+19.17%) Ten location-years were determined to exert a 
negative effect on bran accumulation in the 139 cultivars under development at a 
significance level of α = 0.05. The single environment that promoted bran development 
was Selby in 2016 (+1.25%). Simple regression of shorts accumulation on location-year 
indicated that growing environment had a greater effect (R2 = 0.6165, F(11, 690) = 100.8, p 
< 0.0001) on this trait than did genotype (adjusted R2 = 0.5050, F(138,563) = 4.162, p < 
0.0001). Together, genotype and growing environment explained ~90% of the variation 
in this trait (F(149, 552) = 33.89, p < 0.0001). Eight of the 68 cultivars listed in Table 4.13 
exhibited a smaller quantity of midds than the population mean. Cultivars SD4477 
(14.80%) and SD4313 (10.63%) had the strongest positive effect on shorts development 
of the population. Seven location-years had a positive effect on shorts accumulation; the 
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greatest positive influence occurred at Brookings in 2016 (+13.46%).  
Milling percentage also demonstrated a high response to the combined effects of 
genotype and location-years with 66 genotypes and nine environments demonstrating 
significant contributions to the trait (Table 4.14). Only one genotype demonstrated a 
statistically significant positive effect on milling percentage: SD4579 (+2.60%, p = 
0.0029). For most of the cultivars under development, genotype contributed a depressive 
effect on milling percent. Multiple regression analysis indicated the worst performance 
was demonstrated by SD4477 (-17.09%). Environmental effects varied (Table 4.14). The 
largest loss of milling percentage was observed at Brookings in 2016 (-5.94%), which 
would have depressed the milling percentage further in cultivars such as SD4477.  
Despite the good linear relationship between genotype, environment, and flour 
yield (R2 = 0.87, RSE = 2.85 on 560 df), the effect of genotype alone was negative for all 
cultivars (data not shown). Simple regression indicated that factors other than genotype 
contributed strongly to phenotype (adjusted R2 = 0.623, F(138, 563) = 6.74, p < 0.0001). The 
contribution of location-year of even lower (R2 = 0.4028, F(11, 690) = 43.18, p < 0.0001). 
The most suppressive environment was Brookings in 2016 (-11.74 g), followed by Selby 
in 2016 (-9.37 g). Groton and Selby both promoted flour yield in 2013 (+4.22 g and 
+3.99 g, respectively) and 2014 (+2.89 g and +2.24 g, respectively). The Welch two-
sample t test hypothesis of unequal means between the performance checks and cultivars 
under development was not rejected (t = -4.46, df = 330.66, p < 0.0001) at a confidence 
level of 95% (CI95 = -3.71, -1.43). The higher mean flour yield observed in the 
performance checks is probably the result of directional selection upon this trait. 
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Protein traits measured by NIR 
The performance check cultivar whole-grain protein and flour protein measured 
by NIR are summarized in Tables 4.15 through 4.18. The null hypothesis of normality 
was accepted for both traits at a significance level of α = 0.05, for Case 0 (Acritical = 
2.492), but the rank-based Brown-Forsythe type Levene’s test on location-year medians 
failed to accept the null hypothesis of homogenous variance (Wcritical = 1.802, df = 11 and 
690). The mean, range, and probability density of whole-grain protein and flour protein 
accumulations are illustrated in Figures 4.2 and 4.3.  
The hypothesis of equal means in the cultivars under development was not 
rejected by one-way ANOVA at a significance level of α = 0.05 for either whole-grain 
protein (F(138) = 3.12, p < 0.0001) or flour protein (F(138) = 2.95, p < 0.0001). Equivalence 
of means in response to location-year was also not rejected for either trait (whole-grain 
protein: F(11) = 54.25, flour protein: F(11) = 49.14, p < 0.0001). Fisher’s Least Significant 
Differences with Bonferroni correction for whole-grain protein and flour protein in the 
full population are summarized in Table 4.19. Mean whole-grain protein across the 12 
location-years was 149.48 g kg-1 (CV = 4.27), with a LSD of 1.74 g kg-1. Mean flour 
protein was 137.23 g kg-1 (CV = 4.90), with a LSD of 1.78 g kg-1. Environmental 
conditions varied widely between locations. The Selby location consistently produced 
mean whole grain protein accumulation of 15% or greater over the four-year study 
period. The Groton 2013, Groton 2014, and Watertown 2015 locations promoted 
relatively similar protein accumulations, making Watertown a suitable substitution for the 
hailed-out Groton location in 2015. Flour protein measured in the Brookings population 
varied more widely than at the other locations, which was reflected in both whole-grain 
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protein and flour protein. The 2016 growing season triggered a shift in mean flour protein 
in all locations. The four-year mean for all cultivars at Brookings (134.75 g kg-1) was less 
than the three-year mean (137.31 g kg-1), but greater at Selby (145.67 compared to 144.41 
g kg-1). The three-year mean for flour protein at Groton (135.07 g kg-1) was greater than 
the 2013-2014 mean (134.87 g kg-1). Regression analysis indicated that the combination 
of genotype and location-year had strong predictive power for both protein traits 
measured by NIR (Tables 4.20-4.21). The high R2 (0.86, adjusted R2 = 0.82) and low 
RSE (3.65, df = 552) indicated that whole-grain protein predictably responds to 
environmental and genotypic factors, with other unmodeled factors influencing this trait 
(F(149, 552) = 22.22, p < 0.0001). Fifty-six of the cultivars under development had a 
statistically significant effect on whole-grain protein accumulation (α = 0.05). Of these, 
41 accumulated greater whole-grain protein relative to the mean of the population, with 
10 producing at least 10 g kg-1 more than average (Table 4.20). Five cultivars 
accumulated more than 10 g kg-1 less than the population mean: SD4460 (-11.11), 
SD4557 (-11.79), SD4640 (-14.54), SD4639 (-17.39), and SD4638 (-18.29). Only four 
location-years were determined to exert a positive effect on whole-grain protein 
accumulation in the cultivars under development during the four-year study (Table 4.20). 
Genotype alone explained less of the variation in flour protein observed in the cultivars 
under development (R2 = 0.44, adjusted R2 = 0.43) than growing environment (R2 = 0.42, 
adjusted R2 = 0.28). Environmental effects were more influential in flour protein 
accumulation (F(11) = 49.14, p < 0.0001) than genotypic effects (F(138) = 2.95, p < 
0.0001). Multiple regression results indicated that genotype and growing environment 
together explained 83.24% of the variation in this trait (adjusted R2 = 0.79, F(149, 552) = 
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18.40, p < 0.0001). Only four environments, all at Selby, promoted higher flour protein 
accumulations during the study duration (Table 4.21). The Brookings location in 2016 
depressed accumulations of whole-grain protein (-10.74 g kg-1) and flour protein (-12.00 
g) to the greatest extent of all locations. Comparison of group means accepted the 
alternate hypothesis of unequal means between the performance check cultivars and 
cultivars under development for both whole-grain protein (t = 6.73, df = 395.23) and flour 
protein (t = 6.46, df = 368.7) at the α = 0.05 significance level. The greater protein 
accumulations of the cultivars under development relative to the performance checks 
indicated progress in selection for increased total protein content in the population, but 
gave no indication of stability under different growing conditions. 
Dry gluten assessed by the Gluten Index method  
The measured dry gluten content of the performance check cultivars is 
summarized in Tables 4.15 to 4.18. Mechanical issues prevented assessment of the 2013 
trials, so the analyses of gluten traits include the 80 developing cultivars and performance 
checks assessed during the 2014 through 2016 trials. The Anderson-Darling null 
hypothesis of normality was accepted for dry gluten (A = 0.671, p = 0.0791) at a 
significance level of α = 0.05, for Case 0 (Acritical = 2.492). The rank-based Brown-
Forsythe type Levene’s test on location-year medians failed to reject the null hypothesis 
of homogenous variance in dry gluten accumulation, where the upper critical value of W 
= 1.96 on 8 and 422 degrees of freedom for the 80 cultivars (W = 25.20, p = 0.0014). The 
mean, range, and probability density of observed dry gluten are illustrated in Figure 4.4. 
 The hypothesis of equal means in the cultivars under development was not 
rejected by one-way ANOVA at a significance level of α = 0.05 (F(64) = 1.52, p = 
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0.0128). Equivalence of means in response to location-year was also not rejected (F(8) = 
22.45, p < 0.0001). Post-hoc analysis of all cultivars, checks inclusive, by Fisher’s LSD 
with Bonferroni correction found significant differences in mean dry gluten accumulated 
in different location-years. The three-year mean dry gluten for all location-years was 
112.81 g kg-1 (CV = 8.19). The Selby location promoted greater dry gluten accumulation 
in 2016 (12.32%) than the Brookings and Groton environments (Table 4.22), although 
mean dry gluten accumulation not significantly different between Selby and Brookings in 
other years. The Groton and Watertown locations demonstrated statistically significant 
differences in dry gluten accumulation between 2014 and 2015, indicating that the 
Watertown location was not a perfectly equivalent substitution with regard to this trait. 
Multiple regression analysis indicated that the combination of genotype and location-year 
did not fully explain the variance in the 80 cultivars under development (Table 4.23). The 
moderate R2 (0.6619) and low RSE (7.48, df = 230) indicated that dry gluten predictably 
responds to environmental and genotypic factors, with other unmodeled factors 
influencing this trait (F(72, 230) = 6.253, p < 0.0001). Of the 11 cultivars with significant 
genetic contribution to phenotype, one accumulated more dry gluten than the population 
mean: SD4501 (+11.00 g kg-1). The 10 genotypes contributing negative effects to gluten 
accumulation ranged between -9.57 g kg-1 (SD4493) and -23.26 g kg-1 (SD4557). Two 
Selby environments promoted dry gluten accumulation (Table 4.23). 
Gliadin measured by ELISA 
All cultivars grown in the yield trials (2013 through 2016) were subjected to 
ELISA assessment of gliadin. Of the 912 total cases, six samples failed to pass the 
acceptance criteria for the ELISA procedure (Refer to Chapter 3.). The measured gliadin 
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accumulation of the performance check cultivars is summarized in Tables 4.15 to 4.18. 
The null hypothesis of normal distribution of the 906 remaining observations was not 
accepted for gliadin (A = 4.55) at a significance level of α = 0.05, for Case 0 (Acritical = 
2.492), but the rank-based Brown-Forsythe type Levene’s test on location-year medians 
failed to accept the null hypothesis of homogenous variance (W = 79.55, Wcritical = 1.799, 
df = 11 and 894, p < 0.0001). The mean, range, and probability density of gliadin 
accumulation are illustrated in Figure 4.5.  
 The hypothesis of equal means in the cultivars under development was not 
rejected by one-way ANOVA at a significance level of α = 0.05 (F(138) = 2.26, p < 
0.0001). Post-hoc analysis by Fisher’s LSD with Bonferroni correction identified five 
environments that did not differ significantly for mean gliadin accumulation (Table 4.22). 
Mean gliadin for the 154 cultivars grown in 12 location-years was 29.98 g kg-1 (CV = 
28.06). The divergent Selby 2014 mean was concurrent with observed sprouting damage; 
otherwise, Selby consistently produced higher-than-average gliadin. As with dry gluten, 
multiple regression analysis for gliadin indicated that the combination of genotype and 
location-year did not fully explain the variance observed in gliadin accumulation for the 
varieties under development. Figure 4.6 illustrates the observations of gliadin 
accumulation in the individual performance check cultivars by location and year. Only 14 
cultivars under development exhibited a significant effect (α = 0.05) on gliadin 
accumulation (Table 4.24), as did three performance checks (Table 4.25). SD4503 
accumulated approximately 14.5 g kg-1 less gliadin than the population mean. 
Conversely, ‘Boost’ and ‘Steele-ND’ produced approximately 6 g kg-1more gliadin than 
other cultivars. That a small group of genotypes demonstrating a measurable effect on 
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this trait indicated that environmental factors probably had a greater impact on 
phenotype. Figure 4.7 illustrates the variation in gliadin accumulation in released 
cultivars grown under different conditions. Seven of the 12 environments exerted a 
statistically significant negative effect on gliadin accumulation. Selby in 2013 and 
Brookings in 2016 may have promoted gliadin accumulation (+3.19 and +0.5, 
respectively), but this was not established statistically by regression. The relatively low 
R2 (0.5946, adjusted R2 = 0.4835) and RSE (7.60, df = 546) for the model used to 
evaluate the cultivars under development indicated that gliadin accumulation was 
influenced by unmodeled factors aside from genotype and location (F(149, 546) = 5.37, p < 
0.0001). 
Baking quality traits 
Wet gluten, water binding, and gluten index were assessed for all cultivars, but 
Mixograph peak parameters, baking absorption, and loaf volume were assessed for only 
cultivars planted in the Advanced Yield Trials (AYT). Due to mechanical problems with 
the gluten analyzer, gluten traits were not assayed in 2013. Eighty cultivars grown during 
the 2014-2016 seasons, including the performance check cultivars, were subjected to 
quality testing at the Wheat Quality lab at Fargo (N = 431 cases). The summaries of 
Mixograph traits in the performance check cultivars by year are given in Tables 4.29 to 
4.28. Baking quality traits are given in Tables 4.29 to 4.31. The Anderson-Darling test of 
normality was applied to the cultivars under development. The null hypothesis of normal 
distribution was accepted for most gluten and baking traits at a significance level of α = 
0.05, for Case 0 (Acritical = 2.492 for n ≥ 5). The exceptions were Mixograph midline peak 
time (A = 5.59, p < 0.0001), Mixograph midline peak interval (A = 4.99, p < 0.0001), and 
162 
 
Mixograph band at 8 minutes (A = 2.99, p < 0.0001). The rank-based Brown-Forsythe 
type Levene’s test on location-year medians was applied to the cultivars under 
development. The null hypothesis of homogenous variance for gluten traits, where the 
upper critical value Wcritical = 1.970 on 8 and 294 degrees of freedom, was not accepted 
for wet gluten (W = 18.97, p = 0.0150), gluten index (W = 18.05, p = 0.089), or water 
absorption (W = 12.32, p = 0.1373). The calculated statistics for performance checks 
(Wcritical = 2.017, df = 8 and 119) did not support the hypothesis of homogenous variance 
for wet gluten (W = 3.48, p = 0.9006) and gluten index (W = 12.31, p = 0.0.1381). 
Homoscedasticity in baking mix time, baking absorbance, and loaf volume measurements 
was not accepted (data not shown). Therefore, the alternative hypothesis of heterogenous 
variance in the 80 cultivars was accepted.  
The hypothesis of equal means among the 80 cultivars was not rejected by one-
way ANOVA (α = 0.05, df = 79) for Mixograph parameters midline peak time (MPT; F = 
4.52), midline peak width (MPW; F = 2.30), midline peak value (MPV; F = 2.12), 
midline peak integral (MPI; F = 5.85), and bandwidth at 8 minutes (F = 2.99). Post-hoc 
analyses with Bonferroni correction in location-year means of Mixograph parameters are 
illustrated in Figure 4.8. The LSD for baking traits are depicted in Figure 4.9.  
 Simple regression of trait on location-year indicated that genotype explained 
30.90 to 61.02 % of the variances in end-use quality traits of the 80 cultivars under 
development (data not shown). Environmental effects explained 27.90 to 62.55% of 
variance in end-use quality (data not shown). Baking mixing time (R2 = 0.6102, F(79, 351) 
= 6.96, p < 0.0001) and Mixograph midline peak interval (R2 = 0.5682, F(79,351) = 5.85, p 
< 0.0001) traits were influenced most strongly by genotype, while baking absorption (R2 
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= 0.6255, F(8, 422) = 88.10, p < 0.0001) and loaf volume (R
2 = 0.6200, F(8, 422) = 86.05, p < 
0.0001) traits were most responsive to environmental influences. The 2014 Selby 
location, which suffered germination damage due to late-season rains, still had a positive 
influence on nearly all end-use quality traits in the 80 cultivars. The only negative 
contributions of this environment were to Mixograph midline peak value (-6.26, p < 
0.0001) and to baking absorption (-1.32, p < 0.0001). Loaf volume in breads baked from 
Selby 2014 grain was expected to expand approximately 9.7 cubic centimeters than the 
average of all locations-years. The other environments were expected to produce smaller 
loaf volumes.  
Correlation between traits 
Spearman rank-order correlations among 15 traits were analyzed for the 154 
cultivars grown in 12 environments. Statistically significant correlations (α = 0.05) were 
observed between large and small kernel size percentages (r = - 0.86), flour yield and 
shorts (r = -0.80), milling percentage and shorts (r = -0.86), flour yield and milling 
percent (r = 0.96), and flour protein and whole-grain protein (r = 0.90). Hagberg Falling 
Number score had a statistically significant correlation with gliadin accumulation (r = 
0.28), as did percentage of shorts (r = 0.34). None of the expected predictors, i.e., whole-
grain protein, flour protein, or dry gluten, had statistically significant correlations with 
gliadin accumulation.  
The 80 cultivars for which quality data was available were also subjected to 
Spearman rank correlation analysis (Figure 4.10). No strong correlations at the α= 0.05 
level of significance were observed between gliadin and the other 21 traits. Statistically 
significant correlations included: milling percent and flour yield (r = -0.36), mixing time 
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(r = -0.30), Falling Number score (r = 0.32), test weight (r = 0.36), and shorts (r = 0.43). 
A weakly negative correlation was observed between gliadin accumulation and loaf 
volume (r = -0.17). No statistically significant correlations with any of the expected 
protein traits were noted.  
Principal Component Analysis 
The package ‘nFactors’ (Raiche 2010) was employed to determine the number of 
nontrivial dimensions by parallel analysis. Permutation parallel analysis using bootstrap 
resampling (N = 50) identified six nontrivial dimensions. Cluster 1 comprised the traits 
water binding, wet gluten, dry gluten, flour protein, whole-grain protein, and Mixograph 
midline peak value (MPV). Cluster 2 included test weight, shorts, Falling Number score, 
and gliadin. Mixograph midline peak time (MPT) and midline peak interval (MPI), 8-
minute band, Gluten Index, and baking mix time—traits that correlate with dough 
strength and tenacity—formed Cluster 3. Bran and small kernel size grouped into Cluster 
4, while large kernel size, baking absorption, and loaf volume grouped into Cluster 5. 
Cluster 6 included milling yield and flour yield. Principal components analysis (PCA) 
indicated that components 1 and 2 explained 39.1% of the variance observed in the 22 
traits of the 80 cultivars (Figure 4.11). This indicated that the grain, protein, and end-use 
quality traits evaluated in this population were poor predictors of immunogenic gliadin 
accumulation. These results suggested that unmodeled factors, such as growing 
environment, had a significant influence on end-use quality traits and gliadin 
accumulation.  
DISCUSSION 
Examination of wheat breeding targets demonstrates the challenge posed to wheat 
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breeders when making selections. The variation manifested in the performance check 
cultivars across location-years indicated environmental contributions to phenotype were 
strong for several traits, including gliadin accumulation (Figure 4.7). This environmental 
plasticity will require the use of multi-environment trials (MET) to discern the proportion 
of variance attributable to genotype, and to develop selection strategies to mitigate cost 
versus predictive power of testing (Brennan et al 1998; Yan 2014; Arief 2015). Breeding 
targets are more commonly quantitative traits, such as grain protein profiles, that can vary 
widely as growing conditions change. Environmental influences reduce the efficiency of 
selection on traits as calculated heritability decreases, but expansion of yield trials to 
increase genotypic variance reduces the breeder’s resource pool to complete selections 
with sufficient trait data. Judiciously-chosen traits and appropriate assays obtain the most 
repeatable information while balancing scale with cost. Locations and trial management 
strategies must be representative to produce a well-adapted cultivar, which reveals itself 
through predictable response (or lack of) to environmental stimuli (Becker and Leon 
1988).  
The parallel trait means observed between the performance check cultivars and 
varieties under development demonstrated differential responses to growing environment, 
which was expressed as location-years, in addition to genotypic variation. The probability 
density of trait measurements observed for dry gluten (Figure 4.4) and gliadin 
accumulation (Figure 4.5) indicated clusters of observations that could potentially have 
arisen due to measurement error. A diagnostic Pearson’s test of correlation conducted to 
assess the relationship between ELISA assay (expressed as a numerical count value) and 
gliadin accumulation in the 80 cultivars found a significant relationship (r = 0.54, t = 
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13.21, df = 426, p < 0.0001) at the 95% confidence level; however, analysis using the 154 
cultivars did not find any significant correlation (r = 0.06, t = 1.69, df = 904, p = 0.0924). 
The observed correlations could be the result of the selection process, as quality analysis 
was conducted on a non-random sample. An analysis of the relatedness of the cultivars 
could provide more insight into this phenomenon. The probability densities of the other 
protein traits were more uniformly distributed, with fewer potential outliers.  
The sprouting damage observed in 2014 was probably responsible for at least 
some of the variance observed in gliadin accumulation, as gliadins are hydrolyzed during 
germination. Falling Number score and gliadin accumulation would therefore be 
expected to have a positive correlation. Comparison of Figure 4.6 with Figure 4.1 did not 
qualitatively indicate such a relationship, but the positive correlation depicted in Figure 
4.10 supported the covariance indicated by PCA (Figure 4.11).  
Because gliadin is stored in protein bodies in the cells adjacent to the aleurone 
layer (Tosi et al 2011), milling efficiency could affect the proportion of gliadin in flour. 
The weakly negative correlation between milling percent and measured gliadin in flour 
suggested that decreased milling efficiency could concentrate gliadin in flour. Any 
change in gliadin content might also be mitigated by selection for more desirable scores 
in baking traits. Gliadins increase the viscosity of the dough, which would manifest as 
increased time needed to develop the dough, i.e., the Mixograph midline peak value and 
work input (midline peak integral). The low correlations observed between Mixograph 
parameters and immunogenic gliadin accumulation indicated that selection for baking 
quality traits was unlikely to directly influence gliadin accumulation. The PCA-supported 
inverse relationship between loaf volume, dough stability, mixing time, and gliadin 
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accumulation indicated that selection for ideal baking traits may have indirectly selected 
against gliadin accumulation in the cultivars evaluated. The short vector of gliadin 
depicted in Figure 4.11 indicated that some unmodeled influence, possibly 
environmental, on this trait was lost to the error term of the multivariate model 
underlying the analysis.  
Environmental influence on protein accumulation has been well-described in the 
literature (Graybosch et al 1995; Johansson et al 1998; Triboi et al 2000; Triboi et al 
2003; Shewry et al 2009; Caffe-Treml et al 2011). Daniel and Triboi (2000) determined 
that temperature had a positive relationship with the overall grain protein profile when its 
effects were combined with nitrogen application. Temperature alone could depress 
gliadin accumulation, if excessively high. These authors also determined that nitrogen 
availability alone improved protein accumulation. Other environmental effects on 
individual protein fractions are still under investigation. The lack of significant 
correlation between whole-grain protein, flour protein, and dry gluten discussed in 
previous sections contrasts with reports by other authors. Ribeiro et al (2016), for 
example, found a moderate positive correlation between total gliadins (r = 0.64) and 
protein. These authors found a similar correlation between α-gliadin (r = 0.59) and total 
protein (Ribeiro et al 2016). The variation in four-year averaged performance check 
cultivar gliadin:dry gluten ratios (g kg-1 basis, data not shown) observed in this study 
were somewhat lower than those reported by Plessis et al (~0.57) in their 2013 report. 
Fractionation of prolamins and glutelins was not performed in this study, but the expected 
ratio of prolamins and glutelins was 1:1 (Belitz et al 2004) in the dry gluten isolated by 
the Gluten Index method. The departures from expected values could reflect a difference 
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in gliadin assay method. The ELISA method described in Chapter 3 used a polyclonal 
antibody that targeted the immunogenic core peptide of gliadin. The high-performance 
liquid chromatography (HPLC) method used by other authors is a well-established 
method for assaying gliadin quantity (Huebner and Bietz 1993; Bietz and Lookhart 1996) 
that measures the subfractions on a whole-molecule basis, viz., either by a size exclusion 
or by exploit of hydrophobic interactions. Identification of the short peptides that 
compose an epitope requires finer techniques such as sequencing or mass spectrometry. 
Serological methods are a user-friendly alternative to these two approaches, as the 
benchwork requires less specialized training and equipment and antibodies against 
specific peptide targets can be developed by commercial suppliers. Another reason for 
the observed difference might stem from natural variation in peptide sequence, as 
described by Gell et al (2015).  
CONCLUSION 
The data presented in Chapter 4 supports the conclusion reached by Kasarda 
(2013) and Ribeiro et al (2016) that wheat breeding selection practices have not increased 
gliadin accumulation in HRSW. The evidence presented in this study suggests that the 
opposite may be true in this population of HRSW. Investigation into GEI is needed to 
explain the variance observed in protein—including gliadin—and baking performance 
traits. 
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Figure 4.1. Level plot of Falling Number score by genotype and location, 2014. 
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Figure 4.2. Violin plot of whole-grain protein accumulation. A) Performance check 
cultivars. B) Cultivars under development. The superimposed box plot illustrates the 
mean and range of the population at each location-year. The circles represent outliers. 
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Figure 4.3. Violin plot of flour protein accumulation. A) Performance check 
cultivars. B) Cultivars under development. The superimposed box plot illustrates the 
mean and range of the population at each location-year. The circles represent outliers. 
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Figure 4.4. Violin plot of dry gluten accumulation. A) Performance check cultivars. 
B) Cultivars under development. The superimposed boxplots represent the mean and 
range of observations. The circles represent outliers. Note the change in y-axis scale. 
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Figure 4.5. Violin plot of gliadin accumulation. A) Performance check cultivars. B) 
Cultivars under development. The superimposed boxplots represent the mean and 
range of observations. The circles represent outliers. Note the change in y-axis scale. 
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Figure 4.6. Level plot of gliadin accumulation by location-year, 2014. 
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  Figure 4.7. Boxplot of gliadin accumulation in the performance check cultivars, 
2014-2016.  
183 
 
 
 
  
Figure 4.8. Least significant differences in selected Mixograph traits, 2014-2016.  
184 
 
 
 
 
Figure 4.9. Least significant differences in baking traits, 2014-2016.  
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Figure 4.10. Spearman rank correlation between grain and protein quality traits, 2013-2016. The correlation coefficients with 
colored backgrounds are significant at the α= 0.05 level or lower. White squares indicate non-significant correlations at the α = 
0.05 level. 
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  Figure 4.11. Principal components analysis of grain and protein quality traits, 2013-2016. The 
angles between vectors approximate the correlations between traits. The length of the vector indicates 
the approximate value change in response to a change in a diametric trait value. 
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Table 4.1. Summary of performance check cultivar grain quality traits, 2013. 
All cultivars were planted in one of three nurseries at three locations (n = 3): AYT, PYT, PPY.  
Two check cultivars were planted in each of the three blocks (n = 9). Cultivars in gray text were not check cultivars during this 
growing season, but were grown as part of the yield trial. Observations from all cultivars are included in the location means. 
Cultivar mean across all locations 
  Test weight (lb bu
-1) Large kernels (%) Small kernels (%) Falling Number (seconds) 
Name n Mean Var SD Mean Var SD Mean Var SD Mean Var SD 
ADVANCE 3 61.95 0.81 0.9 43.33 69.33 8.33 14.67 16.33 4.04 447.33 21.33 4.62 
BOOST 3 60.75 1.37 1.17 59.67 58.33 7.64 9.67 9.33 3.06 447.67 16.33 4.04 
BRICK 3 61.31 5.03 2.24 29.33 49.33 7.02 22.00 19.00 4.36 447.67 16.33 4.04 
BRIGGS 9 60.29 2.71 1.65 59.33 83.00 9.11 8.67 2.25 1.50 450.00 0.00 0.00 
FALLER 3 60.69 0.93 0.96 64.67 96.33 9.81 9.67 12.33 3.51 450.00 0.00 0.00 
FOCUS 3 61.63 2.84 1.69 45.67 44.33 6.66 13.00 7.00 2.65 437.33 481.33 21.94 
FOREFRONT 3 60.59 3.69 1.92 41.00 19.00 4.36 16.67 6.33 2.52 438.00 432.00 20.78 
GRANGER 3 60.8 4.32 2.08 63.67 66.33 8.14 10.00 4.00 2.00 426.83 1610.08 40.13 
KNUDSON 3 59.52 5.86 2.42 34.00 148.00 12.17 17.33 22.33 4.73 422.33 646.33 25.42 
OXEN 9 58.22 6.5 2.55 39.78 121.19 11.01 15.11 26.11 5.11 439.44 251.28 15.85 
PREVAIL 3 59.95 0.42 0.65 31.33 82.33 9.07 19.00 3.00 1.73 450.00 0.00 0.00 
SELECT 3 60.56 6.94 2.63 39.00 43.00 6.56 16.67 30.33 5.51 450.00 0.00 0.00 
STEELE-ND 3 61.52 0.83 0.91 58.00 9.00 3.00 12.67 6.33 2.52 450.00 0.00 0.00 
SURPASS 3 59.76 2.43 1.56 28.33 57.33 7.57 17.33 6.33 2.52 431.00 127.00 11.27 
TRAVERSE 3 57.01 6.57 2.56 38.67 312.33 17.67 17.33 41.33 6.43 439.67 320.33 17.90 
Means per location 
Location n Mean Var SD Mean Var SD Mean Var SD Mean Var SD 
Brookings 19 58.01 3.95 1.99 43.74 202.20 14.22 16.42 25.48 5.05 437.50 405.19 20.13 
Groton 19 61.07 2.11 1.45 43.42 232.04 15.23 14.89 23.88 4.89 449.05 9.05 3.01 
Selby 19 61.17 1.16 1.08 50.84 190.70 13.81 10.89 13.54 3.68 440.74 253.32 15.92 
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Table 4.2. Summary of performance check cultivar grain quality traits, 2014. 
All cultivars were planted in one of three nurseries at three locations (n = 3): AYT, PYT, PPY.  
Two check cultivars were planted in each of the three blocks (n = 9). Cultivars in gray text were not check cultivars during this 
growing season, but were grown as part of the yield trial. Observations from all cultivars are included in the location means. 
Cultivar mean across all locations 
  Test weight (lb bu
-1) Large kernels (%) Small kernels (%) Falling Number (seconds) 
Name n Mean Var SD Mean Var SD Mean Var SD Mean Var SD 
ADVANCE 3 59.15 2.19 1.48 65.67 44.33 6.66 6.33 10.33 3.21 327.33 9942.33 99.71 
BOOST 3 58.43 0.97 0.99 72.67 25.33 5.03 5.00 1.00 1.00 340.17 35861.58 189.37 
BRICK 3 60.24 0.66 0.81 58.00 12.00 3.46 9.00 4.00 2.00 328.17 22490.08 149.97 
BRIGGS 3 58.00 0.39 0.62 74.00 12.00 3.46 5.00 3.00 1.73 390.00 10800.00 103.92 
FALLER 3 58.99 0.26 0.51 80.67 2.33 1.53 4.67 1.33 1.15 396.67 1196.33 34.59 
FOCUS 3 59.73 0.64 0.80 61.00 39.00 6.24 7.67 2.33 1.53 303.00 21523.00 146.71 
FOREFRONT 9 58.76 0.77 0.88 63.94 21.03 4.59 7.46 1.29 1.14 401.83 5413.50 73.58 
GRANGER 3 58.67 0.62 0.79 82.33 4.33 2.08 3.33 0.33 0.58 315.17 14107.58 118.78 
KNUDSON 3 57.71 0.16 0.40 58.00 31.00 5.57 6.67 2.33 1.53 364.50 7184.25 84.76 
OXEN 3 55.01 1.77 1.33 48.67 50.33 7.09 11.67 22.33 4.73 375.67 4172.33 64.59 
PREVAIL 9 57.93 0.45 0.67 51.08 26.45 5.14 11.48 2.15 1.47 321.78 21744.51 147.46 
SELECT 3 59.12 2.76 1.66 64.33 156.33 12.50 7.00 19.00 4.36 383.67 6492.33 80.58 
STEELE-ND 3 58.85 2.02 1.42 69.33 26.33 5.13 7.67 2.33 1.53 380.00 6276.00 79.22 
SURPASS 3 57.87 0.03 0.17 57.00 91.00 9.54 7.67 1.33 1.15 339.83 9097.58 95.38 
TRAVERSE 3 54.51 5.79 2.41 56.33 284.33 16.86 10.00 37.00 6.08 301.50 25050.25 158.27 
Means per location 
Location n Mean Var SD Mean Var SD Mean Var SD Mean Var SD 
Brookings 19 57.39 3.30 1.82 60.59 136.76 11.69 9.60 12.58 3.55 393.11 1679.77 40.98 
Groton 19 59.01 1.77 1.33 65.84 123.70 11.12 6.84 7.36 2.71 436.26 365.20 19.11 
Selby 19 58.29 1.93 1.39 61.95 117.72 10.85 7.00 7.00 2.65 231.13 8665.22 93.09 
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Table 4.3. Summary of performance check cultivar grain quality traits, 2015. 
All cultivars were planted in one of three nurseries at three locations (n = 3): AYT, PYT, PPY.  
Two check cultivars were planted in each of the three blocks (n = 9). Cultivars in gray text were not check cultivars during this 
growing season, but were grown as part of the yield trial. Observations from all cultivars are included in the location means. 
Cultivar mean across all locations 
  Test weight (lb bu
-1) Large kernels (%) Small kernels (%) Falling Number (seconds) 
Name n Mean Var SD Mean Var SD Mean Var SD Mean Var SD 
ADVANCE 3 57.47 2.86 1.69 54.33 30.33 5.51 11.33 10.33 3.21 402.67 992.33 31.50 
BOOST 3 58.03 0.17 0.42 67.33 64.33 8.02 7.33 5.33 2.31 405.00 967.00 31.10 
BRICK 3 59.23 0.22 0.47 54.33 296.33 17.21 12.67 22.33 4.73 450.00 0.00 0.00 
BRIGGS 3 56.8 0.52 0.72 68.67 50.33 7.09 7.00 4.00 2.00 450.00 0.00 0.00 
FALLER 3 55.67 1.84 1.36 62.67 30.33 5.51 11.33 2.33 1.53 446.67 33.33 5.77 
FOCUS 3 59.87 0.2 0.45 60.00 73.00 8.54 10.00 4.00 2.00 445.67 56.33 7.51 
FOREFRONT 9 58.7 0.85 0.92 65.56 140.78 11.86 8.56 6.53 2.55 443.67 270.50 16.45 
GRANGER 3 58.57 2.04 1.43 77.33 9.33 3.06 6.67 1.33 1.15 399.67 226.33 15.04 
KNUDSON 3 56.63 1.74 1.32 45.33 40.33 6.35 15.33 17.33 4.16 420.67 186.33 13.65 
OXEN 3 55.47 2.8 1.67 51.00 19.00 4.36 14.00 0.00 0.00 450.00 0.00 0.00 
PREVAIL 9 57.7 0.79 0.89 53.11 203.61 14.27 12.78 16.44 4.06 431.44 430.03 20.74 
SELECT 3 59.47 0.33 0.58 61.33 30.33 5.51 10.33 0.33 0.58 445.67 56.33 7.51 
STEELE-ND 3 57 0.04 0.2 64.33 6.33 2.52 9.33 0.33 0.58 436.33 272.33 16.50 
SURPASS 3 57.23 0.21 0.46 52.67 72.33 8.50 11.67 6.33 2.52 439.67 136.33 11.68 
TRAVERSE 3 54.83 0.82 0.91 57.33 132.33 11.50 10.67 6.33 2.52 418.67 1001.33 31.64 
Means per location 
Location n Mean Var SD Mean Var SD Mean Var SD Mean Var SD 
Brookings 19 58.05 1.99 1.41 67.16 65.70 8.11 8.79 6.29 2.51 437.95 356.16 18.87 
Groton 19 57.40 2.28 1.51 51.05 149.72 12.24 12.21 14.40 3.79 430.74 654.98 25.59 
Selby 19 57.52 3.41 1.85 60.63 79.13 8.90 10.84 10.25 3.20 431.74 528.98 23.00 
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Table 4.4. Summary of performance check cultivar grain quality traits, 2016. 
All cultivars were planted in the AYT nurseries at three locations (n = 3). 
Cultivars in gray text were not check cultivars during this growing season, but were grown as part of the gliadin trial. Observations 
from all cultivars are included in the location means. 
Cultivar mean across all locations 
  Test weight (lb bu
-1) Large kernels (%) Small kernels (%) Falling Number (seconds) 
Name n Mean Var SD Mean Var SD Mean Var SD Mean Var SD 
ADVANCE 3 62.03 0.1 0.32 59.67 97.33 9.87 8.33 2.33 1.53 450.00 0.00 0.00 
BOOST 3 60.51 0.33 0.58 69.00 133.00 11.53 6.00 1.00 1.00 450.00 0.00 0.00 
BRICK 3 62.88 0.08 0.29 58.67 58.33 7.64 10.67 0.33 0.58 430.00 651.00 25.51 
BRIGGS 3 61.36 0.39 0.62 72.00 61.00 7.81 5.00 1.00 1.00 450.00 0.00 0.00 
FALLER 3 60.37 0.11 0.33 76.00 25.00 5.00 6.67 0.33 0.58 450.00 0.00 0.00 
FOCUS 3 62.11 0.14 0.38 58.00 148.00 12.17 8.67 6.33 2.52 450.00 0.00 0.00 
FOREFRONT 3 60.75 0.48 0.69 63.33 105.33 10.26 7.67 1.33 1.15 450.00 0.00 0.00 
GRANGER 0 . . . . . . . . . . . . 
KNUDSON 0 . . . . . . . . . . . . 
OXEN 3 59.76 0.23 0.48 68.33 41.33 6.43 7.00 1.00 1.00 450.00 0.00 0.00 
PREVAIL 3 60.45 0.78 0.88 51.67 277.33 16.65 12.00 12.00 3.46 441.67 52.33 7.23 
SELECT 3 62.61 0.39 0.62 63.67 142.33 11.93 7.33 0.33 0.58 450.00 0.00 0.00 
STEELE-ND 3 62.08 0.36 0.6 73.00 100.00 10.00 6.33 4.33 2.08 450.00 0.00 0.00 
SURPASS 3 60.85 0.28 0.53 51.67 116.33 10.79 10.00 4.00 2.00 438.00 133.00 11.53 
TRAVERSE 3 58.03 0.3 0.54 55.33 208.33 14.43 12.00 9.00 3.00 428.00 588.00 24.25 
Means per location 
Location n Mean Var SD Mean Var SD Mean Var SD Mean Var SD 
Brookings 13 61.35 1.62 1.27 72.85 35.14 5.93 7.08 3.58 1.89 443.54 202.94 14.25 
Groton 13 61.30 2.10 1.45 62.77 119.69 10.94 8.69 9.40 3.07 445.85 44.81 6.69 
Selby 13 60.53 1.75 1.32 53.69 94.90 9.74 9.08 7.24 2.69 446.23 184.69 13.59 
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Table 4.5. Least significant differences between location-years  
for test weight and falling number score. 
Observations from performance checks and cultivars under development are included 
in the location means. Location-years where trait means were found significantly 
different by Bonferroni-corrected post-hoc test at α = 0.05 family-wise error level are 
represented with different letters. 
Test weight 
  CI95 Range   
Location-year n Mean SD LCL UCL Min Max LSD 
BRK2013 78 59.13 1.78 58.79 59.46 54.16 62.16 bc 
BRK2014 90 57.82 1.52 57.51 58.13 52.00 60.48 de 
BRK2015 88 58.44 1.57 58.13 58.75 52.00 61.36 cd 
BRK2016 48 62.03 1.15 61.61 62.46 58.64 63.92 a 
GRO2013 78 61.93 1.43 61.59 62.26 57.76 66.00 a 
GRO2014 90 59.70 1.24 59.39 60.01 56.08 62.96 b 
WAT2015 88 58.39 1.99 58.08 58.71 51.68 62.10 cd 
GRO2016 48 62.19 1.20 61.77 62.62 57.60 64.40 a 
SEL2013 78 61.75 1.07 61.41 62.08 59.12 63.68 a 
SEL2014 90 59.05 1.33 58.74 59.36 54.72 63.20 bc 
SEL2015 88 57.35 1.77 57.04 57.66 50.96 60.20 e 
SEL2016 48 61.28 1.14 60.85 61.70 57.84 62.96 a 
Falling Number score 
  CI95 Range   
Location-year n Mean SD LCL UCL Min Max LSD 
BRK2013 78 432.09 26.90 423.53 440.65 333.50 450 a 
BRK2014 90 396.36 47.07 388.39 404.33 279.50 450 b 
BRK2015 88 437.58 19.55 429.52 445.64 353.00 450 a 
BRK2016 48 441.88 18.91 430.96 452.79 365.00 450 a 
GRO2013 78 441.68 18.60 433.12 450.24 362.50 450 a 
GRO2014 90 434.88 29.79 426.91 442.85 269.50 450 a 
WAT2015 88 422.94 33.23 414.88 431.00 309.00 450 a 
GRO2016 48 438.17 27.19 427.25 449.08 307.00 450 a 
SEL2013 78 433.69 25.44 425.13 442.25 346.50 450 a 
SEL2014 90 248.78 86.07 240.81 256.75 79.50 435 c 
SEL2015 88 432.98 30.04 424.92 441.04 329.00 450 a 
SEL2016 48 445.94 13.77 435.02 456.85 390.00 450 a 
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Table 4.6. Summary of multiple regression analysis  
for the 139 cultivars under development. 
Cultivars are ordered from most- to least-susceptible to sprouting damage (expressed 
in seconds). R2 = 0.8046, F(149, 552) = 15.25, p < 0.0001. 
      Coefficient SE t Significance 
(Intercept)  436.32 19.69 22.16 *** 
SD4552 -89.74 24.19 -3.71 *** 
SD4313 -81.50 27.38 -2.98 ** 
SD4648 -71.76 27.95 -2.57 * 
SD4330 -70.36 23.84 -2.95 ** 
SD4562 -57.89 27.82 -2.08 * 
SD4532 -56.36 23.84 -2.36 * 
SD4572 -56.22 27.82 -2.02 * 
SD4460 -53.33 27.38 -1.95 . 
SD4637 -50.76 27.95 -1.82 . 
SD4450 -48.19 23.84 -2.02 * 
SD4638 -47.10 27.95 -1.69 . 
SD4543 -46.12 21.95 -2.10 * 
SD4559 43.34 24.19 1.79 . 
SD4578 46.01 24.19 1.90 . 
SD4558 66.44 27.82 2.39 * 
SD4594 68.44 27.82 2.46 * 
SD4511 73.44 27.82 2.64 ** 
Significance (p) < 0 ‘***’ 0.001 ‘**’ 0.01 ‘*’ 0.05 ‘.’  
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Table 4.7. Summary of performance check cultivar milling quality traits, 2013. 
All cultivars were planted in one of three nurseries at three locations (n = 3): AYT, PYT, PPY.  
Two check cultivars were planted in each of the three blocks (n = 9). Cultivars in gray text were not check cultivars during this 
growing season, but were grown as part of the yield trial. 
  Bran (%) Shorts (%) Milling efficiency (%) Flour yield (g) 
Name n Mean Var SD Mean Var SD Mean Var SD Mean Var SD 
ADVANCE 3 52.47 12.33 3.51 14.47 1.84 1.36 68.89 4.56 2.13 148.17 17.14 4.14 
BOOST 3 51.77 4.82 2.2 19.83 1.26 1.12 66.69 1.62 1.27 143.33 7.80 2.79 
BRICK 3 53.83 33.33 5.77 16.23 2.00 1.42 67.26 8.98 3.00 143.90 37.56 6.13 
BRIGGS 9 52.66 19.82 4.45 16.92 1.55 1.25 66.79 5.12 2.26 139.93 38.03 6.17 
FALLER 3 48.13 9.94 3.15 15.93 0.36 0.60 70.33 3.54 1.88 151.93 23.05 4.80 
FOCUS 3 52.93 7.69 2.77 18.50 0.19 0.44 66.91 2.47 1.57 144.50 16.51 4.06 
FOREFRONT 3 51.87 55.04 7.42 14.57 2.84 1.69 68.71 7.94 2.82 145.83 29.70 5.45 
GRANGER 3 53.53 24.97 5 17.03 0.85 0.92 67.34 5.14 2.27 145.47 24.00 4.90 
KNUDSON 3 53.87 12.24 3.5 16.63 0.52 0.72 67.16 3.79 1.95 144.20 19.93 4.46 
OXEN 9 53.1 9.5 3.08 14.42 1.60 1.27 67.70 1.97 1.40 141.59 25.22 5.02 
PREVAIL 3 51.53 9.5 3.08 16.13 1.56 1.25 68.46 3.65 1.91 146.87 16.82 4.10 
SELECT 3 53.67 30.77 5.55 18.00 0.21 0.46 66.70 7.70 2.78 143.63 44.50 6.67 
STEELE-ND 3 50.77 17.77 4.22 16.97 1.01 1.01 68.39 4.33 2.08 146.43 11.72 3.42 
SURPASS 3 54.23 3.77 1.94 18.73 0.97 0.99 66.16 1.44 1.20 142.63 4.01 2.00 
TRAVERSE 3 55.93 42.4 6.51 16.90 0.25 0.50 66.18 10.58 3.25 142.60 57.00 7.55 
Means per location 
Location n Mean Var SD Mean Var SD Mean Var SD Mean Var SD 
Brookings 19 57.04 7.75 2.78 16.51 4.19 2.05 65.50 1.92 1.39 139.64 14.35 3.79 
Groton 19 51.51 4.89 2.21 17.16 2.90 1.70 67.86 1.54 1.24 144.98 15.12 3.89 
Selby 19 49.63 5.96 2.44 15.91 2.50 1.58 69.16 3.08 1.76 147.07 30.59 5.53 
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Table 4.8. Summary of performance check cultivar milling quality traits, 2014. 
All cultivars were planted in one of three nurseries at three locations (n = 3): AYT, PYT, PPY.  
Two check cultivars were planted in each of the three blocks (n = 9). Cultivars in gray text were not check cultivars during this 
growing season, but were grown as part of the yield trial. 
  Bran (%) Shorts (%) Milling efficiency (%) Flour yield (g) 
Name n Mean Var SD Mean Var SD Mean Var SD Mean Var SD 
ADVANCE 3 53.57 2.04 1.43 14.80 2.41 1.55 67.02 2.02 1.42 139.00 16.87 4.11 
BOOST 3 53.90 1.92 1.39 20.70 8.68 2.95 64.23 2.19 1.48 134.03 17.32 4.16 
BRICK 3 52.27 3.77 1.94 16.83 6.04 2.46 66.77 0.57 0.75 138.80 1.29 1.14 
BRIGGS 3 55.17 0.70 0.84 16.60 2.37 1.54 65.57 0.56 0.75 136.67 6.30 2.51 
FALLER 3 48.87 0.52 0.72 18.30 3.63 1.91 67.74 0.75 0.86 141.10 10.27 3.20 
FOCUS 3 51.70 5.23 2.29 16.97 0.30 0.55 67.04 0.67 0.82 139.64 1.43 1.20 
FOREFRONT 9 54.91 2.18 1.48 14.99 3.13 1.77 66.55 2.10 1.45 139.14 18.65 4.32 
GRANGER 3 51.97 1.56 1.25 17.60 5.23 2.29 66.59 0.96 0.98 138.73 14.20 3.77 
KNUDSON 3 53.50 1.56 1.25 16.97 4.04 2.01 66.06 2.08 1.44 137.20 18.03 4.25 
OXEN 3 56.60 6.79 2.61 14.07 1.42 1.19 65.88 3.57 1.89 136.53 28.00 5.29 
PREVAIL 9 51.83 2.52 1.59 14.50 4.62 2.15 68.29 2.82 1.68 142.88 22.71 4.77 
SELECT 3 55.57 3.25 1.80 20.30 1.29 1.14 63.61 2.65 1.63 132.67 20.04 4.48 
STEELE-ND 3 53.37 2.81 1.68 18.67 5.29 2.30 65.32 0.84 0.92 135.73 11.76 3.43 
SURPASS 3 54.83 1.00 1.00 18.37 1.58 1.26 65.01 0.67 0.82 136.00 5.25 2.29 
TRAVERSE 3 55.90 20.41 4.52 20.23 3.66 1.91 63.55 8.07 2.84 132.73 38.16 6.18 
Means per location 
Location n Mean Var SD Mean Var SD Mean Var SD Mean Var SD 
Brookings 19 53.87 10.21 3.20 17.65 8.21 2.86 65.37 5.42 2.33 134.99 24.16 4.92 
Groton 19 52.65 4.87 2.21 17.53 5.79 2.41 66.34 2.14 1.46 138.33 11.23 3.35 
Selby 19 54.13 2.61 1.62 15.17 4.65 2.16 67.07 2.27 1.51 141.14 13.16 3.63 
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Table 4.9. Summary of performance check cultivar milling quality traits, 2015. 
All cultivars were planted in one of three nurseries at three locations (n = 3): AYT, PYT, PPY.  
Two check cultivars were planted in each of the three blocks (n = 9). Cultivars in gray text were not check cultivars during this 
growing season, but were grown as part of the yield trial. 
  Bran (%) Shorts (%) Milling efficiency (%) Flour yield (g) 
Name n Mean Var SD Mean Var SD Mean Var SD Mean Var SD 
ADVANCE 3 54.3 1.96 1.4 18.67 6.32 2.51 64.92 2.64 1.63 135.00 6.13 2.48 
BOOST 3 54.53 1.34 1.16 24.17 2.40 1.55 62.09 2.05 1.43 128.90 12.01 3.47 
BRICK 3 53.27 0.44 0.67 22.03 13.52 3.68 63.75 1.83 1.35 132.40 5.88 2.42 
BRIGGS 3 55.9 1.96 1.4 20.63 8.74 2.96 63.19 1.64 1.28 131.40 6.37 2.52 
FALLER 3 49.8 0.13 0.36 19.57 3.90 1.98 66.75 0.86 0.93 139.27 1.92 1.39 
FOCUS 3 52.07 1.01 1.01 20.40 6.84 2.62 65.23 1.58 1.26 135.97 6.62 2.57 
FOREFRONT 9 53.28 2.07 1.44 18.31 3.67 1.92 65.07 0.76 0.87 133.36 6.97 2.64 
GRANGER 3 52.83 1.16 1.08 21.63 3.62 1.90 64.18 1.28 1.13 133.40 2.77 1.66 
KNUDSON 3 54.9 0.49 0.7 20.70 2.23 1.49 63.60 0.64 0.80 132.10 2.37 1.54 
OXEN 3 55.3 1.72 1.31 17.33 1.29 1.14 65.08 0.02 0.15 135.37 0.25 0.50 
PREVAIL 9 50.56 2.91 1.71 18.14 2.56 1.60 66.54 0.88 0.94 136.60 3.16 1.78 
SELECT 3 53.4 0.28 0.53 23.33 6.45 2.54 63.25 1.71 1.31 132.03 6.26 2.50 
STEELE-ND 3 53.27 0.82 0.91 21.90 7.03 2.65 63.84 1.94 1.39 132.67 4.82 2.20 
SURPASS 3 54.17 1.85 1.36 20.50 1.47 1.21 64.19 1.27 1.13 133.87 10.02 3.17 
TRAVERSE 3 54.37 1.34 1.16 20.57 12.20 3.49 64.03 3.59 1.89 133.37 15.84 3.98 
Means per location 
Location n Mean Var SD Mean Var SD Mean Var SD Mean Var SD 
Brookings 19 53.41 3.87 1.97 20.30 7.79 2.79 64.36 3.11 1.76 133.06 9.91 3.15 
Groton 19 53.59 3.58 1.89 18.58 4.87 2.21 65.05 2.16 1.47 134.31 10.66 3.27 
Watertown 19 52.42 4.50 2.12 21.24 6.13 2.48 64.63 2.60 1.61 134.57 8.49 2.91 
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Table 4.10. Summary of performance check cultivar milling quality traits, 2016. 
All cultivars were planted in the AYT nurseries at three locations (n = 3).  
Cultivars in gray text were not check cultivars during this growing season, but were grown as part of the gliadin trial. 
  Bran (%) Shorts (%) Milling efficiency (%) Flour yield (g) 
Name n Mean Var SD Mean Var SD Mean Var SD Mean Var SD 
ADVANCE 3 54.20 0.09 0.30 28.13 3.36 1.83 60.85 0.62 0.79 127.97 4.41 2.10 
BOOST 3 55.43 0.42 0.65 32.93 8.08 2.84 57.88 3.08 1.76 121.43 17.20 4.15 
BRICK 3 54.03 0.16 0.40 30.73 4.76 2.18 59.65 1.37 1.17 125.33 10.80 3.29 
BRIGGS 3 56.47 0.72 0.85 29.57 5.30 2.30 59.08 0.66 0.81 124.23 4.17 2.04 
FALLER 3 48.70 0.28 0.53 28.63 5.50 2.35 63.10 2.39 1.55 132.27 15.66 3.96 
FOCUS 3 53.43 4.12 2.03 26.93 7.37 2.72 61.37 0.85 0.92 127.70 12.04 3.47 
FOREFRONT 3 54.93 2.09 1.45 26.53 1.85 1.36 60.75 0.11 0.33 126.10 2.68 1.64 
GRANGER 0 . . . . . . . . . . . . 
KNUDSON 0 . . . . . . . . . . . . 
OXEN 3 51.97 1.00 1.00 24.60 4.21 2.05 63.11 2.74 1.66 131.03 16.85 4.11 
PREVAIL 3 51.07 4.65 2.16 24.53 6.64 2.58 63.61 0.24 0.48 132.17 3.10 1.76 
SELECT 3 54.73 0.06 0.25 32.53 6.25 2.50 58.21 2.52 1.59 121.60 17.91 4.23 
STEELE-ND 3 52.83 3.25 1.80 29.90 15.16 3.89 60.32 8.31 2.88 125.80 42.51 6.52 
SURPASS 3 55.33 0.65 0.81 28.90 23.88 4.89 59.85 6.65 2.58 125.53 26.40 5.14 
TRAVERSE 3 56.10 3.73 1.93 29.20 1.17 1.08 59.50 0.57 0.75 125.30 3.09 1.76 
Means per location 
Location n Mean Var SD Mean Var SD Mean Var SD Mean Var SD 
Brookings 13 53.50 5.92 2.43 31.41 9.57 3.09 59.18 4.91 2.22 123.04 17.67 4.20 
Groton 13 53.92 5.69 2.39 27.97 6.76 2.60 60.89 3.67 1.92 127.48 13.90 3.73 
Selby 13 53.94 6.22 2.49 26.73 6.93 2.63 61.61 3.17 1.78 129.44 11.72 3.42 
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Table 4.11. Least significant differences  
between location-years for bran and shorts.  
Observations from performance checks and cultivars under development are included 
in the location means. Location-years where trait means differ are represented with 
different letters (α = 0.05). 
Bran (%) 
  CI95 Range   
Location-year n Mean SD LCL UCL Min Max LSD 
BRK2013 78 57.33 4.65 48.77 65.89 47.80 82.00 a 
BRK2014 90 54.20 3.44 46.23 62.17 48.40 73.10 bcd 
BRK2015 88 53.49 2.16 45.43 61.55 49.20 60.40 cdef 
BRK2016 48 53.49 2.74 42.57 64.40 47.20 59.50 cdef 
GRO2013 78 52.87 3.73 44.31 61.43 45.10 72.90 def 
GRO2014 90 52.57 3.31 44.60 60.54 45.50 71.40 ef 
WAT2015 88 52.14 2.41 44.08 60.20 47.00 59.30 f 
GRO2016 48 53.92 2.67 43.00 64.83 48.30 60.60 bcdef 
SEL2013 78 52.11 3.72 43.54 60.67 43.70 70.30 f 
SEL2014 90 55.05 2.95 47.08 63.02 49.70 74.20 bc 
SEL2015 88 54.08 2.60 46.02 62.14 49.10 64.30 bcde 
SEL2016 48 55.86 2.77 44.95 66.78 48.50 63.70 ab 
Shorts (%) 
  CI95 Range   
Location-year n Mean SD LCL UCL Min Max LSD 
BRK2013 78 18.33 3.04 9.77 26.89 12.00 33.20 e 
BRK2014 90 19.03 3.19 11.06 27.00 12.40 34.10 de 
BRK2015 88 21.90 2.97 13.84 29.96 15.50 31.30 c 
BRK2016 48 31.65 3.54 20.73 42.56 24.00 42.10 a 
GRO2013 78 18.62 2.20 10.06 27.19 14.10 28.90 e 
GRO2014 90 18.51 3.12 10.54 26.48 12.10 30.00 e 
WAT2015 48 27.66 3.17 13.77 29.89 16.80 28.50 b 
GRO2016 78 18.48 2.71 16.75 38.58 21.30 33.10 e 
SEL2013 90 18.19 3.24 9.92 27.04 12.90 32.30 e 
SEL2014 88 20.27 2.36 10.22 26.16 11.40 33.00 d 
SEL2015 48 27.76 2.44 12.21 28.33 16.40 27.00 b 
SEL2016 88 21.83 2.30 16.84 38.67 21.00 31.60 c 
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Table 4.12. Summary of multiple regression analysis for bran content.  
Genotypes and location-years with significant effect are listed (α = 0.05).  
R2 = 0.8285, F(149, 552)= 17.89, p < 0.0001. 
      Coefficient SE t Significance 
(Intercept) 55.89 1.00 56.16 *** 
SD4506 -5.37 1.21 -4.45 *** 
SD4507 -4.97 1.38 -3.59 *** 
SD4655 -4.72 1.41 -3.34 *** 
SD4597 -4.39 1.23 -3.57 *** 
SD4579 -3.90 1.16 -3.38 *** 
SD4656 -3.86 1.41 -2.73 ** 
SD4681 -3.86 1.23 -3.14 ** 
SD4489 -3.80 1.38 -2.74 ** 
SD4614 -3.17 1.41 -2.25 * 
SD4678 -2.94 1.23 -2.39 * 
SD4595 -2.88 1.16 -2.49 * 
SD4492 -2.56 1.16 -2.22 * 
SD4552 -2.50 1.22 -2.04 * 
SD4631 -2.47 1.23 -2.01 * 
SD4618 -2.47 1.41 -1.76 . 
SD4584 -2.45 1.22 -2.00 * 
SD4602 -2.40 1.41 -1.71 . 
SD4496 -2.30 1.22 -1.88 . 
SD4582 -2.20 1.16 -1.91 . 
SD4529 1.91 1.11 1.73 . 
SD4330 2.00 1.21 1.66 . 
SD4403 2.01 1.11 1.82 . 
SD4577 2.43 1.41 1.73 . 
SD4518 2.48 1.21 2.06 * 
SD4450 2.50 1.21 2.07 * 
SD4517 2.52 1.21 2.09 * 
SD4215 2.53 1.38 1.83 . 
SD4502 2.53 1.38 1.83 . 
SD4648 2.54 1.41 1.80 . 
SD4416 2.71 1.11 2.44 * 
SD4599 2.74 1.22 2.24 * 
SD4504 2.97 1.38 2.14 * 
SD4434 3.17 1.38 2.29 * 
SD4572 3.37 1.41 2.39 * 
SD4543 3.61 1.11 3.26 ** 
SD4400 3.83 1.21 3.18 ** 
SD4321 4.07 1.21 3.37 *** 
SD4638 4.24 1.41 3.01 ** 
SD4427 4.30 1.38 3.11 ** 
SD4585 4.40 1.41 3.13 ** 
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Table 4.12, continued. 
SD4609 4.40 1.41 3.13 ** 
SD4352 4.57 1.38 3.30 ** 
SD4530 4.70 1.38 3.39 *** 
SD4565 5.20 1.41 3.70 *** 
SD4640 5.91 1.41 4.19 *** 
SD4639 6.01 1.41 4.26 *** 
SD4313 19.17 1.38 13.84 *** 
SD4477 19.62 1.21 16.27 *** 
Location-year 
SEL2013 -4.51 0.31 -14.56 *** 
GRO2013 -4.07 0.31 -13.13 *** 
GRO2014 -3.91 0.34 -11.36 *** 
WAT2015 -3.47 0.37 -9.38 *** 
BRK2014 -2.17 0.34 -6.31 *** 
BRK2015 -2.03 0.37 -5.49 *** 
BRK2016 -1.84 0.42 -4.37 *** 
GRO2016 -1.41 0.42 -3.35 *** 
SEL2015 -1.31 0.37 -3.54 *** 
SEL2014 -1.18 0.34 -3.43 *** 
SEL2016 1.25 0.42 2.96 ** 
Significance (p) < 0.0001 '***', 0.001 '**', 0.01 '*', 0.05 '.' 
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Table 4.13. Summary of multiple regression analysis for shorts content.  
Genotypes and location-years with significant effect are listed (α = 0.05). 
R2 = 0.9015, F(149, 552) = 33.89, p < 0.0001. 
      Coefficient SE t Significance 
(Intercept) 16.74 0.94 17.78 *** 
SD4477 14.80 1.14 12.98 *** 
SD4313 10.63 1.31 8.12 *** 
SD4649 6.82 1.16 5.86 *** 
SD4583 6.70 1.33 5.04 *** 
SD4609 6.67 1.33 5.01 *** 
SD4577 6.27 1.33 4.71 *** 
SD4673 6.04 1.16 5.19 *** 
SD4656 5.81 1.34 4.35 *** 
SD4569 5.77 1.33 4.34 *** 
SD4578 5.59 1.16 4.83 *** 
SD4659 5.52 1.16 4.75 *** 
SD4548 5.44 1.33 4.08 *** 
SD4439 5.13 1.31 3.92 *** 
SD4427 5.10 1.31 3.89 *** 
SD4543 5.04 1.05 4.80 *** 
SD4660 4.65 1.16 4.00 *** 
SD4562 4.60 1.33 3.46 *** 
SD4561 4.54 1.33 3.41 *** 
SD4434 4.40 1.31 3.36 *** 
SD4650 4.34 1.16 3.73 *** 
SD4672 4.11 1.34 3.08 ** 
SD4400 4.00 1.14 3.51 *** 
SD4678 3.92 1.16 3.37 *** 
SD4366 3.80 1.31 2.90 ** 
SD4643 3.64 1.34 2.73 ** 
SD4496 3.47 1.16 3.00 ** 
SD4398 3.23 1.31 2.47 * 
SD4631 3.19 1.16 2.74 ** 
SD4589 3.17 1.16 2.74 ** 
SD4432 3.17 1.31 2.42 * 
SD4572 3.07 1.33 2.31 * 
SD4490 3.07 1.31 2.34 * 
SD4465 2.90 1.05 2.76 ** 
SD4418 2.90 1.31 2.21 * 
SD4684 2.72 1.16 2.34 * 
201 
 
Table 4.13., continued. 
SD4529 2.54 1.05 2.42 * 
SD4565 2.50 1.33 1.88 . 
SD4454 2.50 1.31 1.91 . 
SD4633 2.44 1.34 1.83 . 
SD4215 2.43 1.31 1.86 . 
SD4504 2.43 1.31 1.86 . 
SD4599 2.42 1.16 2.09 * 
SD4655 2.38 1.34 1.78 . 
SD4441 2.37 1.31 1.81 . 
SD4576 2.32 1.16 2.01 * 
SD4663 2.31 1.34 1.73 . 
SD4518 2.30 1.14 2.02 * 
SD4605 2.27 1.33 1.71 . 
SD4634 2.21 1.34 1.65 . 
SD4532 2.15 1.14 1.89 . 
SD4501 2.07 1.14 1.81 . 
SD4450 2.05 1.14 1.80 . 
SD4451 2.04 1.08 1.89 . 
SD4321 1.98 1.14 1.74 . 
SD4469 1.97 1.14 1.73 . 
SD4493 1.94 1.05 1.84 . 
SD4546 1.93 1.05 1.84 . 
SD4537 1.93 1.08 1.78 . 
SD4416 1.90 1.05 1.81 . 
SD4471 1.78 1.08 1.65 . 
SD4624 -1.93 1.16 -1.66 . 
SD4625 -2.18 1.16 -1.88 . 
SD4640 -2.26 1.34 -1.69 . 
SD4614 -2.33 1.33 -1.75 . 
SD4613 -2.56 1.33 -1.93 . 
SD4579 -3.02 1.09 -2.76 ** 
SD4668 -3.02 1.34 -2.26 * 
SD4524 -3.20 1.33 -2.40 * 
Location-year 
BRK2016 13.46 0.40 33.45 *** 
SEL2016 9.86 0.40 24.52 *** 
GRO2016 9.27 0.40 23.05 *** 
BRK2015 4.26 0.35 12.02 *** 
WAT2015 3.92 0.35 11.03 *** 
SEL2015 2.66 0.35 7.50 *** 
BRK2014 0.90 0.33 2.72 ** 
Significance (p) < 0.0001 '***', 0.001 '**', 0.01 '*', 0.05 '.' 
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Table 4.14. Summary of multiple regression analysis for milling percentage. 
Genotypes and location-years with significant effect are listed (α = 0.05).  
R2 = 0.8687, F(149, 552) = 24.50, p < 0.0001 
      Coefficient SE t Significance 
(Intercept) 66.49 0.75 88.53 *** 
SD4579 2.61 0.87 2.99 ** 
SD4532 -1.82 0.91 -2.00 * 
SD4493 -1.85 0.84 -2.21 * 
SD4520 -1.85 0.91 -2.03 * 
SD4537 -1.89 0.86 -2.20 * 
SD4330 -1.97 0.91 -2.17 * 
SD4451 -2.05 0.86 -2.38 * 
SD4366 -2.08 1.04 -1.99 * 
SD4503 -2.10 1.04 -2.01 * 
SD4656 -2.12 1.07 -1.99 * 
SD4441 -2.13 1.04 -2.04 * 
SD4471 -2.16 0.86 -2.51 * 
SD4643 -2.23 1.07 -2.09 * 
SD4658 -2.32 1.07 -2.17 * 
SD4607 -2.34 0.87 -2.69 ** 
SD4398 -2.42 1.04 -2.31 * 
SD4522 -2.43 1.04 -2.32 * 
SD4672 -2.46 1.07 -2.30 * 
SD4432 -2.48 1.04 -2.37 * 
SD4684 -2.51 0.93 -2.71 ** 
SD4515 -2.52 0.91 -2.77 ** 
SD4589 -2.62 0.92 -2.84 ** 
SD4215 -2.64 1.04 -2.52 * 
SD4352 -2.69 1.04 -2.57 * 
SD4450 -2.75 0.91 -3.02 ** 
SD4561 -2.78 1.06 -2.62 ** 
SD4633 -2.78 1.07 -2.61 ** 
SD4659 -2.82 0.93 -3.04 ** 
SD4465 -2.83 0.84 -3.38 *** 
SD4490 -2.84 1.04 -2.72 ** 
SD4501 -2.86 0.91 -3.15 ** 
SD4517 -2.86 0.91 -3.15 ** 
SD4562 -2.86 1.06 -2.70 ** 
SD4416 -2.87 0.84 -3.43 *** 
SD4648 -2.92 1.07 -2.74 ** 
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Table 4.14., continued. 
SD4585 -3.02 1.06 -2.85 ** 
SD4569 -3.05 1.06 -2.87 ** 
SD4650 -3.09 0.93 -3.33 *** 
SD4529 -3.12 0.84 -3.73 *** 
SD4599 -3.22 0.92 -3.49 *** 
SD4439 -3.26 1.04 -3.12 ** 
SD4572 -3.28 1.06 -3.09 ** 
SD4634 -3.28 1.07 -3.08 ** 
SD4673 -3.33 0.93 -3.59 *** 
SD4638 -3.37 1.07 -3.16 ** 
SD4660 -3.38 0.93 -3.64 *** 
SD4640 -3.40 1.07 -3.19 ** 
SD4548 -3.53 1.06 -3.32 *** 
SD4321 -3.54 0.91 -3.89 *** 
SD4578 -3.59 0.92 -3.89 *** 
SD4518 -3.62 0.91 -3.98 *** 
SD4434 -3.67 1.04 -3.51 *** 
SD4502 -3.69 1.04 -3.53 *** 
SD4565 -3.88 1.06 -3.66 *** 
SD4504 -4.21 1.04 -4.03 *** 
SD4583 -4.24 1.06 -4.00 *** 
SD4530 -4.26 1.04 -4.08 *** 
SD4577 -4.29 1.06 -4.04 *** 
SD4400 -4.47 0.91 -4.91 *** 
SD4427 -4.59 1.04 -4.39 *** 
SD4639 -4.70 1.07 -4.41 *** 
SD4649 -4.98 0.93 -5.37 *** 
SD4543 -5.10 0.84 -6.09 *** 
SD4609 -5.83 1.06 -5.49 *** 
SD4313 -14.38 1.04 -13.77 *** 
SD4477 -17.09 0.91 -18.79 *** 
Location-year 
SEL2013 1.91 0.24 8.12 *** 
GRO2013 1.89 0.24 8.04 *** 
GRO2014 1.27 0.26 4.81 *** 
WAT2015 -0.81 0.28 -2.85 ** 
SEL2015 -1.24 0.28 -4.37 *** 
BRK2015 -1.81 0.28 -6.38 *** 
GRO2016 -4.03 0.32 -12.57 *** 
SEL2016 -5.35 0.32 -16.66 *** 
BRK2016 -5.94 0.32 -18.52 *** 
Significance (p) < 0 ‘***’, 0.001 ‘**’, 0.01 ‘*’, 0.05 ‘.’ 
  
 
 
2
0
4
 
Table 4.15. Summary of performance check cultivar protein traits, 2013.  
All cultivars were planted in one of three nurseries at three locations (n = 3): AYT, PYT, PPY. Two check cultivars were planted in 
each of the three nurseries (n = 9). Cultivars in gray text were not check cultivars during this growing season, but were grown as 
part of the yield trial. Dry gluten was not evaluated in 2013. 
  Whole-grain protein Flour protein Dry gluten Gliadin 
  (g kg
-1 grain) (g kg-1 flour) (g kg-1 flour) (g kg-1 flour) 
Name n Mean Var SD Mean Var SD Mean Var SD Mean Var SD 
ADVANCE 3 141.44 52.90 7.27 130.68 91.77 9.58 . . . 28.42 109.60 10.47 
BOOST 3 151.89 46.73 6.84 143.63 30.96 5.56 . . . 45.73 2.85 1.69 
BRICK 3 147.00 21.42 4.63 135.73 24.05 4.90 . . . 27.40 11.18 3.34 
BRIGGS 9 152.52 21.36 4.62 140.12 31.34 5.60 . . . 37.93 143.02 11.96 
FALLER 3 140.22 28.70 5.36 134.44 21.76 4.67 . . . 42.85 259.58 16.11 
FOCUS 3 150.67 10.76 3.28 139.78 16.16 4.02 . . . 38.65 12.75 3.57 
FOREFRONT 3 149.45 34.50 5.87 139.31 34.76 5.90 . . . 50.63 421.66 20.53 
GRANGER 3 152.00 17.43 4.17 143.28 24.11 4.91 . . . 32.83 76.71 8.76 
KNUDSON 3 146.22 3.38 1.84 135.94 6.01 2.45 . . . 34.12 300.71 17.34 
OXEN 9 151.22 53.63 7.32 138.44 51.17 7.15 . . . 33.88 100.02 10.00 
PREVAIL 3 145.56 50.06 7.08 133.55 106.06 10.30 . . . 34.97 49.25 7.02 
SELECT 3 148.89 18.05 4.25 137.17 5.25 2.29 . . . 35.40 114.35 10.69 
STEELE-ND 3 151.89 32.69 5.72 145.32 35.42 5.95 . . . 53.70 114.69 10.71 
SURPASS 3 148.44 41.00 6.40 137.47 30.46 5.52 . . . 37.96 124.72 11.17 
TRAVERSE 3 142.44 8.06 2.84 133.75 5.08 2.25 . . . 42.14 31.29 5.59 
Means per location 
Location n Mean Var SD Mean Var SD Mean Var SD Mean Var SD 
Brookings 19 149.02 28.54 5.34 138.12 29.23 5.41 . . . 39.16 124.64 11.16 
Groton 19 143.47 14.13 3.76 133.09 17.83 4.22 . . . 32.21 78.03 8.83 
Selby 19 153.94 20.17 4.49 143.38 22.72 4.77 . . . 42.35 166.26 12.89 
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Table 4.16. Summary of performance check cultivar protein traits, 2014. 
Dry gluten analysis was conducted using (n = 3) for cultivars, except for 'Knudson' (n = 2). Two check cultivars were planted in 
each of the three nurseries (n = 9). The number of observations for dry gluten by location are indicated in parentheses. Cultivars in 
gray text were not check cultivars during this growing season, but were grown as part of the yield trial. 
   Whole-grain protein Flour protein Dry gluten Gliadin 
  (g kg
-1 grain) (g kg-1 flour) (g kg-1 flour) (g kg-1 flour) 
Name n Mean Var SD Mean Var SD Mean Var SD Mean Var SD 
ADVANCE 3 144.92 19.87 4.46 126.90 90.23 9.50 98.93 183.56 13.55 21.94 30.89 5.56 
BOOST 3 149.69 9.74 3.12 135.78 33.07 5.75 108.03 199.24 14.12 24.95 35.39 5.95 
BRICK 3 145.44 26.89 5.19 126.67 116.85 10.81 99.60 111.37 10.55 24.50 17.98 4.24 
BRIGGS 3 151.21 9.51 3.08 137.53 46.27 6.80 116.00 16.00 4.00 25.11 29.38 5.42 
FALLER 3 138.56 17.77 4.22 122.49 97.25 9.86 99.80 315.61 17.77 27.91 67.51 8.22 
FOCUS 3 148.36 72.53 8.52 131.23 143.49 11.98 112.53 964.20 31.05 19.15 11.80 3.44 
FOREFRONT 9 146.14 34.08 5.84 133.81 44.99 6.71 105.60 92.44 9.61 25.13 40.57 6.37 
GRANGER 3 149.72 9.63 3.10 137.42 74.48 8.63 115.23 57.54 7.59 22.92 13.75 3.71 
KNUDSON 3 137.37 16.07 4.01 122.51 65.84 8.11 107.50 246.42 15.70 25.42 32.17 5.67 
OXEN 3 149.76 8.38 2.90 127.36 15.18 3.90 99.90 16.21 4.03 28.39 41.87 6.47 
PREVAIL 9 139.68 20.97 4.58 124.79 19.98 4.47 103.70 76.44 8.74 23.80 31.04 5.57 
SELECT 3 148.84 29.66 5.45 134.91 7.90 2.81 109.97 3.20 1.79 22.19 0.70 0.83 
STEELE-ND 3 147.71 25.50 5.05 136.34 18.15 4.26 111.33 24.70 4.97 22.61 11.25 3.35 
SURPASS 3 144.56 46.26 6.80 130.46 50.02 7.07 102.17 231.50 15.22 19.04 12.04 3.47 
TRAVERSE 3 141.20 80.55 8.97 125.72 224.39 14.98 107.13 164.80 12.84 20.50 1.37 1.17 
Means per location 
Location n Mean Var SD Mean Var SD Mean Var SD Mean Var SD 
Brookings 19 (15) 145.14 29.01 5.39 131.39 54.71 7.40 110.69 80.20 8.96 25.15 27.48 5.24 
Groton 19 (14) 140.49 27.73 5.27 123.49 55.72 7.46 95.59 102.25 10.11 24.53 18.76 4.33 
Selby 19 (15) 149.33 24.84 4.98 135.29 33.80 5.81 112.42 117.08 10.82 21.60 30.78 5.55 
  
 
 
2
0
6
 
Table 4.17. Summary of performance check cultivar protein traits, 2015. 
Dry gluten analysis was conducted using (n = 3) for cultivars. Two check cultivars were planted in each of the three nurseries (n = 
9). Fifteen (n = 15) observations were used to calculate dry gluten by location. Cultivars in gray text were not check cultivars during 
this growing season, but were grown as part of the yield trial. 
   Whole-grain protein Flour protein Dry gluten Gliadin 
  (g kg
-1 grain) (g kg-1 flour) (g kg-1 flour) (g kg-1 flour) 
Name n Mean Var SD Mean Var SD Mean Var SD Mean Var SD 
ADVANCE 3 141.00 41.46 6.44 127.44 41.11 6.41 103.00 134.83 11.61 31.11 139.59 11.81 
BOOST 3 151.22 13.49 3.67 138.07 4.65 2.16 115.17 12.60 3.55 29.37 214.65 14.65 
BRICK 3 151.11 50.03 7.07 137.42 50.61 7.11 113.33 104.06 10.20 30.39 153.09 12.37 
BRIGGS 3 152.00 37.33 6.11 137.94 25.98 5.10 117.30 76.96 8.77 29.81 119.39 10.93 
FALLER 3 138.78 23.13 4.81 128.68 28.54 5.34 102.37 25.24 5.02 26.96 154.18 12.42 
FOCUS 3 153.45 25.47 5.05 138.28 12.02 3.47 116.80 66.51 8.16 29.26 203.86 14.28 
FOREFRONT 9 148.89 26.65 5.16 136.13 15.80 3.97 114.40 67.75 8.23 30.59 126.26 11.24 
GRANGER 3 152.33 25.33 5.03 140.03 28.62 5.35 120.20 133.33 11.55 25.28 71.44 8.45 
KNUDSON 3 136.00 139.00 11.79 125.47 78.80 8.88 91.47 90.42 9.51 20.37 90.33 9.50 
OXEN 3 150.89 72.26 8.50 136.23 73.32 8.56 108.00 52.75 7.26 25.45 194.71 13.95 
PREVAIL 9 142.31 21.85 4.67 129.67 22.94 4.79 106.57 4.50 2.12 26.96 80.89 8.99 
SELECT 3 146.11 52.70 7.26 132.16 73.34 8.56 109.53 25.40 5.04 25.60 118.10 10.87 
STEELE-ND 3 152.22 15.16 3.89 142.06 12.64 3.55 120.67 22.56 4.75 27.19 94.45 9.72 
SURPASS 3 149.56 30.08 5.48 135.16 21.27 4.61 119.23 53.81 7.34 27.51 217.12 14.73 
TRAVERSE 3 142.11 3.37 1.83 129.29 2.98 1.73 110.87 9.74 3.12 26.59 160.78 12.68 
Means per location 
Location n Mean Var SD Mean Var SD Mean Var SD Mean Var SD 
Brookings 19 147.74 49.63 7.04 133.78 37.93 6.16 112.81 90.49 9.51 20.70 44.29 6.65 
Groton 19 151.75 23.49 4.85 139.04 19.24 4.39 105.12 95.02 9.75 37.73 51.85 7.20 
Watertown 19 141.09 30.04 5.48 129.12 26.68 5.17 115.85 68.30 8.26 24.86 65.36 8.08 
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Table 4.18. Summary of performance check cultivar protein traits, 2016. 
Dry gluten analysis was conducted using (n = 3) for cultivars, except for 'Knudson' (n = 2). Thirteen (n = 13) observations were 
used to calculate dry gluten by location. Cultivars in gray text were not check cultivars during this growing season, but were grown 
as part of the gliadin trial. 
    Whole-grain protein Flour protein Dry gluten Gliadin 
  (g kg
-1 grain) (g kg-1 flour) (g kg-1 flour) (g kg-1 flour) 
Name n Mean Var SD Mean Var SD Mean Var SD Mean Var SD 
ADVANCE 3 139.44 104.67 10.23 128.59 115.92 10.77 102.33 72.09 8.49 34.70 136.52 11.68 
BOOST 3 149.96 61.96 7.87 140.04 60.29 7.76 115.33 42.12 6.49 40.27 31.95 5.65 
BRICK 3 148.52 111.91 10.58 134.98 77.12 8.78 110.47 49.44 7.03 39.47 35.03 5.92 
BRIGGS 3 147.83 18.39 4.29 138.13 37.31 6.11 114.57 46.25 6.80 37.67 95.86 9.79 
FALLER 3 136.21 2.41 1.55 126.66 14.32 3.78 102.73 29.94 5.47 35.73 70.66 8.41 
FOCUS 3 150.28 152.54 12.35 139.92 98.37 9.92 115.50 26.13 5.11 35.84 61.26 7.83 
FOREFRONT 3 145.74 84.09 9.17 135.06 72.88 8.54 110.97 69.62 8.34 31.69 12.29 3.51 
GRANGER 0 NA NA NA NA NA NA NA NA NA NA NA NA 
KNUDSON 0 NA NA NA NA NA NA NA NA NA NA NA NA 
OXEN 3 144.46 15.38 3.92 132.36 33.13 5.76 104.17 4.62 2.15 31.54 35.05 5.92 
PREVAIL 3 138.99 157.63 12.56 129.42 75.83 8.71 109.17 19.08 4.37 35.87 66.46 8.15 
SELECT 3 143.29 73.49 8.57 134.79 130.41 11.42 111.23 32.57 5.71 36.11 75.39 8.68 
STEELE-ND 3 151.24 80.74 8.99 139.39 75.75 8.70 114.27 120.89 11.00 36.59 33.45 5.78 
SURPASS 3 140.97 84.33 9.18 132.05 95.35 9.76 102.13 47.64 6.90 37.14 47.38 6.88 
TRAVERSE 3 136.61 45.18 6.72 126.30 64.27 8.02 109.70 52.99 7.28 31.50 7.79 2.79 
Means per location 
Location n Mean Var SD Mean Var SD Mean Var SD Mean Var SD 
Brookings 13 137.44 41.76 6.46 125.53 26.62 5.16 103.99 27.02 5.20 40.23 25.72 5.07 
Groton 13 142.21 17.30 4.16 133.66 22.63 4.76 109.19 29.88 5.47 29.67 34.84 5.90 
Selby 13 152.71 58.16 7.63 141.82 37.69 6.14 115.10 54.53 7.38 37.20 17.09 4.13 
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Table 4.19. Least significant differences between location-years for whole-grain 
protein and flour protein. 
Observations from performance checks and cultivars under development are included 
in the location means. Location-years where trait means were found significantly 
different by Bonferroni-corrected post-hoc test at α = 0.05 family-wise error level are 
represented with different letters. 
Whole-grain protein (g kg-1) 
  CI95 Range   
Location-year n Mean SD LCL UCL Min Max LSD 
BRK2013 78 151.72 5.93 150.31 153.14 138.00 166.33 cd 
BRK2014 90 147.52 6.13 146.20 148.85 133.75 161.33 ef 
BRK2015 88 149.48 7.09 148.14 150.82 126.05 160.91 de 
BRK2016 48 139.71 6.97 137.90 141.52 124.95 156.50 h 
GRO2013 78 146.73 5.30 145.31 148.15 134.00 159.33 ef 
GRO2014 90 144.73 6.42 143.41 146.05 129.20 158.16 fg 
WAT2015 88 141.96 7.18 140.62 143.30 114.52 154.84 gh 
GRO2016 48 144.99 5.02 143.18 146.80 133.92 156.40 fg 
SEL2013 78 158.48 6.48 157.06 159.90 143.33 173.50 a 
SEL2014 90 155.06 6.78 153.74 156.38 138.74 167.46 bc 
SEL2015 88 153.53 5.67 152.20 154.87 138.33 165.47 c 
SEL2016 48 158.40 7.09 156.59 160.21 137.93 170.98 ab 
Flour protein (g kg-1) 
  CI95 Range   
Location-year n Mean SD LCL UCL Min Max LSD 
BRK2013 78 138.66 5.64 137.17 140.15 123.99 151.47 bc 
BRK2014 90 135.80 7.43 134.41 137.19 111.33 153.24 c 
BRK2015 88 135.62 6.22 134.22 137.03 117.66 149.83 c 
BRK2016 48 126.67 5.46 124.77 128.57 114.39 141.15 f 
GRO2013 78 135.99 5.58 134.49 137.48 122.65 149.13 c 
GRO2014 90 131.02 9.16 129.63 132.41 108.56 150.25 de 
WAT2015 48 134.98 4.46 133.07 136.88 124.70 144.76 cd 
GRO2016 78 146.86 6.57 145.37 148.36 131.10 165.53 a 
SEL2013 90 141.23 7.46 139.84 142.62 125.68 156.22 b 
SEL2014 88 141.93 5.70 140.52 143.34 126.20 158.88 b 
SEL2015 48 147.36 6.87 145.46 149.26 128.76 161.54 a 
SEL2016 88 130.59 7.07 129.19 132.00 104.79 142.93 ef 
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Table 4.20. Summary of multiple regression analysis for whole-grain protein. 
Genotypes and location-years with significant effect are listed (α = 0.05).  
R2 = 0.8571, F(149, 552) =22.22, p < 0.0001. 
      Coefficient SE t Significance 
(Intercept) 149.27 2.13 69.97 *** 
SD4548 13.79 3.02 4.56 *** 
SD4501 13.21 2.59 5.10 *** 
SD4321 12.79 2.59 4.93 *** 
SD4313 12.33 2.98 4.14 *** 
SD4660 12.12 2.64 4.58 *** 
SD4504 11.89 2.98 3.99 *** 
SD4605 11.18 3.02 3.70 *** 
SD4568 11.06 3.02 3.66 *** 
SD4569 10.93 3.02 3.61 *** 
SD4585 10.25 3.02 3.39 *** 
SD4626 9.76 3.04 3.21 ** 
SD4659 9.76 2.64 3.69 *** 
SD4515 9.59 2.59 3.70 *** 
SD4522 9.39 2.98 3.15 ** 
SD4628 9.34 2.64 3.54 *** 
SD4352 9.11 2.98 3.06 ** 
SD4658 9.02 3.04 2.97 ** 
SD4530 8.72 2.98 2.93 ** 
SD4503 8.39 2.98 2.82 ** 
SD4577 8.34 3.02 2.76 ** 
SD4506 7.98 2.59 3.08 ** 
SD4479 7.88 2.98 2.65 ** 
SD4502 7.55 2.98 2.54 * 
SD4529 7.52 2.39 3.15 ** 
SD4427 7.11 2.98 2.39 * 
SD4533 7.05 2.98 2.37 * 
SD4542 7.05 2.98 2.37 * 
SD4583 6.67 3.02 2.21 * 
SD4490 6.39 2.98 2.15 * 
SD4516 6.22 2.98 2.09 * 
SD4582 6.12 2.49 2.46 * 
SD4576 6.05 2.63 2.30 * 
SD4559 6.01 2.63 2.29 * 
SD4595 5.86 2.49 2.36 * 
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Table 4.20., continued. 
SD4403 5.82 2.39 2.44 * 
SD4520 5.56 2.59 2.15 * 
SD4514 5.52 2.39 2.31 * 
SD4580 5.26 2.63 2.00 * 
SD4587 5.26 2.49 2.11 * 
SD4552 5.23 2.63 1.99 * 
SD4393 4.90 2.39 2.05 * 
SD4648 -5.99 3.04 -1.97 * 
SD4671 -6.48 2.64 -2.45 * 
SD4218 -7.11 2.98 -2.39 * 
SD4677 -8.41 3.04 -2.77 ** 
SD4637 -8.47 3.04 -2.79 ** 
SD4556 -8.57 3.02 -2.83 ** 
SD4572 -8.70 3.02 -2.88 ** 
SD4647 -9.05 3.04 -2.98 ** 
SD4524 -9.27 3.02 -3.07 ** 
SD4594 -9.82 3.02 -3.25 ** 
SD4460 -11.11 2.98 -3.73 *** 
SD4557 -11.79 2.49 -4.74 *** 
SD4640 -14.54 3.04 -4.79 *** 
SD4639 -17.39 3.04 -5.72 *** 
SD4638 -18.29 3.04 -6.02 *** 
Location-year 
SEL2016 9.22 0.91 10.09 *** 
SEL2013 7.34 0.67 10.94 *** 
SEL2014 4.83 0.75 6.45 *** 
SEL2015 4.24 0.81 5.26 *** 
BRK2014 -3.60 0.75 -4.80 *** 
GRO2013 -4.82 0.67 -7.18 *** 
GRO2016 -5.27 0.91 -5.77 *** 
GRO2014 -5.90 0.75 -7.86 *** 
WAT2015 -7.58 0.81 -9.40 *** 
BRK2016 -10.74 0.91 -11.75 *** 
Significance (p) < 0 ‘***’ 0.001 ‘**’ 0.01 ‘*’ 0.05 ‘.’ 
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Table 4.21. Summary of multiple regression analysis for flour protein. 
Genotypes and location-years with significant effect are listed (α = 0.05).  
R2 = 0.8324, F(149, 552) =18.40, p < 0.0001. 
      Coefficient SE t Significance 
(Intercept) 137.14 2.37 57.89 *** 
SD4605 14.85 3.35 4.44 *** 
SD4585 12.96 3.35 3.87 *** 
SD4321 12.90 2.87 4.50 *** 
SD4568 12.76 3.35 3.81 *** 
SD4501 12.56 2.87 4.38 *** 
SD4569 12.43 3.35 3.71 *** 
SD4583 11.95 3.35 3.57 *** 
SD4660 9.97 2.93 3.41 *** 
SD4313 9.63 3.29 2.92 ** 
SD4618 9.48 3.35 2.83 ** 
SD4659 9.41 2.93 3.22 ** 
SD4515 9.32 2.87 3.25 ** 
SD4352 9.11 3.29 2.77 ** 
SD4548 9.02 3.35 2.69 ** 
SD4628 8.95 2.93 3.06 ** 
SD4615 8.86 3.35 2.65 ** 
SD4623 8.80 2.93 3.01 ** 
SD4656 8.72 3.36 2.59 ** 
SD4503 8.49 3.29 2.58 * 
SD4576 8.46 2.91 2.91 ** 
SD4542 8.37 3.29 2.54 * 
SD4658 8.35 3.36 2.48 * 
SD4626 8.14 3.36 2.42 * 
SD4595 8.09 2.75 2.94 ** 
SD4506 8.08 2.87 2.82 ** 
SD4502 7.90 3.29 2.40 * 
SD4504 6.57 3.29 1.99 * 
SD4579 5.84 2.75 2.12 * 
SD4403 5.23 2.64 1.98 * 
SD4556 -6.97 3.35 -2.08 * 
SD4677 -7.52 3.36 -2.24 * 
SD4218 -7.65 3.29 -2.32 * 
SD4471 -7.81 2.72 -2.87 ** 
SD4594 -8.13 3.35 -2.43 * 
SD4477 -8.35 2.87 -2.91 ** 
212 
 
Table 4.21., continued. 
SD4637 -9.60 3.36 -2.86 ** 
SD4557 -11.61 2.75 -4.22 *** 
SD4640 -12.48 3.36 -3.71 *** 
SD4460 -13.63 3.29 -4.14 *** 
SD4524 -14.54 3.35 -4.35 *** 
SD4639 -15.92 3.36 -4.74 *** 
SD4638 -17.01 3.36 -5.06 *** 
Location-year 
SEL2016 10.32 1.01 10.20 *** 
SEL2013 9.15 0.74 12.32 *** 
SEL2015 4.72 0.89 5.29 *** 
SEL2014 3.35 0.83 4.04 *** 
BRK2015 -1.87 0.89 -2.10 * 
GRO2013 -1.92 0.74 -2.58 * 
BRK2014 -2.48 0.83 -2.99 ** 
GRO2016 -3.63 1.01 -3.59 *** 
GRO2014 -6.43 0.83 -7.75 *** 
WAT2015 -7.01 0.89 -7.85 *** 
BRK2016 -12.01 1.01 -11.87 *** 
Significance (p) < 0 ‘***’ 0.001 ‘**’ 0.01 ‘*’ 0.05 ‘.’ 
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Table 4.22. Least significant differences between location-years  
for dry gluten and gliadin.  
Observations from performance checks and cultivars under development are included 
in the location means. Location-years where trait means were found significantly 
different by Bonferroni-corrected post-hoc test at α = 0.05 family-wise error level are 
represented with different letters. Gluten traits were not assessed in 2013. 
Dry gluten (g kg-1) 
  CI95 Range   
Location-year n Mean SD LCL UCL Min Max LSD 
BRK2014 48 113.63 9.62 111.01 116.25 86.20 137.20 bcd 
BRK2015 48 115.54 7.82 112.91 118.16 87.60 130.50 bc 
BRK2016 48 106.18 7.68 103.56 108.81 87.90 130.00 ef 
GRO2014 47 100.41 10.58 97.76 103.06 81.30 128.90 f 
WAT2015 48 108.25 9.85 105.62 110.87 84.50 131.80 de 
GRO2016 48 112.77 7.05 110.15 115.40 94.60 136.60 cd 
SEL2014 48 119.03 11.59 116.41 121.66 96.40 153.00 ab 
SEL2015 48 116.02 8.93 113.40 118.64 95.20 137.50 bc 
SEL2016 48 123.16 9.16 120.54 125.78 98.90 140.80 a 
Gliadin (g kg-1) 
  CI95 Range   
Location-year n Mean SD LCL UCL Min Max LSD 
BRK2013 78 37.06 9.17 35.19 38.93 17.45 66.05 a 
BRK2014 90 24.95 5.64 23.21 26.69 16.21 39.34 cd 
BRK2015 88 23.85 10.34 22.09 25.61 11.09 51.56 de 
BRK2016 47 36.52 8.06 34.11 38.93 21.27 65.31 a 
GRO2013 76 36.43 8.49 34.54 38.33 17.40 61.85 a 
GRO2014 90 24.01 5.87 22.27 25.75 13.82 41.79 d 
WAT2015 88 28.68 8.18 26.92 30.44 13.48 52.84 bc 
GRO2016 48 29.39 7.12 27.00 31.77 13.88 46.60 bc 
SEL2013 77 40.20 10.02 38.32 42.08 20.94 64.21 a 
SEL2014 90 19.63 7.58 17.89 21.37 7.25 45.22 e 
SEL2015 88 31.32 10.97 29.56 33.08 14.61 50.11 b 
SEL2016 46 37.63 6.37 35.19 40.06 26.62 53.08 a 
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Table 4.23. Summary of multiple regression analysis for dry gluten in 80 cultivars 
grown in nine location-years. 
Cultivars and location-years with significant effect are listed (α = 0.05).  
R2 = 0.6564, F(79, 343) = 7.53, p < 0.0001. 
      Coefficient SE t Significance 
(Intercept) 119.55 4.45 26.89 *** 
SD4471 -11.12 5.34 -2.08 * 
SD4477 -12.20 6.10 -2.00 * 
SD4470 -13.93 6.10 -2.28 * 
SD4469 -14.97 6.10 -2.45 * 
SD4584 -17.98 6.28 -2.86 ** 
SD4524 -22.93 6.10 -3.76 *** 
SD4557 -23.26 5.46 -4.26 *** 
Location-year 
SEL2016 8.90 2.17 4.10 *** 
SEL2014 7.07 1.84 3.84 *** 
WAT2015 -5.15 2.10 -2.45 * 
BRK2016 -10.26 2.17 -4.73 *** 
GRO2014 -12.51 1.84 -6.80 *** 
Significance (p) < 0 ‘***’ 0.001 ‘**’ 0.01 ‘*’ 0.05 ‘.’ 
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Table 4.24. Multiple regression analysis for gliadin accumulation in the 139 
cultivars under development.  
Genotypes and location-years with significant effect are listed (α = 0.05).  
R2 = 0.5946, F(149, 552) = 5.37, p < 0.0001. 
      Coefficient SE t Significance 
(Intercept) 37.57 4.46 8.42 *** 
SD4656 15.92 6.33 2.52 * 
SD4670 12.14 6.33 1.92 . 
SD4666 12.01 6.33 1.90 . 
SD4613 11.72 6.30 1.86 . 
SD4668 11.41 6.33 1.80 . 
SD4655 10.99 6.33 1.74 . 
SD4650 -10.30 5.51 -1.87 . 
SD4649 -10.55 5.51 -1.92 . 
SD4647 -10.72 6.33 -1.69 . 
SD4648 -11.28 6.33 -1.78 . 
SD4502 -12.40 6.20 -2.00 * 
SD4638 -12.52 6.33 -1.98 * 
SD4637 -12.62 6.33 -1.99 * 
SD4503 -14.48 6.20 -2.33 * 
Location-year 
SEL2013 3.20 1.41 2.27 * 
WAT2015 -7.33 1.69 -4.35 *** 
SEL2015 -7.51 1.69 -4.45 *** 
GRO2016 -7.54 1.91 -3.95 *** 
BRK2014 -12.11 1.57 -7.73 *** 
BRK2015 -12.34 1.69 -7.32 *** 
GRO2014 -13.15 1.57 -8.39 *** 
SEL2014 -17.91 1.57 -11.43 *** 
Significance (p) < 0 ‘***’ 0.001 ‘**’ 0.01 ‘*’ 0.05 ‘.’ 
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Table 4.25. Multiple regression analysis for gliadin accumulation in the 15 
performance check cultivars. 
All genotypes and location-years are included, regardless of contribution significance 
(α = 0.05). R2 = 0.5453, F(25, 184) =8.83, p < 0.0001. 
 Coefficient SE t Significance 
(Intercept) 37.26 2.81 13.28 *** 
BOOST 6.04 3.14 1.92 . 
STEELE-ND 5.98 3.14 1.90 . 
FOREFRONT 4.93 2.73 1.80 . 
FALLER 4.32 3.14 1.38  
BRIGGS 3.03 2.88 1.05  
FOCUS 1.68 3.14 0.54  
PREVAIL 1.63 2.73 0.60  
BRICK 1.39 3.14 0.44  
SURPASS 1.37 3.14 0.44  
TRAVERSE 1.14 3.14 0.36  
SELECT 0.78 3.14 0.25  
OXEN -0.19 2.88 -0.07  
GRANGER -0.64 3.41 -0.19  
KNUDSON -1.01 3.41 -0.30  
Location-year 
SEL2013 3.19 2.50 1.28  
BRK2016 0.50 2.79 0.18  
SEL2015 -1.83 2.52 -0.73  
SEL2016 -2.53 2.79 -0.91  
GRO2013 -6.95 2.50 -2.79 ** 
GRO2016 -10.06 2.79 -3.61 *** 
BRK2014 -14.40 2.52 -5.71 *** 
WAT2015 -14.69 2.52 -5.82 *** 
GRO2014 -15.03 2.52 -5.95 *** 
SEL2014 -17.96 2.52 -7.12 *** 
BRK2015 -18.85 2.52 -7.47 *** 
Significance (p) < 0 ‘***’ 0.001 ‘**’ 0.01 ‘*’ 0.05 ‘.’ 
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Table 4.26. Summary of performance check cultivar Mixograph assessment, 2014. 
All cultivars were planted in the AYT nurseries at three locations (n = 3). Cultivars in gray text were not check cultivars during this 
growing season, but were grown as part of the yield trial. 
  Mixograph midline time 
Mixograph midline peak 
value 
Mixograph midline peak 
width Bandwidth at 8 min 
  (min) (%) (%) (%) 
Name n Mean Var SD Mean Var SD Mean Var SD Mean Var SD 
ADVANCE 3 7.13 6.90 2.63 48.60 17.91 4.23 19.90 12.01 3.47 12.51 37.09 6.09 
BOOST 3 6.40 2.47 1.57 52.33 19.06 4.37 22.53 5.64 2.38 16.97 11.49 3.39 
BRICK 3 8.10 5.47 2.34 50.57 11.57 3.40 24.13 11.57 3.40 18.24 3.50 1.87 
BRIGGS 3 3.83 0.44 0.67 52.70 11.83 3.44 22.73 4.85 2.20 7.84 24.30 4.93 
FALLER 3 6.20 7.27 2.70 49.03 39.30 6.27 19.53 3.94 1.99 13.06 44.93 6.70 
FOCUS 3 5.43 0.20 0.45 51.83 5.52 2.35 24.17 12.89 3.59 12.30 23.93 4.89 
FOREFRONT 3 7.13 9.05 3.01 49.60 16.36 4.04 20.33 5.30 2.30 12.71 27.71 5.26 
GRANGER 3 4.13 0.72 0.85 54.90 12.52 3.54 23.60 4.96 2.23 9.32 34.06 5.84 
KNUDSON 3 9.73 7.94 2.82 49.73 9.77 3.13 22.47 1.76 1.33 19.75 37.91 6.16 
OXEN 3 5.97 2.25 1.50 51.97 18.25 4.27 28.17 44.81 6.69 18.08 103.35 10.17 
PREVAIL 3 5.37 1.60 1.27 48.53 6.50 2.55 19.27 0.25 0.50 11.38 44.60 6.68 
SELECT 3 5.77 2.82 1.68 50.77 17.06 4.13 22.37 2.64 1.63 13.19 44.74 6.69 
STEELE-ND 3 5.23 3.20 1.79 52.20 35.56 5.96 23.47 3.08 1.76 14.67 55.64 7.46 
SURPASS 3 9.07 4.56 2.14 48.60 4.27 2.07 22.63 3.94 1.99 20.02 4.60 2.14 
TRAVERSE 3 2.97 0.08 0.29 53.10 23.88 4.89 21.30 12.09 3.48 3.82 1.06 1.03 
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Table 4.27. Summary of performance check cultivar Mixograph traits, 2015. 
All cultivars were planted in the AYT nurseries at three locations (n = 3). Cultivars in gray text were not check cultivars during this 
growing season, but were grown as part of the yield trial. 
  Mixograph midline time 
Mixograph midline peak 
value 
Mixograph midline peak 
width Bandwidth at 8 min 
  (min) (%) (%) (%) 
Name n Mean Var SD Mean Var SD Mean Var SD Mean Var SD 
ADVANCE 3 6.12 0.12 0.35 48.54 8.67 2.95 17.45 14.25 3.78 10.70 17.21 4.15 
BOOST 3 6.06 1.52 1.23 49.30 27.19 5.21 21.36 9.35 3.06 13.49 9.71 3.12 
BRICK 3 7.35 2.33 1.53 50.35 5.76 2.40 18.26 0.38 0.61 15.40 59.24 7.70 
BRIGGS 3 3.83 0.42 0.65 48.05 11.48 3.39 15.71 5.57 2.36 4.64 6.71 2.59 
FALLER 3 5.84 0.50 0.71 46.98 8.23 2.87 15.72 0.86 0.93 10.13 11.46 3.39 
FOCUS 3 6.48 2.00 1.42 49.14 9.65 3.11 17.18 2.57 1.60 11.14 30.66 5.54 
FOREFRONT 9 5.92 1.50 1.22 49.20 7.52 2.74 15.15 1.78 1.33 8.35 18.09 4.25 
GRANGER 3 4.01 0.11 0.33 51.61 8.41 2.90 19.70 11.82 3.44 6.67 14.15 3.76 
KNUDSON 3 8.69 0.30 0.55 48.06 5.60 2.37 19.91 3.28 1.81 22.54 5.75 2.40 
OXEN 3 6.15 1.27 1.13 51.71 31.78 5.64 20.71 15.85 3.98 13.37 7.74 2.78 
PREVAIL 9 5.17 1.55 1.24 47.95 16.65 4.08 16.37 1.73 1.32 8.33 23.97 4.90 
SELECT 3 6.03 1.37 1.17 46.70 23.27 4.82 15.89 2.65 1.63 8.48 15.35 3.92 
STEELE-ND 3 5.09 0.20 0.45 50.56 39.40 6.28 19.55 12.27 3.50 11.16 5.60 2.37 
SURPASS 3 8.21 5.93 2.43 47.50 23.14 4.81 18.44 3.40 1.85 15.19 21.60 4.65 
TRAVERSE 3 3.35 0.29 0.54 47.80 6.68 2.59 15.51 17.17 4.14 3.19 2.00 1.41 
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Table 4.28. Summary of performance check cultivar Mixograph traits, 2016. 
All cultivars were planted in the AYT nurseries at three locations (n = 3). Cultivars in gray text were not check cultivars during this 
growing season, but were grown as part of the gliadin trial. 
  Mixograph midline time 
Mixograph midline peak 
value 
Mixograph midline peak 
width Bandwidth at 8 min 
  (min) (%) (%) (%) 
Name n Mean Var SD Mean Var SD Mean Var SD Mean Var SD 
ADVANCE 3 7.5 1.87 1.37 48.09 17.78 4.22 16.11 12.94 3.60 15.88 26.55 5.15 
BOOST 3 6.75 1.81 1.35 49.48 6.17 2.48 17.49 29.38 5.42 14.56 18.98 4.36 
BRICK 3 8.19 0.89 0.94 49.33 7.38 2.72 17.36 6.16 2.48 18.67 4.23 2.06 
BRIGGS 3 4.95 2.04 1.43 48.87 9.72 3.12 14.78 6.01 2.45 7.13 1.89 1.37 
FALLER 3 7.23 6.63 2.57 46.35 5.31 2.30 14.44 3.09 1.76 12.07 9.10 3.02 
FOCUS 3 6.75 0.72 0.85 49.71 11.19 3.35 19.62 7.69 2.77 16.00 22.26 4.72 
FOREFRONT 3 6.52 0.9 0.95 48.47 8.35 2.89 16.11 8.62 2.94 12.78 33.60 5.80 
GRANGER 0 . . . . . . . . . . . . 
KNUDSON 0 . . . . . . . . . . . . 
OXEN 3 6.95 1.34 1.16 50.78 8.81 2.97 19.01 44.15 6.64 15.04 3.09 1.76 
PREVAIL 3 6.07 0.58 0.76 49.61 2.98 1.73 18.74 3.90 1.97 12.51 32.41 5.69 
SELECT 3 6.35 1.5 1.23 51.63 10.43 3.23 20.84 41.28 6.42 12.71 4.52 2.13 
STEELE-ND 3 6.16 2.28 1.51 51.74 21.19 4.60 19.21 29.40 5.42 13.08 0.56 0.75 
SURPASS 3 10.96 8.9 2.98 47.69 19.42 4.41 16.86 25.84 5.08 17.93 76.10 8.72 
TRAVERSE 3 3.46 0.3 0.55 47.95 23.48 4.85 14.64 18.11 4.26 3.00 1.86 1.36 
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Table 4.29. Summary of performance check cultivar baking quality traits, 2014. 
All cultivars were planted in the AYT nurseries at three locations (n = 3). Cultivars in gray text were not check cultivars during 
this growing season, but were grown as part of the yield trial. 
  Mixing time Baking absorption Baked loaf volume 
  (min) (%) (cc) 
Name n Mean Var SD Mean Var SD Mean Var SD 
ADVANCE 3 5.17 0.58 0.76 58.77 4.10 2.03 220.00 208.00 14.42 
BOOST 3 5.08 0.02 0.14 60.99 1.01 1.01 234.67 690.33 26.27 
BRICK 3 6.42 0.02 0.14 59.78 1.73 1.31 223.00 700.00 26.46 
BRIGGS 3 3.17 0.15 0.38 60.06 4.44 2.11 197.33 386.33 19.66 
FALLER 3 4.33 0.02 0.14 58.39 3.70 1.92 207.00 84.00 9.17 
FOCUS 3 5.00 0.06 0.25 60.00 0.78 0.88 220.00 273.00 16.52 
FOREFRONT 3 5.00 0.81 0.90 57.94 0.23 0.48 211.67 226.33 15.04 
GRANGER 3 3.83 0.15 0.38 60.76 5.28 2.30 221.33 281.33 16.77 
KNUDSON 3 7.08 1.02 1.01 59.46 0.59 0.77 214.67 240.33 15.50 
OXEN 3 5.00 0.25 0.50 61.26 4.36 2.09 218.67 286.33 16.92 
PREVAIL 3 4.17 0.08 0.29 58.75 0.27 0.52 210.00 784.00 28.00 
SELECT 3 4.83 0.52 0.72 60.39 0.29 0.54 211.33 252.33 15.89 
STEELE-ND 3 4.58 0.15 0.38 61.06 11.92 3.45 221.00 961.00 31.00 
SURPASS 3 6.75 0.06 0.25 58.77 0.04 0.20 219.33 676.33 26.01 
TRAVERSE 3 2.75 0.00 0.00 61.81 6.44 2.54 201.67 426.33 20.65 
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Table 4.30. Summary of performance check cultivar baking quality traits, 2015. 
All cultivars were planted in the AYT nurseries at three locations (n = 3). Cultivars in gray text were not check cultivars during 
this growing season, but were grown as part of the yield trial. 
  Mixing time Baking absorption Baked loaf volume 
  (min) (%) (cc) 
Name n Mean Var SD Mean Var SD Mean Var SD 
ADVANCE 3 4.42 0.15 0.38 55.15 6.82 2.61 181.67 132.33 11.50 
BOOST 3 4.67 0.15 0.38 55.70 9.63 3.10 185.00 76.00 8.72 
BRICK 3 5.83 1.40 1.18 56.64 3.54 1.88 190.67 114.33 10.69 
BRIGGS 3 3.25 0.25 0.50 56.42 2.88 1.70 176.00 48.00 6.93 
FALLER 3 4.50 0.06 0.25 54.95 2.24 1.50 184.67 46.33 6.81 
FOCUS 3 4.83 0.08 0.29 56.44 1.62 1.27 188.67 110.33 10.50 
FOREFRONT 3 4.58 1.02 1.01 55.40 1.22 1.11 185.00 156.00 12.49 
GRANGER 3 3.83 0.33 0.58 58.18 3.16 1.78 196.33 204.33 14.29 
KNUDSON 3 6.75 0.06 0.25 56.70 0.81 0.90 188.00 129.00 11.36 
OXEN 3 5.25 0.00 0.00 56.48 15.04 3.88 190.33 82.33 9.07 
PREVAIL 3 3.83 0.58 0.76 55.19 3.84 1.96 178.33 22.33 4.73 
SELECT 3 4.75 0.56 0.75 54.98 2.80 1.67 183.00 279.00 16.70 
STEELE-ND 3 3.83 0.15 0.38 55.65 4.88 2.21 188.33 108.33 10.41 
SURPASS 3 5.83 0.65 0.80 55.02 5.58 2.36 182.00 7.00 2.65 
TRAVERSE 3 2.83 0.15 0.38 54.99 3.13 1.77 176.33 166.33 12.90 
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Table 4.31. Summary of performance check cultivar baking quality traits, 2016. 
All cultivars were planted in the AYT nurseries at three locations (n = 3). Cultivars in gray text were not check cultivars during 
this growing season, but were grown as part of the yield trial. 
  Mixing time Baking absorption Baked loaf volume 
  (min) (%) (cc) 
Name n Mean Var SD Mean Var SD Mean Var SD 
ADVANCE 3 3.83 0.65 0.80 56.98 0.91 0.95 189.33 102.33 10.12 
BOOST 3 3.08 0.58 0.76 57.24 0.78 0.88 193.33 162.33 12.74 
BRICK 3 4.08 0.15 0.38 57.85 3.48 1.86 192.33 364.33 19.09 
BRIGGS 3 2.33 0.65 0.80 57.40 1.15 1.07 181.67 44.33 6.66 
FALLER 3 3.00 0.75 0.87 57.38 6.12 2.47 181.67 52.33 7.23 
FOCUS 3 3.42 0.27 0.52 57.59 8.73 2.95 194.00 48.00 6.93 
FOREFRONT 3 3.08 0.15 0.38 57.38 6.76 2.60 193.00 49.00 7.00 
GRANGER 3 NA NA NA NA NA NA NA NA NA 
KNUDSON 3 NA NA NA NA NA NA NA NA NA 
OXEN 3 3.25 0.00 0.00 58.26 2.39 1.55 195.67 136.33 11.68 
PREVAIL 3 2.92 0.15 0.38 57.42 8.90 2.98 190.00 49.00 7.00 
SELECT 3 3.00 0.44 0.66 58.46 1.31 1.15 177.00 61.00 7.81 
STEELE-ND 3 2.75 0.44 0.66 58.90 4.87 2.21 201.00 147.00 12.12 
SURPASS 3 4.92 0.52 0.72 57.63 8.06 2.84 193.33 42.33 6.51 
TRAVERSE 3 1.92 0.15 0.38 57.05 2.62 1.62 176.33 532.33 23.07 
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CHAPTER 5. TRAIT STABILITY OF GLIADIN 
ABSTRACT 
Public misunderstanding of wheat (Triticum aestivum L.) breeding objectives has 
led to misconceptions regarding the effects of selection on immunogenic proteins in 
wheat, and the interaction of genotype and environment and phenotypic outcomes is 
typically unaddressed in these discussions. The aim of this study was to evaluate the 
stability of gliadin expression in different growing environments in a population of 191 
hard red spring wheat cultivars. One hundred fifty-four contemporary cultivars and 37 
accessions obtained from the National Small Grains Collection (Aberdeen, ID), were 
grown in 12 and two location-years, respectively. Nonparametric summed ranks and 
genotype and genotype-by-environment (GGE) biplot analysis were employed to 
determine the relative stability rankings of the population. Twenty-four cultivars grown 
in three locations during the 2013 to 2016 SDSU yield trials, for a total of 12 location-
years, were used in the GGE biplot analysis. Parametric and nonparametric rankings 
agreed that SD4416 was one of the three most stable cultivars for ELISA-measured 
gliadin accumulation. Eight accessions from the Small Grains Collection ranked among 
the highest gliadin-accumulating cultivars. Mean gliadin accumulation in the 37 
accessions increased from 19.76 g kg-1 (var = 44.39) in 2015 to 45.72 g kg-1 (var = 66.90) 
in 2016 at the Brookings location, as compared to 26.75 g kg-1 and 34.45 g kg-1 
accumulated by the 48 contemporary cultivars grown in the same location-years. GGE 
biplot analysis (which-won-where, using double-centered or GE scaling) identified the 
performance check ‘Focus’ instead of ‘Briggs’ and ‘Prevail’ among the three most-stable 
cultivars.  
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INTRODUCTION 
Trait stability is a modern plant breeding target. Unpredictable genotypic 
responses to environmental factors such as soil type, temperature and cumulative growing 
degree days, precipitation, and management practices lead to rank changes over trial 
environments (Baker 1998; Becker and Leon 1988; Crossa 1990; Yan 2014). These 
genotype by environment interactions (GEI) complicate the plant breeder’s decision 
process when making selections. The first statistical methods developed and applied to 
plant breeding were parametric models that partitioned main effects of genotype and 
environment, i.e., ANOVA and linear regression (Elias et al 2016). Nonparametric, 
multivariate approaches, and crossover analyses evolved from the early regression 
methods as plant breeders identified new methods to better judge the performance of new 
cultivars over multi-environment trials (MET). Reviews of analytical methods can be 
found elsewhere (Eberhart and Russell 1966; Crossa 1990; Flores et al 1998; Elias et al 
2016). What trait stability means in specific contexts, and the summed rank and genotype 
and genotype-by-environment (GGE) biplot approaches employed to evaluate it, will be 
discussed in the following sections. 
Trait stability can be static—or dynamic 
Becker and Leon (1988) outlined two classes of trait stability: 1) biological 
stability and 2) agronomic stability. Biological stability, also called the static concept of 
stability, is characterized by a lack of variation and deviation across environments. 
Conversely, agronomic stability is marked by a response of predictable magnitude 
relative to the environmental stimulus. Variation in trait measurement is observed in 
agronomic stability, but deviation from the coefficient is not. Becker and Leon did not, 
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however, clarify whether the genome has intrinsic limits beyond which no difference in 
trait value can be detected.  
Evolutionary biologist Theodosius Dobzhansky once noted that “The performance 
of a genotype cannot be tested in all possible environments, because the latter are 
infinitely variable” (Dobzhansky 1955, cited in Platt and Sanislow 1988). If agronomic 
stability can be likened to the concept of ‘norm-of-reaction’ described by psychology and 
behavior researchers, then the differences in phenotype expressed by a genotype across 
environments can be considered an expression of fitness under stressful conditions 
(Simms 2000).  
Summed ranking is a nonparametric approach 
Kang’s summed rank is a straightforward method for selection on a few traits, 
with no assumptions made about the distribution or correlations of the observations 
(Huehn 1990; Souza et al 1993; Flores et al 1998). Instead of using the trait values 
directly, each value or its variance is assigned an ordinal rank based on desirability. 
Weighting may be applied. Low variance in rankings is taken as a sign of stability. The 
ranks can be graphed in a parallel plot to visualize potential crossover interactions for 
proper analyses (Crossa 1990). Reliance on simple line graphs is inadvisable, as the 
difference between groups may not be statistically significant. Some authors recommend 
conducting an Azzalini and Cox test or other statistical assessment for crossover 
interactions (Baker 1998).  
The GGE biplot analysis is a multivariate approach  
MET trials often generate data sets that are large, unbalanced, and noisy. The 
purpose of GGE analysis is to search for patterns in data sets that characterize the 
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agronomic stability of cultivars and identify representative target environments (Yan and 
Kang 2003; Yan 2013). Estimating variance components can be complicated by the 
distribution of the data, which is often skewed due to selection, and resource-limited 
numbers of replications. Estimates of environmental variance are therefore difficult to 
calculate as the GEI component can be lost to the error term (Elias et al 2016).  
That a superior phenotype is exclusively controlled by genotype and not the result 
of a desirable GEI is a misconception. Environmental main effects produce the greatest 
influence on phenotype (Yan and Kang 2003), but are considered fixed and therefore 
equal to zero for a cohort of genotypes within them (Yan 2014). This reduces the terms of 
the expanded heritability (h2) model  
h2 = σ2G / (σ2G +σ2E + σ2I) 
where σ2G is the total genetic variance, σ2E is the environmental variance, and σ2I is the 
variance in interaction effects, to 
h2 = σ2G / (σ2G + σ2I) 
which can be expanded further, with adjustments: 
h2 = σ2G / (σ2G + (σ2GL/nL) + (σ2GY/nY) + (σ2GLY/nLnY) + (σ2ε/nLnYnr)) 
where σ2GL is the genotype-by-location variance over nL number of locations, σ2GY 
is the genotype-by-year variance over nY number of years, σ2GLY is the genotype-by-
location-by-year variance over nLnY number of locations and years, and σ2ε is the error 
variance over nLnY number of years and locations and nr number of replications. 
Heritability of the trait, calculation of which is based on genotype, location, and year, can 
be determined by optimized MET after analysis of trait mean correlations across 
environments (Coe 2012a, 2012b). Heritability estimates increase as genotypic variance 
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or number of environments increase. The agronomic stability of a trait therefore depends 
on the predictability of the GEI. Recovering a genotypic effect buried in the error term 
improves the characterization of GEI. The GGE model 
Ŷij = μ + αi + βj + ϕij   
describes expected trait value (Ŷij) as a function of the grand mean of all 
observations (µ), the main effect of genotype αi, the main effect of environment βj, and 
the interaction between them ϕij (Yan 2014).  
Graphical methods are tools for evaluation of GEI. The GGE biplot maps the 
matrix multiplication of a two-way table P. Singular value (λ) decomposition of P creates 
three matrices: G, E, and L (Yan and Tinker 2006). These matrices characterize the 
number of genotypes (matrix G) as m genotypes in rows, environments (matrix E) as n 
environments in columns, and singular values (matrix L) as r singular values in a 
diagonal matrix. The r derivative principal components of table P summarize the 
genotype (ξi) and environment (ηj) associations as vectors, and their combined singular 
value (λ) that is partitioned to approximate the two-way data. These values are then 
graphed as a biplot. The partitioning approach depends on which relationships are to be 
plotted. To graph GEI, the column-metric preserving partition of λ is the most accurate 
approach. 
Repeatable crossover interactions indicate the need to examine the target 
environment carefully to identify sources of the GEI. With the goal of basing selections 
on GEI to achieve trait stability, the GGE biplot strategy should 1) identify ideal 
environments for trait expression and 2) identify the genotypes expressing the ideal 
values for that trait. 
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MATERIALS AND METHODS 
Plant materials 
One hundred ninety-one hard red spring wheat cultivars were grown in the South 
Dakota State University Spring Wheat Breeding Program yield trials between 2013 and 
2016. Fifteen performance check cultivars and 139 cultivars under development were 
planted in a randomized block design with three replicates at three locations per year. 
These locations included four sites in South Dakota: Brookings (lat. 44.31, long. -96.67), 
Groton (45.49, -100.01), Selby (45.108, -97.103), and Watertown (45.42, -97.91 Due to 
hail damage at the Groton location in 2015, a location substitution (Watertown) was 
made to balance the dataset. Thirty-seven HRSW accessions (see Appendix B) were 
obtained from the National Small Grains Collection (Aberdeen, ID) and planted in head 
rows at the Brookings location in 2015 and 2016. The label ‘GRIN’ used hereafter refers 
to the 37 accessions. 
Statistical analysis 
All statistical analyses were performed using R version 3.3.2 (The R Core Team 
2016) and the packages named hereafter. Summed ranks were calculated, interaction 
plots drawn, and t tests conducted using base R functions. Nonparametric stability 
analysis for the gliadin trait was carried out using the R package ‘agricolae’ (de 
Mendiburu 2016). GGE stability analysis and biplot construction were performed using 
base R functions and the packages ‘minque’ (Wu 2014), ‘gge’ (Wright and Laffont 
2017), and ‘GGEBiplotGUI’ (Frutos et al 2014).  
Nonparametric summed ranks on means without scaling and stability analysis was 
performed using the 139 cultivars under development and 15 performance checks. These 
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cultivars were assessed by location for 15 grain and flour quality traits (Table 5.1). These 
traits, save gliadin, were used to select cultivars to undergo the USDA quality tests 
described in Chapter 4. USDA baking quality data were not ranked in this part of the 
study. Replicates from each location were composited as described in Chapter 4, 
effectively making each observation a location-year mean. The 37 GRIN accessions were 
subjected to the gliadin ELISA described in Chapter 3. Traits with the most desirable 
value were ranked ‘1’. Less-desirable trait values were assigned ranks in ascending order. 
Cultivars with the lowest summed rank for all traits per year were considered as 
candidates for selection. Two performance check cultivars were replaced during the 
study, leaving 13 checks with data for four years. Each genotype-location-year (GLY) 
was treated as a unique individual for ranking gliadin accumulation only; unique cultivars 
in the top and bottom 10% were used to select candidates for later genotyping (see 
Chapter 6). A Welch two-sample t test was conducted to compare the mean gliadin 
accumulation of the 57 AYT and 37 GRIN cultivars grown at Brookings in 2015 and 
2016.  
Nonparametric stability analysis on the gliadin trait was performed on 24 
cultivars, including performance check cultivars, grown in four yield trials (2013-2014). 
Mean gliadin accumulation was 31.66 g kg-1 for this group. The z-statistics for each set of 
ranks were calculated and compared to a Chi-square distribution as a measure of stability.  
Twenty-four cultivars were grown four years in the yield trials; these cultivars 
were used for stability analysis by GGE. Gliadin accumulation in response to genotype 
and environmental factors by the 24 cultivars was assessed using a linear mixed model of 
the form  
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y = μ + Gi + βiEj + GEij + εhijk 
where µ equals the population mean, Gi is the effect of genotype i, βiEj is the 
effect of location-year j, GEij is the GEI effect, and εij is the residual random error, with 
jackknife resampling (N = 10) to calculate variance components at a significance level of 
α = 0.05. All effects were random. GGE biplot analysis of gliadin used column-metric 
preservation and scaling by the standard deviation of the group. 
RESULTS 
Nonparametric: summed ranks on means without scaling and stability analysis 
Cultivars under development were ranked for each of the 15 traits listed in Table 
5.1. The ‘winning’ score, ‘1’, was assigned to the cultivar that expressed the most 
desirable trait value. Ultimately test weight, Falling Number score, whole-grain protein, 
flour protein, and dry gluten were used to calculate summed ranks. Cultivars grown in 
2013 were not assessed for gluten traits. Only Advance Yield Trial (AYT) entries were 
subjected to gluten analysis in 2014, so this trait was disregarded for the 2013 and 2014 
trial ranks. Only one cultivar under development, SD4660, ranked as one of the top five 
candidates in both 2014 and 2015 (Table 5.2). The 20 lowest- and 20 highest-ranks for 
yearly mean gliadin accumulation are listed in Table 5.3.  
The top and bottom 10% gliadin-accumulating GLY combinations of each year 
were selected to compile a base list to ensure each cultivar was given the opportunity to 
be selected for genotyping. Each year was therefore represented by a different number of 
cultivars (2013, 16 cultivars; 2014, 18 cultivars; 2015, 24 cultivars; 2016, 18 cultivars) 
for a total of 76 selections. As a result, seven cultivars appeared in both the low and high 
gliadin groups. These cultivars were removed from the penultimate ranking group to 
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leave a total of 62 cultivars that exhibited less-extreme crossover interactions. ‘Lancer’ 
exhibited the greatest variation in gliadin accumulation of the 191 total cultivars (var = 
1330.83), with a two-year mean of 34.08 g kg-1. Its 2015 (8.28 g kg-1) and 2016 (59.87 g 
kg-1) gliadin measurements placed ‘Lancer’ in both low- and high-gliadin groups, 
therefore this cultivar was dropped from the final ranking group. Eight GRIN accessions 
ranked among the highest gliadin-accumulating cultivars (Table 5.3). ‘Marquis’, 
registered as CItr 3641 in 1911, exhibited the third-greatest overall measured gliadin of 
all cultivars with an accumulation of 61.39 g kg-1 per kg of flour at Brookings in 2016. 
The two-year average for ‘Marquis’ was 39.76 g kg-1 (var = 936.10). ‘Red Fife’, 
registered as CItr 6196 in 1918 and male parent of ‘Marquis’ (Clark et al 1923), ranked 
just above the 20-highest gliadin accumulating lines (22nd highest) with a two-year 
average of 33.90 g kg-1 of gliadin (variance = 222.35) at Brookings. ‘Red Fife’ produced 
44.44 g gliadin per kg flour in 2016. The average gliadin produced by ‘Hope’ (31.01 g 
kg-1, var = 683.82) was less than that produced by ‘Red Fife’. The mean gliadin 
accumulated by all GRIN cultivars grown in Brookings was 19.76 g kg-1 (var = 44.39) in 
2015 and 45.72 g kg-1 (var = 66.90) in 2016.  
Analysis of the yield trial population (N= 154) showed that SD4650 had the 
greatest variation (var = 411.29) in gliadin accumulation (three-year mean = 27.37 g kg-1) 
in the cultivars under development. The lowest variance in mean gliadin accumulation 
was exhibited by SD4594 (three-year mean = 31.80, var = 0.68). The phenotypic range of 
24 yield trial cultivars grown in four years is illustrated in Figure 5.1. ‘Steele-ND’ 
exhibited the greatest variation in gliadin accumulation (var = 200.71) of the performance 
check cultivars. The four-year mean for this cultivar was 35.02 g kg-1, with a range of 
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18.79 g kg-1 to 66.06 g of gliadin per kg of flour accumulated in the Selby 2014 and 
Brookings 2016 location-years, respectively. Conversely, ‘Granger’, ‘Prevail’, and 
‘Brick’ exhibited the lowest variance in gliadin accumulation of the performance check 
cultivars (Table 5.4). Crossover interactions were observed among cultivars grown in 
different environments; the rank changes among six cultivars are illustrated in Figure 5.2.  
Comparison between the AYT cultivars and GRIN accessions grown in 
Brookings during the 2015 and 2016 seasons is illustrated in Figure 5.3. The 2015 GRIN 
group had a lower mean gliadin accumulation (19.76 g kg-1) with a greater probability of 
observed values near the group mean, compared to the AYT group (26.75 g kg-1) with a 
wider range of observed values. A Welch two-sample t test (|tcritical| = 1.20, df = 75.35, α 
= 0.05) rejected the null hypothesis of equal means in the 2015 data set (t = 5.23, p < 
0.0001). The 2016 observations indicated a reversal in group trends. The 2016 GRIN 
accessions accumulated a mean of 45.72 g kg-1 gliadin, while the AYT cultivar mean 
gliadin was 34.45 g kg-1). A Welch two-sample t test accepted the alternate hypothesis of 
unequal means (t = -7.63, |tcritical| = 2.00, df = 59.99, p < 0.0001) at the 95% significance 
level. One-way ANOVA assessed the primary source of variation as year (F(1) = 141.50, 
p < 0.0001) and not genotype (F(101) = 0.43, p = 1). A Welch two-sample t test accepted 
the alternate hypothesis of unequal means between the 2015 and 2016 years (t = -15.18, 
df = 163.06, p < 0.0001). The combined mean gliadin accumulation in the GRIN and 
AYT cultivars was 40.70 g kg-1 in 2016, compared to 21.03 g kg-1 flour in 2015.  
Nonparametric stability analysis on the gliadin trait is summarized in Table 5.5. 
Calculations of absolute rank difference and variance for the 24 cultivars grown in 12 
location-years were assessed for significance using a Chi-square distribution. No 
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significant genotypic effect was identified, but detection of GEI was significant at a 
critical value of χ2 = 36.41 with one degree of freedom. This approach ranked two 
performance checks, ‘Briggs’ (27.17 g kg-1) and ‘Prevail’ (27.70 g kg-1), and SD4416 
(28.69 g kg-1) as the ‘winning’ cultivars based on absolute rank differences across 
environments (Table 5.5). ‘Steele-ND’ ranked 13th and ‘Brick’, despite its low variance 
in gliadin accumulation, ranked 21st when the 24 cultivars were sorted by absolute rank 
variance (s1). ‘Brick’ rose to 20th place when the sort was based on variance in ranks 
(s2). This indicated that rank switching had occurred among the GLY combinations. 
SD4539 consistently ranked last out of 24 regardless of whether sorting was based on 
gliadin accumulation, absolute rank difference, or variance in rank.  
GGE analysis 
Genotype was a minor contributor to gliadin accumulation in the 24 cultivars 
grown in 12 location-years. Due to the use of composited samples, each observation was 
effectively the mean of each location-year. This relegated the GEI effect to the error term, 
making it impossible to determine the magnitude of the GEI. The linear mixed model 
identified location-year as the greatest contributor to gliadin accumulation. The extracted 
variance components are summarized in Table 5.6, while the predicted location-year 
effects on gliadin accumulation are summarized in Table 5.7. GGE biplot analysis 
(which-won-where, using double-centered or GE scaling) indicated that developing 
cultivars SD4416 and SD4456 were the most broadly-adapted to all environments, 
accumulating similar amounts of gliadin in all trials (Figure 5.4). The GGE biplot 
analysis identified ‘Focus’ and SD4472 as less responsive to most environments, though 
these two cultivars ranked 4th and 8th in the nonparametric stability analysis (Table 5.5). 
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The GGE biplot analysis results agreed with the nonparametric stability analysis in 
identifying two of the least-stable cultivars, ‘Forefront’ and SD4543, and identified four 
additional cultivars: ‘Advance’, SD4514, SD4493, and SD4403. Of the six least-stable 
cultivars, ‘Forefront’ accumulated the most gliadin in four location-years (Brookings 
2013, Brookings 2014, Selby 2013, and Selby 2015. SD4403 and SD4529 accumulated 
less gliadin in most environments than other cultivars, but were more prone to 
considerable rank switching across environments. ‘Steele-ND’ clustered near these 
cultivars in Figure 5.4. The ‘which-won-where’ analysis identified five clusters of similar 
environments, marked by the position of the first letters of the environment label. Figure 
5.4 indicated that the Watertown 2015 location-year stood apart, though it was most 
similar to the Brookings 2015 and Selby 2016 environments (Figure 5.5). The Groton 
2014 vector in Figure 5.5 indicated that this environment held the most discrimination 
value of the 12 location-years for selection directly on gliadin accumulation.  
DISCUSSION 
Both parametric and nonparametric methods identified SD4416 in the top three 
cultivars that were relatively stable with regard to gliadin accumulation. ‘Focus’ was 
ranked as fourth-most stable by the nonparametric approach (Table 5.5). The advantages 
of using a nonparametric method to assess stability (i.e. that nonparametric tests make no 
assumptions about the distribution of the population and are robust against outlier bias) 
make this approach a convenient way to make selections on a few traits (Huehn 1990) 
that are best represented by a median value. Agronomic stability can then be 
approximated by the variation in ranks across environments. The large pool of cultivars 
tested in a breeding program makes nonparametric approaches more complicated to use 
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than parametric methods.  
Modern plant breeding has increasingly focused on multivariate analyses to assess 
multiple quality traits and potential interactions (Crossa 1990; Flores et al 1998). When 
applied to METs, plant breeders need to refine their predictive models to balance 
allocation of resources with data accuracy. Streamlining those multivariate models into 
ordination analyses such as PCA reduces the data set into a more-manageable load. 
Further transformation of correlations for use in GGE analyses can identify the most 
appropriate testing environments as well (Yan and Kang 2003). Construction of GGE 
biplots make genotype and environment assessment less time-consuming for the plant 
breeder. For example: in this study, the inconsistent clustering of locations across years 
indicated that the four geographic locations shared a similar climate, and therefore could 
form part of one mega-environment (Figure 5.4). Additional years’ data would have 
improved the analysis. Figure 5.5 indicated that Watertown did cluster with the other two 
environments, so the wide density distribution of gliadin illustrated in Figure 4.5 may 
have been due to other unmodeled factors. The unexpected discovery of the 
discrimination value of Groton 2014 was probably due to its statistically non-significant 
effect on gliadin accumulation. The relatively larger environmental effects of all 2013 
locations and the Groton 2016 would make these suitable ‘killer climates’ to select 
against high-gliadin cultivars (Table 5.6).  
The effect of growing environment on phenotypic expression was demonstrated 
several times over in this study, in agreement with the de Santis et al report on Italian 
durum (2017) and the Boukid et al analysis of Tunisian durum (2017). Conversely, 
Prandi et al (2014) found that genotype was a stronger influence on gliadin accumulation 
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in their collection of Mediterranean-region durum wheats. Nutrient management practices 
and temperatures or crop calendars were not evaluated in the present study, although 
these factors have been discussed by other authors (Pechanek et al 1997; Daniel and 
Triboi 2000; Triboi et al 2000; Triboi et al 2003; Altenbach et al 2002; Souza et al 2004; 
Dupont et al 2006). Temperature during grain fill has been implicated in differential 
expression of gliadin, which has subsequent impact on assays of gluten strength 
(Blumenthal et al 1993; Graybosch et al 1995). Triboi et al (2003) conducted a closed-top 
chamber experiment in which gliadin accumulation decreased in response to higher 
temperatures during early grain fill, with a concurrent shortening of expression duration. 
This effect was studied in combination with drought stress, which depressed gliadin 
expression rate more, and nitrogen application. In their investigation of temperature on 
quality traits, Graybosch et al (1995) found that variance in protein content decreased in a 
response to higher temperatures during the grain fill stage of hard red winter wheat. 
These authors determined that temperature alone did not explain the variance observed in 
the protein traits measured, and concluded that multiple environmental inputs contributed 
to trait expression. Likewise, Blumenthal et al (1993) observed an increase in gliadin 
accumulation relative to glutenin in cultivars subjected to heat stress. Suspecting that 
gliadin expression was collateral to upregulation of heat shock proteins, Blumenthal et al 
searched for and found heat shock regulatory elements within gliadin gene sequences that 
might promote gliadin gene expression in response to heat stress. No such regulatory 
elements were associated with glutenin genes. The authors proposed that gliadin might 
perform some physiological function in response to heat stress, and that climate cycles 
could influence expression of this trait. If gliadins do provide antioxidant protection 
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during seed storage, like other seed storage proteins described by El Maarouf-Bateau et al 
(2013), the variation in gliadin accumulation observed in this study could indicate 
differences in local adaptation in the 191 HRSW cultivars evaluated. The interpretations 
of the stability analysis conducted in this study might have been improved had 
temperature, growing degree days, and plant development stages been modeled.  
The box plot of gliadin accumulation in the 24 cultivars grown in four years 
(Figure 5.1) illustrates the range of phenotypic expression possible even in late-
generation wheat cultivars. Rank switching between years (Table 5.2) suggested that the 
extremes of this trait may be correlated with local adaptation. The cultivars most stable 
for gliadin accumulation did not appear on the summed rank table for test weight and 
other protein traits. No direct selection on gliadin accumulation in the cultivars under 
development was identified in this study.  
   The assessment of older varieties obtained from GRIN and the breeding 
program materials did not find a statistically significant effect of genotype on gliadin 
accumulation. Figure 5.3 clearly shows a trend of increased gliadin in both groups in 
2016 that was statistically supported by the two-sample t test. This indicated that 
environmental conditions influenced gliadin accumulation in both old and new cultivars, 
as proposed by van den Broeck et al (2010). The results observed in this study indicated 
that old and new cultivars will accumulate similar amounts of gliadin when grown in the 
same environment. Other authors have reported similar results (Kasarda 2013).  
Malalgoda (2016) reported some differences in reverse-phase HPLC fractions of 
γ- and ω-gliadins, but not α-gliadins, in an analysis of 30 wheat cultivars. Ten of these 
cultivars overlapped with this dissertation work, including ‘Marquis’, ‘Steele-ND’, 
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‘Faller’, and ‘Alsen’. Malalgoda successfully used mass spectroscopy to identify 
differences in gliadin epitopes among the cultivars, but failed to assign these differences 
to a release year by cluster analysis. This author concluded that old and new cultivars had 
similar levels of immunogenic potential as determined by epitope sequence. The van den 
Broeck study also sought differences in immunogenic epitope content between new and 
old wheat cultivars, and successfully identified differences in protein variation. These 
authors found that protein sequence diversity was greater in landrace materials, but failed 
to associate seed storage protein profiles with a geographic source. Using monoclonal 
antibodies raised against specific immunogenic gliadin epitopes, van den Broeck et al 
performed Western blots to identify relative differences in staining intensity. Western 
blotting is not a true quantitative method, and requires a defined quantity of a 
constitutively expressed control protein, such as tubulin, to measure differences in signal 
intensity (Taylor and Posch 2014). The authors used a gluten extract from a single 
cultivar to serve as a control instead. Van den Broeck also classified intensities by 
binning, instead of comparing the signal intensity of each unknown to a characterized 
control to identify a proportional signal. Therefore, van den Broeck et al identified 
variation in the protein profile but not a true measure of each protein quantity.  
Qualitative assessment of the probability densities of the violin plot indicated that 
GRIN cultivar gliadin values were more likely to cluster around the group mean, while 
current cultivars tended to accumulate less-than-average gliadin with some large outliers. 
The large outliers in this study were found in observations of ‘Marquis’, ‘Knudson’, and 
‘Steele-ND’, which were developed in Ottawa, Canada, Colorado, and North Dakota, 
respectively (Clark et al 1923; Mergoum et al 2005). The expression of high gliadin 
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accumulation in these lines may have been an expression of a stress response to an 
environment to which they were not adapted. The relative gliadin accumulation of some 
GRIN cultivars not listed in Table 5.3, however, indicated that adaptation might not be 
the only responsible factor. (Refer to Appendix B.)  
Genetic background and interactive effects between genetic loci could also have 
influenced gliadin accumulation in response to environmental inputs. The claim that plant 
breeders have altered protein content to create more-immunogenic forms of gluten is 
therefore untenable when the source of the genetically-diverse parental stock needed to 
capture genetic gain is considered. Prebreeding germplasm derived from hybridizations 
between wheat and related species may exhibit greater genetic diversity of evolutionarily-
conserved storage protein genes. Subsequent crosses would therefore reintroduce ‘wild-
type’ seed storage proteins into the elite breeding germplasm. If wild-type proteins are 
less immunogenic than those of cultivars, then the historical introgressions of traits from 
emmer and einkorn would have improved the relative safety of cultivated wheat. If wild-
type proteins are equally or more immunogenic, then the seed storage proteins of other 
species of wheat would induce the same adverse reactions in consumers as those of elite 
cultivars. Mutation and transgenic breeding, which may have unpredictable effects, could 
disrupt the normal physiological function of the conserved protein and potentially render 
the seed inviable. For this reason, related cultivars and those with known introgressions 
were chosen for inclusion in this study. ‘Marquis’ accumulated more gliadin (two-year 
mean = 39.76 g kg-1) than did its male parent ‘Red Fife’ (two-year mean = 33.90 g kg-1) 
and descendent ‘Hope’ (two-year mean = 31.01 g kg-1) when grown in the same 
conditions. Additional comparison with its female parent ‘Hard Red Calcutta’ (Clark et al 
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1923) might have given more insight into potential gliadin expression in ‘Marquis’. 
‘Steele-ND’ has an emmer ancestor, but so does ‘Hope’, which fell between the 10th and 
90th percentiles for the evaluated cultivars. These cultivars have increased resistance to 
Fusarium head blight and leaf rust (Mergoum et al 2005) and black stem rust and leaf 
rust (Clark et al 1928), respectively. Their genetic backgrounds differ in that the older 
‘Hope’ accession was derived from a cross between Yaroslov emmer and ‘Marquis’ 
(wheatpedigree.net/sort/renderPedigree/24791, accessed 15 Jan 2017), while ‘Steele-ND’ 
descended from ‘Hope’ through both sides of its pedigree 
(wheatpedigree.net/sort/renderPedigree/83591, accessed 17 Jan 2017) via ‘ND-507’ 
(wheatpedigree.net/sort/renderPedigree/43837, accessed 17 Jan 2017). The pedigree of 
‘Steele-ND’ includes ‘Stoa’ and ‘Grandin.’ The origin of each cultivar may have 
influenced its gliadin accumulation in the SDSU yield trials, as each breeding program 
from which these cultivars were released may have its own unique population structure 
(Chao et al 2007; Zhang et al 2010). Pedigree analysis might better explain the effect of 
genetic background on gliadin accumulation in response to environmental inputs.  
CONCLUSION 
Genotypic contributions to gliadin accumulation were outstripped by the 
substantial influence of growing environment on phenotype. Stability analysis indicated 
that direct selection on immunogenic gliadin content may be possible, and identified at 
least one discriminatory environment in which to make selections. The choice of 
parametric or nonparametric evaluation approach could result in different selection 
outcomes. The degree of change in gliadin accumulation in cultivars under development 
would therefore vary between wheat breeding programs. Pedigree analysis may have 
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strengthened the results of this study through identification of genetic backgrounds that 
were less responsive to environmental conditions and therefore would have demonstrated 
less variation in gliadin accumulation across environments. Further investigation into the 
individual and combined effects of genetic background and environmental factors is 
warranted. 
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Figure 5.1. Boxplot of mean gliadin accumulation in the 24 cultivars grown over 
12 location-years. 
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Figure 5.2. Rank changes of six cultivars by year for gliadin accumulation across 
12 location-years. Twenty-four cultivars grown in 12 location-years were subjected 
to nonparametric stability analysis. Note the y-axes are reversed. Legends are in 
alphabetical order. A.) The three most-stable cultivars. B.) The three least-stable 
cultivars.  
A. 
B. 
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Figure 5.3. Violin plot of gliadin accumulation in AYT and GRIN cultivars 
grown in Brookings, 2015-2016. Mean gliadin accumulation for the 37 GRIN 
cultivars was 19.76 g kg-1 in 2015 and 45.72 g kg-1 in 2016. Mean gliadin for the 48 
AYT cultivars was 26.75 g kg-1 in 2015 and 34.45 g kg-1 in 2016. 
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Figure 5.4. GGE biplot of gliadin accumulation in 24 cultivars grown in 12 
location-years.  
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Figure 5.5. GGE biplot of location-years discriminativeness versus 
representativeness. The small circle touching the Groton 2014 vector indicated that 
this environment had the best discrimination value for gliadin accumulation. The 
grouping of the environmental vectors indicated similarity between environmental 
conditions. 
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Table 5.1. The fifteen traits used to rank cultivars by trait 
value. 
 
Test weight (lb bu-1) 
Falling Number score (seconds) 
Kernel size, large (%) 
Kernel size, small (%) 
Bran (%) 
Shorts (%) 
Milling efficiency (% yield) 
Flour yield (g kg-1 grain) 
Whole-grain protein (g kg-1) 
flour protein (g kg-1) 
Wet gluten 
Water binding 
Gluten Index 
Vital gluten 
Gliadin 
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Table 5.2. Candidates for selection using summed ranks for five traits. 
The 139 cultivars under development were ranked for the most desirable test weight, 
Falling Number score, whole-grain and flour protein accumulation, and dry gluten 
accumulation. Variance of the location-year ranks is given. 
Name Brookings 
Summed 
Rank 
Groton 
(Watertown 
2015) 
Summed Rank 
Selby 
Summed 
Rank 
Overall 
2013 (N = 59) Score Var 
SD4501 57 18 23 98 450.33 
SD4504 29 37 37 103 21.33 
SD4321 50 22 33 105 199.00 
SD4533 43 56 24 123 259.00 
SD4506 53 22 54 129 331.00 
2014 (N = 71)        
SD4569 21 40 62 123 421.00 
SD4559 21 34 72 127 702.33 
SD4548 28 60 44 132 256.00 
SD4515 43 32 59 134 184.33 
SD4618 49 16 70 135 741.00 
2015 (N = 69)        
SD4678 60 34 63 157 254.33 
SD4660 66 50 57 173 64.33 
SD4628 73 63 55 191 81.33 
SD4656 61 97 68 226 364.33 
SD4626 77 84 70 231 49.00 
2016 (N = 35)        
SD4659 13 13 11 37 1.33 
SD4623 22 14 31 67 72.33 
SD4660 6 16 48 70 481.33 
SD4673 68 15 41 124 702.33 
SD4582 44 73 24 141 607.00 
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Table 5.3. Ranks of mean gliadin per year for  
the 20 lowest- and 20-highest accumulating lines. 
Cultivars that could be included in both groups were removed from analysis. 
Name Year Gliadin (g kg-1) Overall rank 
Low group       
Kota 2015 10.86 2 
SD4579 2014 13.71 5 
SD4572 2014 14.28 9 
SD4577 2014 14.29 10 
Butte86 2015 14.39 11 
SD4562 2014 14.59 12 
Centana_Short 2015 15.19 13 
SD4580 2014 15.20 14 
SD4578 2014 15.20 15 
SD4576 2014 15.71 16 
SD4637 2015 15.88 18 
SD4638 2015 15.99 19 
SD4565 2014 16.27 20 
Apex 2015 16.33 21 
SD4649 2015 16.46 22 
SD4569 2014 16.57 23 
SD4650 2015 16.64 24 
Stanley 2015 17.00 25 
Butte 2015 17.04 26 
SD4561 2014 17.06 27 
High group       
SD4299 2013 45.73 346 
SD4656 2015 45.87 347 
SD4313 2013 46.02 348 
SD4542 2013 46.64 349 
SD4494 2013 46.84 350 
SD4543 2013 46.96 351 
Olaf 2016 47.17 352 
Chinook 2016 47.39 353 
P8901-AQ1A2B1B 2016 48.88 354 
SD4403 2013 48.96 355 
SD4529 2013 49.07 356 
Ruby 2016 50.28 359 
FOREFRONT 2013 50.63 360 
Rescue 2016 51.59 362 
Montana_King 2016 51.79 363 
Chris 2016 52.09 364 
STEELE-ND 2013 53.70 366 
KNUDSON 2016 56.56 368 
SD4540 2013 57.08 369 
Marquis 2016 61.39 372 
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Table 5.4. Mean gliadin accumulation of the performance check cultivars. 
'Oxen' and 'Briggs' were planted in AYT, PYT, and PPY nurseries as performance 
check cultivars. 'Prevail' and 'Forefront' observations include trials prior to release and 
subsequent inclusion as performance check cultivars. Cultivars are sorted by variance 
in ascending order. 
Name N Mean Var SD 
GRANGER 9 27.01 60.59 7.78 
PREVAIL 24 27.89 70.73 8.41 
BRICK 12 30.44 73.87 8.59 
OXEN 18 31.17 90.08 9.49 
SELECT 12 29.83 96.13 9.8 
ADVANCE 12 29.04 99.51 9.98 
TRAVERSE 12 30.18 105.18 10.26 
FOCUS 12 30.73 114.04 10.68 
BRIGGS 18 34.4 123.51 11.11 
BOOST 12 35.08 126.99 11.27 
SURPASS 12 30.41 138.41 11.76 
KNUDSON 9 26.64 142.12 11.92 
FALLER 12 33.36 145.73 12.07 
FOREFRONT 24 31.18 159.63 12.63 
STEELE-ND 12 35.02 200.71 14.17 
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Table 5.5. Nonparametric stability analysis of gliadin accumulation for 24 
cultivars grown in four yield trials (2013-2016). 
The absolute rank difference (s1) and variance of the rank (s2) for genotypic effect 
were compared to the Chi-square critical value 9.47. The tests of significance for the 
GEI (sum of the z-scores) were compared to the Chi-square critical value of 36.41 with 
one degree of freedom. Cultivars were sorted by absolute rank differences.  
  Mean gliadin Absolute rank difference Variance of rank 
Name (g kg-1) Rank s1 Rank  z s2 Rank z 
BRIGGS 33.08 16 6.08 1 2.52 27.17 1 2.30 
PREVAIL 30.52 8 6.21 2 2.17 27.70 2 2.19 
SD4416 28.69 3 6.26 3 2.06 28.08 3 2.10 
FOCUS 31.08 11 6.29 4 1.99 30.57 6 1.61 
SD4393 29.18 6 6.38 5 1.78 28.81 4 1.95 
BOOST 33.47 18 6.47 6 1.59 30.02 5 1.71 
TRAVERSE 31.03 10 6.82 7 0.94 33.61 7 1.09 
SD4472 31.65 12 7.11 8 0.53 39.72 9 0.36 
SELECT 28.68 2 7.20 9 0.43 36.63 8 0.68 
SD4465 27.92 1 7.42 10 0.22 40.00 10 0.34 
OXEN 32.18 13 7.62 11 0.09 40.99 11 0.26 
SURPASS 29.00 4 8.18 12 0.03 50.42 12 0.03 
STEELE-ND 33.70 20 8.45 13 0.15 50.88 13 0.05 
SD4529 32.44 14 8.76 14 0.41 54.42 14 0.23 
SD4403 33.62 19 8.85 15 0.51 58.33 15 0.58 
SD4546 33.26 17 9.12 16 0.89 68.61 19 2.29 
ADVANCE 29.04 5 9.18 17 0.99 63.42 16 1.29 
FALLER 33.85 21 9.29 18 1.17 63.84 17 1.36 
FOREFRONT 35.19 23 9.70 19 2.02 68.36 18 2.24 
SD4493 32.67 15 9.82 20 2.32 69.79 21 2.56 
BRICK 30.64 9 9.83 21 2.35 69.48 20 2.49 
SD4543 33.92 22 10.26 22 3.56 76.63 23 4.41 
SD4514 29.41 7 10.38 23 3.95 76.45 22 4.35 
SD4539 35.69 24 10.55 24 4.52 87.06 24 8.19 
Sum Z-score         37.19     44.63 
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Table 5.6. Variance components on gliadin accumulation  
extracted from the linear mixed model. 
    CI95 
  Estimate SE PValue LL UL 
Location-year 65.32 2.50 <0.0001 56.49 74.15 
Genotype   0.87 0.78 <0.0001  -1.90   3.64 
Location-year*genotype 28.26 0.76 <0.0001 25.58 30.95 
Residual error 28.26 0.76 <0.0001 25.58 30.95 
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Table 5.7. Predicted effects on gliadin accumulation by location-years. 
The location-year effect was significant at the α = 0.05 level. 
    CI95 
Location Estimate SE PValue LL UL 
BRK2013 6.93 0.80 <0.0001 4.10 9.76 
GRO2013 5.52 0.82 <0.0001 2.63 8.40 
SEL2013 11.07 0.70 <0.0001 8.58 13.56 
BRK2014 -6.60 0.37 <0.0001 -7.92 -5.27 
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CHAPTER 6. GLIADIN GENOTYPING ANALYSIS 
ABSTRACT 
Forty hard red spring wheat (Triticum aestivum L.) cultivars were selected on the 
basis of mean annual gliadin accumulation and sorted into either a low- or a high-gliadin 
group. A panel of ten 6D genome-specific point mutation markers for α-gliadin genes 
were used to genotype the 40 HRSW cultivars. Little polymorphism was observed for 
nine of the ten markers. A Chi-square test indicated that the most polymorphic marker, 
195T, did not explain the differences in gliadin accumulation between groups (χ2 = 0.80, 
df = 1, p = 0.3715). It was concluded that the amplified loci did not explain the 
differences in gliadin accumulation between the low- and high-gliadin groups, and that 
other factors were probably more influential than the genotypes at these loci. 
INTRODUCTION 
Breeding ‘celiac-safe’ wheat (Triticum aestivum L.) is an ambitious project. The 
first obstacle is the sheer number of genes that govern the expression of the immunogenic 
prolamins, including the gliadins. Other researchers have reported varied numbers of 
genes (up to hundreds) clustered at six major gliadin loci present on the A, B, and D 
genomes, especially the Gli-D1- and Gli-D2 loci (Okita et al 1985; Sumner-Smith et al 
1985; Anderson and Greene 1997; Anderson et al 1997; Mitea et al 2010; Qi et al 2010; 
Anderson et al 2012). These prolamins exhibit a high degree of conservation not only 
within the Triticeae genera and closely-related cereals, but in the wild wheat relatives and 
some paralogs in other grasses (Spaenij-Dekking et al 2005; Silano et al 2008; Gregorini 
et al 2009; Salentijin et al 2009), which may be seen in the bootstrapped consensus tree 
of gliadin protein sequences for 22 species of cereals and grasses from Chapter 2 (Figure 
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2.1). Genotype-by-environment interactions have been described in the literature 
(Altenbach et al 2002; Blumenthal et al 1993; Daniel and Triboi, 2000; Park et al 2000) 
and were observed during this dissertation project (Chapter 5).   
Surveys of gliadin genes indicate genetic diversity is present in germplasm around 
the world (Okita et al 1985; Metakovsky et al 1997a, 1997b; Branlard et al 2001; Ruiz et 
al 2002) and in the hexaploid common and spelt wheats (Mayer et al 2012; Dubois et al 
2016). Ozuna et al (2015) and van Herpen et al (2006) determined that α-gliadin isoforms 
vary in amino acid sequence and, consequently, in epitope content. Although recent 
advances in genetic technologies offer great promise in reducing or outright removing 
immunogenic peptides from the wheat genome (van de Wiel 2017; Sanchez-Leon et al 
2017), natural variation already exists. Screening the extant germplasm for less-
immunogenic wheat with established methods can make use of the training and 
equipment that a research program already owns.  
Qi et al (2012) developed a set of 11 D genome-specific point mutation markers, 
verified against ‘Chinese Spring’. Using these markers, the authors screened a group of 
Chinese landrace wheats for differences in gliadin genotypes. They found variation in the 
number of positive versus null bands (presence vs. absence), and concluded that genetic 
variation in the marker priming sites contributed to amplification efficiency. The Qi et al 
markers were used in this study to genotype the low- and high-gliadin genotypes 
identified in Chapter 5. 
MATERIALS AND METHODS 
Plant materials 
Forty hard red spring wheat (HRSW) cultivars were grown in the South Dakota 
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State University Spring Wheat Breeding Program yield trials between 2013 and 2016. 
These locations included four sites in South Dakota: Brookings (lat. 44.31, long. -96.67), 
Groton (45.49, -100.01), Selby (45.108, -97.103), and Watertown (45.42, -97.91). All 
plant materials were planted in a randomized block design with three replicates at the 
three locations. Due to hail damage at the Groton location in 2015, a location substitution 
(Watertown) was made to balance the dataset. A subset of these genotypes was obtained 
from the National Small Grains Collection (Aberdeen, ID) in 2015. Because the National 
Plant Germplasm System allocated only 5 g seed per requested accession, the 37 
genotypes (hereafter called GRIN accessions) were grown in head rows only in the 
Brookings location in 2015 and 2016. 
Genotype selection and genotyping 
The low- and high-gliadin groups were selected on the basis of ranked mean 
gliadin accumulation within a population of 191 cultivars, with each genotype-location-
year (GLY) combination treated as a unique individual. A rank of ‘1’ was assigned to the 
lowest mean gliadin accumulation. The top and bottom 10% of the entire dataset were 
chosen to obtain 20 low- and 20 high-gliadin genotypes (N = 40).  
DNA was extracted using a modified CTAB method (Appendix C) followed by 
Nanodrop quantitation and 260:230 nm ratio assessment of contamination. The 40 
genotypes, ‘Red Fife’ and two accessions of ‘Chinese Spring’ were genotyped using the 
point mutation markers developed by Qi et al (2012; Table 6.1.) PCR conditions are 
described in Appendix D. Electrophoresis was conducted at 100V on a 1% agarose gel, 
stained with ethidium bromide for visualization. 
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RESULTS 
Ten of the 11 markers amplified a PCR product in this group of HRSW (Table 
6.2). Only marker 195T demonstrated sufficient polymorphism to conduct a Chi-square 
test. The test statistic (χ2 = 0.80, df = 1, p = 0.3715) indicated that no significant 
difference in band frequency (positive versus null) between low- and high-gliadin groups 
was detectable at a significance level of α = 0.05. The parent of ‘Marquis’, ‘Red Fife’ did 
not produce a PCR product with any of the ten markers, despite no difference in sample 
quality or contamination relative to the other DNA samples. 
DISCUSSION 
The genotyping results as presented are not wholly unexpected. It is reasonable to 
observe similar genotypes within the germplasm of a single breeding program. Several of 
the GRIN accessions were ancestors of the released performance checks and cultivars 
under development. The near-homogeneity of the assessed genotypes indicated that the 
presence or absence of these DNA loci was probably irrelevant to gliadin accumulation in 
the 40 cultivars. The difference between these results from those reported by Qi et al 
(2012) might be explained by the difference in PCR conditions used. The authors used 
higher annealing temperatures than were used in this study, which probably promoted 
greater specificity of primer binding. The temperatures used in this study were closer to 
the calculated Tm of the primer-pairs, and might have permitted primer binding to 
imperfectly matched priming sites. Further analysis of the genotypes by sequencing or 
denaturing gradient gel electrophoresis might have identified single nucleotide 
polymorphisms within the amplified regions.   
The next step is to evaluate other influences on gliadin gene expression. 
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Altenbach et al (2002) cited reports describing gene regulatory events during grain 
development, and advocated for further investigation into environmental influences on 
gene expression. Investigation into epigenetic factors that influence protein expression is 
a promising avenue. Wen et al (2012a, 2012b) successfully used RNAi to downregulate 
DME transcription in durum and bread wheat. However, RNA interference technology 
required use of a transgenic construct introduced into the host cells by biolistic particle 
delivery, a technique that qualified the resulting plant material as a genetically-modified 
organism. The authors of the manuscript reported incidence of male gametophyte 
anomalies that reduced fertility in transformed plants, the mechanisms of which were 
described earlier in Arabidopsis thaliana (Schoft et al 2011). Other attempts at epigenetic 
modification were conducted by Rustgi et al (2012, 2013), with some success at silencing 
the DEMETER genes and RNAi-targeted elimination of prolamin transcripts. 
Maternal effects in plants, particularly regarding plant nutrition, have a limited 
body of literature. A cursory Web of Science search using the terms (TOPIC (‘maternal 
effects’) AND TOPIC (plants) refined by TOPIC (wheat) AND TOPIC (protein)) only 
returned 11 hits. A 1992 report by Millet et al discussed the paternal and maternal effects 
on protein traits in wheat; a second written by Kristensen (2003) addressed the topic in 
spring barley grown in organic and conventional production systems. Reports of 
nutritional management regimes and subsequent influence on protein fraction profiles 
(Pechanek et al 1997; Daniel and Triboi 2000; Triboi et al 2000; Triboi et al 2003) 
implicated nitrogen fertilization and timing, and temperature as factors in gliadin 
expression. Bridging the knowledge gap with environmental modeling has been made 
easier with the recent development of online decision support tools, similar to the U2U 
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Corn Growing Degree Day Tool already in development by Angel et al (2017) for use by 
producers. These tools will be valuable for conducting research as well as assisting 
producers in implementing recommended strategies for reducing immunogenic potential 
in their crop.  
Other strategies for reducing immunogenic protein content have targeted the 
genes directly. A recent effort by Sanchez-Leon, et al (2017) has also successfully 
reduced—although not eliminated—immunogenic gliadin from bread and durum wheats 
using CRISPR/Cas9 genome editing. These authors generated three reduced-gliadin 
bread wheat and six durum genotypes without off-target effects or remnants of the Cas9 
expression vector in the mutant genomes. The authors noted that overall gene expression 
of prolamins was affected. Some other gliadins and glutenins were also expressed to a 
lower degree. Sanchez-Leon et al (2017) also found that new forms of gliadin were 
expressed as a consequence of mutation, or in the case of four bread wheat cultivars, 
shifted to other, unedited gliadin genes. Sanchez-Leon et al reported greater upregulation 
of ω-gliadins in response to the induced repression of other gliadins, which Palosuo et al 
(2001) identified as a Type-I hypersensitive response trigger. The observations of 
Sanchez-Leon et al could have serious implications for people who suffer acute allergic 
responses to wheat.  
Sanchez-Leon et al (2017) noted that base deletions were more frequent than 
insertions in their plant population, and that insertions appeared to be the result of 
microhomology-mediated end joining. Although the authors admitted that higher 
mutation loads negatively impacted plant development, the mutations were confirmed 
heritable. Impact on quality varied (Sanchez-Leon et al 2017). The predicted loaf volume, 
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as determined by SDS sedimentation testing on flour from the mutant lines, would more 
likely be smaller in lines with the lowest gliadin accumulation. A similar reduction in 
Chinese noodle quality and pasta quality of the durum wheats would likely be observed. 
Increased HMW glutenin accumulation observed in some of the mutant bread wheat 
genotypes would produce strong, stable doughs. Basing their conclusions on these 
observations, Sanchez-Leon et al predicted that their CRISPR/Cas9 mutants would have 
acceptable end-use quality. The genome editing route seems promising and research into 
its effects on the phenome are just beginning.  
CONCLUSION 
Older and contemporary cultivars were not significantly polymorphic for the ten 
gliadin genes evaluated in this study. Further analysis is needed to identify environmental 
factors that influence gliadin gene expression, and to what extent. Whatever course of 
action is chosen, plant breeders will need to ensure that reductions in the immunogenic 
properties of wheat seed storage proteins will not reverse progress made in other aspects 
of wheat quality. 
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Table 6.1. The 11 D genome-specific primers evaluated in this study.  
The marker panel was generated by Qi et al (2012), and only markers targeted to 
chromosome 6D were used. The annealing temperatures used for this study are listed. 
Name Main Sequence (5' --> 3') Complement 
Product 
size 
Temperature 
(oC) 
Gli-724G TCCTACCAGCAGCCTAAGG R1 230 52 
Gli-723A TCTCCTTCCAACAGCCTGAA R2 230 54 
Gli-533G TGTTGTATTGCAGCAACGCAG R1 420 50 
Gli-268A CGCAACTACCATATCCGAAGA R1 645 50 
Gli-695T GTTGGAAGGAGACCTGGCTAA F1 710 62 
Gli-195T CCACAACAGCCATATCCGAAT R1 730 52 
Gli-734T AAGGAGCCCTGGCCTGTTA F2 740 54 
Gli-135G ACAAGAGCAAGTTCCATTGACG R2 810 54 
Gli-841G CACATTGCAGGTAGCGTCAC F1 860 54 
Gli-857CC TGGAGGGATGTAGACATTGAAGG F2 875 52 
Gli-39A TTGCCCTCCTTGCTATTGGA R1 900 54 
F1 GSTCAATACAAATCCAYCATG    
F2 ATGAAGACCTTTCTCATCCTTG    
R1 TTCTCTTCTCAGTTRGTACCR    
R2 TCAGTTRGTACCRAAGATGCC       
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Table 6.2. Genotype count data. 
           
Name 135G 195T 268A 533G 695T 723A 724G 734T 841G 857CC 
Low                      
Kota + + + + + + + + + + 
SD4579 + + + + + + + + + + 
SD4572 + + + + + + + + + + 
SD4577 + + + + + + + + + + 
Butte86 + + + + + + + + + + 
SD4562 + 0 + + + + + + + + 
Centana_Short + 0 + + + + + + + + 
SD4580 + 0 + + + + + + + + 
SD4578 + + + + + + + + + + 
SD4576 + + + + + + + + + + 
SD4637 + + + + + + + + + + 
SD4638 + + + + + + + + + + 
SD4565 + + + + + + + + + + 
Apex + 0 + + + + + + + + 
SD4649 + 0 + + + + + + + + 
SD4569 + + + + + + + + + + 
SD4650 + + + + + + + + + + 
Stanley + + + + + + + + + + 
Butte + + + + + + + + + + 
SD4561 + + + + + + + + + + 
Chinese_Spring + + + + + + + + + + 
High                     
SD4299 + + + + + + + + + + 
SD4656 + + + + + + + + + + 
SD4313 + + + + + + + + + + 
SD4542 + + + + + + + + + 0 
SD4494 + + + + + + + + + + 
SD4543 + + + + + + + + + + 
Olaf + + + + + + + + + + 
Chinook + + + + + 0 + + + + 
P8901-AQ1A2B1B + + + + + + + + + + 
SD4403 + + + + + + + + + + 
SD4529 + + + + + + + + + + 
Ruby + + + + + + + + + + 
FOREFRONT + + + + 0 + + + + + 
Rescue + + + + + + + + + + 
Montana_King + + + + + + + + + + 
Chris + + + + + + + + + + 
STEELE-ND + + + + + + + + + + 
KNUDSON + + + + + + + + + + 
SD4540 + + + + + + + + + + 
Marquis + + + + + + + + + + 
Chinese_Spring + + + + + + + + + + 
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CHAPTER 7. SUMMARY AND RECOMMENDATIONS 
EVALUATION OF IMMUNOGENIC GLIADIN BY ELISA  
Despite reports describing the results of enzyme-linked immunosorbent assays 
(ELISAs) used to evaluate wheat (Triticum aestivum L.) cultivars for immunogenic 
gliadin accumulation (Park et al 2000; Gregorini et al 2009; Colomba and Gregorini 
2012; Gell et al 2015), the results of this study indicated that ELISAs were unsuitable for 
this purpose. The proteins that comprise gluten make up 80 to 85% of the total flour 
protein (Shewry et al 2009). The proportion of prolamins to glutelins is approximately 
1:1 (Belitz et al 2004), although some variation has been reported due to cultivar and 
extraction differences (Shewry et al 2009). The commercially available ELISAs were 
developed to identify and measure trace amounts of immunogenic prolamins in foods. 
These amounts were defined by legislation as less than 20 parts per million, or 20 mg kg-1 
(Thompson and Mendez 2008; C. F. R. § 101.91 2017), rather than the levels that 
naturally exist in wheat flour (g kg-1). Samples extracted from flour would need larger 
dilution factors to keep the unknown sample absorbance within the functional range of 
the assay. Additional pipetting steps or other methodological factors can increase the 
uncertainty of the measurement (Hayashi et al 2004a, 2004b; Daly et al 2005; Toussaint 
et al 2007), which leads to problems with assay interpretation. Technical issues also 
complicate application of the ELISA method to gliadin measurement (Diaz-Amigo and 
Popping 2013; Rzychon et al 2017) with meaningful results to wheat breeders. Near 
infrared (NIR) spectroscopy would be easier to implement in a breeding program, as this 
method would be less prone to user error (Garcia-Molina et al 2016).  
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PLANT BREEDING AND CELIAC PREVALENCE 
Celiac disease (CD), while certainly a concern worldwide, perhaps gets more 
attention than other diseases with more-lethal effects on human health. The results 
presented here did not find evidence of selection for agronomic or end-use quality traits 
as the cause of increasing gliadin accumulation in contemporary wheat cultivars. This 
supports the conclusions of Kasarda (2013) and Ribeiro et al (2017). The evidence 
provided in Chapters 4 and 5 is insufficient to implicate plant breeding activities as the 
reason for increased CD. The conclusion reached in this study contradicts the conclusion 
of van den Broeck et al (2010). Future studies might examine other loci, such as disease 
resistance genes (Czarnecki 1992), located near gliadin-encoding loci for evidence of 
indirect selection on gliadin accumulation. Future studies that model environmental 
conditions, such as nitrogen availability (Daniel and Triboi 2000), temperature 
(Blumenthal et al 1993), or other weather conditions would probably better explain the 
process of gliadin accumulation in old and new cultivars. 
GENOTYPE-BY-ENVIRONMENT INTERACTION 
The body of evidence indicates that environment influences immunogenic gliadin 
accumulation. Unmodeled factors probably contribute to the discrepancy in reports. 
Potential lines of inquiry include maternal effects, inclusion of environmental modeling, 
and epigenetic control of phenotypic range. A meta-analysis of the current literature 
would identify inconsistencies in reporting gliadin accumulation in wheat. Further 
comparisons between the cultivated and wild wheats is needed to identify natural 
variation in seed storage proteins that can be adopted to develop less-immunogenic 
wheats with improved quality and trait stability, as suggested by Henry and Nevo (2014). 
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Plant breeders should be cautious about introgression from wild relatives; in the case of 
gliadin this may be a step backward. Wild-type proteins with greater immunogenic 
potential could be reintroduced into elite cultivars through wide crosses. If gliadin is 
deposited in the caryopsis in response to abiotic stress, then evaluation of climate cycles 
or trends would aid in predicting immunogenic potential of wheat and related cereals. 
Examining natural diversity and developing prebreeding populations may be 
preferable to genetic engineering. Unpredictable off-target effect could diminish the 
viability of the plant. Reliance on genome editing can result in transgenic plants and add 
to the cost of cultivar development by requiring confirmation of zero transgenes. Wheat 
that has undergone genome editing may not be well-accepted by people who have already 
expressed concern about mutated proteins. The indels generated by Sanchez-Leon (2017) 
led to such mutated proteins. Furthermore, shifts in protein expression could lead to 
increased allergenic protein expression (e.g., ω-gliadins, which stimulate an IgE-
mediated wheat allergy in ~ 0.2% of the population). At this time, evaluation of 
genotype-by-environment interactions and choosing genotypes that stably accumulate 
less immunogenic proteins appears to be the most fruitful approach.   
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APPENDIX A. GRIN GERMPLASM HRSW ACCESSIONS AND RELEASED 
CULTIVARS USED IN THIS STUDY 
Variety 
name 
GRIN 
accession Origin 
Release
d Registration or reference 
Advance PI 6644820 SD 2011 Glover et al 2015 
Alsen PI 615543 ND 2000 Mergoum et al 2006 
Apex CItr 11636 SK 1937 Clark 1937 
B775 PI 352211 SWZ NA NA 
Boost PI 678681 SD 2016 SDWC 2015; Schmidt 2016 
Brick PI 657697 SD 2009 Glover et al 2010 
Briggs PI 632970 SD 2002 Devkota et al 2007 
Butte CItr 17681 ND 1977 Frohberg et al 1977 
Butte86 * ND 1986 . 
Centana CItr 12974 MT 1952 . 
Centana SD CItr 17393 MT 1975 no access online. 
Centana 
Short CI 17400 MT 1975 no access online. 
Centana Std 
Height CItr 17392 MT 1975 no access online. 
Chinook CItr 13220 AB 1952 Grant and McKenzie 1964 
Chris CItr 13751 MN 1965 Heiner and Johnston 1967 
CI 11694 CItr 11694 ID 1934 NA 
Conley CItr 13157  ND 1955 Heyne 1960 
Faller PI 648350 ND 2007 Mergoum et al 2008 
Fletcher CItr 13985 MN 1970 Heiner and McVey 1971 
Focus  SD  In preparation 
Forefront PI 664483 SD 2012 Glover et al 2012 
Glyndon PI 25991 MN 1898 Clark et al 1923; Clark et al 1926 
Grandin PI 531005  ND 1989 Deregistered in Canada (producer.com) 
Granger PI 636134 SD 2004 Glover et al 2006 
Hope 
CItr 8178,  
CItr 13133 SD 1927 Clark et al 1926; Clark 1927 
Huron CItr 3315 ON 1894 Clark et al 1926 
Kelby PI 643091 KS 2006 Ransom et al 2013 
Knudson PI 619609 CO 2001 NA 
Kota CItr 5878 RUS 1903 
Waldron and Clark 1919; Clark et al 
1926 
Ladoga PI 393962 RUS NA Clark 1922; Clark et al 1926 
Lancer PI 508271 SK 1985 DePauw et al 1987 
Lee CItr 12488 MN 1951 Bayles and Clark 1954 
Marquillo CItr 6887 MN 1923 Clark et al 1926; Clark and Bayles 1942 
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Marquis CItr 3641 ON 1911 Clark et al 1923; Clark et al 1926 
McKay CItr 17903 ID 1981 Sunderman and Connell, 1984 
Montana 
King CItr 8878 SK 1928 Clark 1936 
Olaf CItr 15930  ND 1973 Frohberg et al 1973; Ebeltoft et al 2010 
Oxen PI 596770 SD 1996 NA 
P8901-
AQ1A2B1B PI 613176  SK 2000 Knox et al 2001 
Planet CItr 10077 SK 1929 NA 
Prelude CItr 4323 ON 1913 Clark 1922; Clark et al 1926 
Preston CItr 3328 ON 1904 Clark 1927 
Prevail PI 672486 SD 2013 Glover et al 2016 
Red Fife CItr 6196 ON 1918 Clark 1922; Clark et al 1926 
Reliance CItr 7370 OR 1924 Clarak et al 1926 
Rescue CItr 12435 SK 1946 Bayles and Clark 1954 
Ruby CItr 6047 ON 1918 Clark et al 1926; Clark 1927 
Select PI 659554 SD 2010 Glover et al 2011 
Stanley CItr 4796 ON 1893 Clark et al 1926; Clark 1927 
Steele-ND PI 634981 ND 2004 Mergoum et al 2005 
Stoa PI 520297 ND 1984 NA 
Surpass PI 678682  SD 2015 In preparation 
T-2636 PI 352199  MT 1969 NA 
Traverse PI 642780 SD 2006 Glover and Hall 2006. 
Varieties not available through GRIN are indicated with *. 
D = dwarf, SD = semi-dwarf, CONV = conventional height 
NA = information not available 
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APPENDIX B. DIRECT ELISA METHOD 
MATERIALS: 
 96-well ELISA plate 
 2.0 mL microcentrifuge tubes 
 10 uL pipette tips 
 200 uL pipette tips 
 1 mL pipette tips 
 2.5 or 5.0 ml syringe combitips 
 Acetate sealing tape 
 Repeating pipetter 
 Centrifuge with plate rotor 
 Plate reader  
REAGENTS: 
 Garcia gliadin extraction buffer 
 Carbonate/bicarbonate coating buffer, pH 9.4 
 1X PBS, pH 7.4 
 Blocking buffer 
 Washing buffer 
 primary antibody (rabbit polyclonal, anti-gliadin, conjugated with HRP) 
 TMB colorimetric solution 
 H2O2 TMB substrate 
 1M H2SO4 Stop solution 
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PROCEDURE NOTES: 
1. USE A FUME HOOD WHEN WORKING WITH GARCIA GLIADIN 
EXTRACTION BUFFER.  
a. This substance is toxic by skin contact and inhalation. 
b. Collect waste for disposal by proper authority. 
2. Perform ELISA in a room free of airborne flour particles. 
3. Change tips between reagents and samples. 
4. Wear gloves at all times. 
5. Mix samples using a vortex mixer. 
6. Use fresh sealing tape after HRP step to avoid contamination during TMB 
reaction step. 
7. Dilute samples equally across plate whenever possible; back-calculation of 
original concentrations is easier. 
8. If signal from unknown exceeds that of the standard curve, dilute the 
sample accordingly. 
9. Use a 4-parameter fit for the standard curve: 
y = D + [(A – D) / 1 + (x / C)B] 
 
a. Calculate results from standard curve: 
x = C * [(A – y) / (D – y)1/B] 
 
b. Back-calculate unknowns to obtain g/kg:  
(Result * extraction volume * dilution factor * well volume) 
(1000 * 0.9 dry matter * grams of flour) 
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REAGENT PREPARATION: 
1. Garcia gliadin extraction buffer 
a. Mix together: 
i. Guanidine-HC l19.1 g 
ii. Sterile ultrapure H2O 450.0 mL 
iii. 2-mercaptoethanol     8.75 mL 
b. Store at room temperature UNDER A FUME HOOD. 
2. 80% ethanol 
a. Mix together: 
i. Molecular-grade ethanol 800.0 mL 
ii. Sterile deionized water:    q.s. to 1.0 L 
b. Store at room temperature. 
3. ELISA coating buffer 
a. Mix together: 
i. Sodium carbonate      1.82 g   
ii. Sodium bicarbonate      2.75 g 
iii. Sodium chloride      3.03 g 
iv. Sterile ultrapure water: q.s. to 500.0 mL 
b. Correct pH to 9.6. 
c. Store at room temperature. 
4. 1X PBS, pH 7.4 
a. Mix together: 
i. 10X PBS stock solution 100.0 mL 
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ii. Ultrapure water  900.0 mL 
b. Correct pH to 7.4. 
c. Autoclave and store at room temperature. 
5. Blocking buffer (PBST+NFDM) 
a. Mix together: 
i. Sterile 1X PBS, pH 7.4  500.0 mL 
ii. Nonfat dry milk (NFDM)   25.0 g 
iii. Molecular-grade Tween-20      0.5 mL 
b. Store at 4 oC. Make fresh weekly. 
6. Washing buffer 
a. Mix together: 
i. Sterile 1X PBS, pH 7.4  500.0 mL 
ii. Sterile ultrapure water  500.0 mL 
iii. Molecular-grade Tween-20      0.5 mL 
b. Store at 4 oC. 
7. TMB colorimetric solution 
a. JUST BEFORE USE, mix together: 
i. TMB colorimetric solution  50 ul/well 
ii. H2O2 substrate  50 ul/well 
8. Stop solution, 1 M H2SO4 
a. Mix together: 
i. 99% sulfuric acid (18M)    32.4 mL 
ii. Ultrapure water  270.4 mL 
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b. ALWAYS ADD ACID TO WATER, never other way round!  
c. Store at room temperature in acid cabinet. 
PROCEDURE: 
1. Prepare ELISA plate. 
a. Mark the standard curve and control wells. 
b. Plate layout: 
 1 2 3 4 5 6 7 8 9 10 11 12 
A STD1 STD2 STD3 STD4 STD5 STD6 STD7 STD8 Rice    
B STD1 STD2 STD3 STD4 STD5 STD6 STD7 STD8 Rice    
C             
D             
E             
F             
G             
H             
 
2. Prepare standard curve. 
a. Start with ethanol-extracted gliadin solution, previously diluted to a stock 
solution [10 ug mL-1]. 
b. Dilute according to the table below: 
Standard Stock solution 
(uL) 
Previous dilution 
(uL) 
3:1 Coating 
buffer + 80% 
EtOH (uL) 
Ng per 100 
uL (2015) 
A 125 0 875 33 
B 100 0 900 27 
C 75 0 925 20 
D 0 B = 500 500 13 
E 0 C = 500 500 10 
F 0 D = 500 500 7 
G 0 F = 500 500 3 
H 0 0 500 0 
 
c. Add 100 uL of standard to each of two wells. 
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3. Prepare unknowns. 
a. Starting with ethanol-extracted gliadin, 25 mg/mL flour equivalent (refer 
to extraction procedure). 
b. Dilute according to the table below: 
Dilution Previous dilution 
(uL) 
Garcia 
buffer 
(uL) 
1:3 Coating 
buffer + 80% 
EtOH (uL) 
Concentration 
#1 25 mg/mL = 50 1200 0 1 mg mL-1 
#2 #1 = 100 900 0 0.1 mg mL-1 
#3 #2 GRIN, AYT = 50 uL 
PYT, PPY = 25 uL 
0 
0 
975 
950 
 
 
c. Add 100 uL of unknown to each well. 
4. Prepare sample control. 
a. Starting with 0.1 mg mL-1 rice ethanol extract, dilute to match the rates 
described in the table above for the unknowns.  
b. Add 100 uL of control to each well (duplicate). 
5. Incubate overnight at 4 oC. 
6. Next morning, discard liquid by inverting quickly over a sink, to avoid spilling 
samples across wells. 
7. Tap inverted plate on paper towels to remove any remaining liquid. 
8. Wash unadsorbed sample from plate.  
a. Add up to 300 uL 0.5X PBST wash buffer, using a repeating pipette. 
b. Repeat 4X. Discard liquid and tap plate on paper towels after each wash. 
9. Block. 
a. Add 200 uL blocking solution to each well. Avoid touching bottom of 
wells.  
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b. Incubate 1 h at 37 oC. 
10. Discard blocking buffer. Washing is unnecessary. 
11. Add 100 uL of detection antibody to each well. 
a. Concentration as determined by checkerboard method: e.g., 5 uL (x 
mg/mL stock) per 10 mL of blocking solution. 
12. Incubate 35 minutes at 37 oC. 
13. Wash. 
a. Add up to 300 uL 0.5X PBST wash buffer, using a repeating pipette. 
b. Repeat 4X. Discard liquid and tap plate on paper towels after each wash. 
14. Colorimetric substrate reaction. 
a. Mix TMB solution with H2O2 solution [1:1], 5 mL each for a total of 10 
mL per plate. 
b. Add 100 uL of mixed TMB + H2O2 per well. 
c. Seal with new sealing tape. 
d. Incubate 20 minutes at 37 oC, in darkness. 
15. Stop reaction. 
a. Add 100 uL stop solution to each well. 
16. Read within 30 minutes at 450 nm. Back-calculate unknowns. 
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REAGENTS AND SUPPLIES 
Description Catalog Number Vendor Size 
1.5 ml centrifuge tubes 05-408-129 Fisher 500 pack 
10X PBS solution BP399-1 Fisher 1L 
2.0 ml centrifuge tubes 05-408-138 Fisher 500 pack 
2-mercaptoethanol M3148-25ML Sigma-Aldrich 25 mL 
Combitips/Syringe dispenser tip, 2.5 ml 13-668-704 Fisher 100 pack 
Disodium carbonate BP357-1 Fisher 1kg 
Ethanol, 200-proof, Mol Bio Grade BP2818-4 Fisher 4 L 
Guanidine HCl BP178-500 Fisher 500 g 
Immulon 2HB ELISA plates 14-245-61 Fisher pack of 50 
Koda Farms Rice flour  --  
Non-Fat milk, powdered  --  
Rabbit polyclonal antibody (+HRP) ab49713 AbCam 500 uL 
Sealing tape 15036 Fisher 100 
Sodium bicarbonate BP328-500 Fisher 500g 
Space saver universal tips 1000ul GPS-1000 Rainin pack of 780 
Space saver universal tips 200ul GPS-250 Rainin pack of 1000 
Sulfuric acid, ACS 95-98% A300-500 Fisher 500 mL 
TMB substrate kit PI34021 Fisher 400 mL 
Tween-20 BP337-100 Fisher 100 mL 
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APPENDIX C. CTAB DNA EXTRACTION PROCEDURE 
Source: Doyle J. J., and Doyle J. L. 1990. A rapid total DNA preparation procedure for 
fresh plant tissue. Focus 12:13-15. 
MATERIALS: 
 1.5 mL microcentrifuge tubes 
 Scissors 
 1 mL pipette tips 
 1 mL pipette 
 Microcentrifuge 
 Water or dry bath set to 65 oC 
 -20 oC freezer 
REAGENTS: 
 CTAB Buffer 
 24:1 chloroform:isoamyl alcohol 
 100% isopropanol 
 70% ethanol 
 1X TE, pH 8.0 
 Sterile deionized water 
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PROCEDURE NOTES: 
1. Clean scissors between samples. 
2. Change tips between samples. 
3. Young leaves work best. Old leaves are more difficult to work with. 
4. Work in a fume hood when using chloroform. 
5. Wear gloves at all times. 
6. To ensure every DNA reaction receives the same amount of template, measure the 
DNA in each sample and dilute to the same concentration in the 1X TE storage 
buffer.  
7. Dilute to the working solutions to the same concentration in water. 
a. Too much EDTA in the PCR reaction will chelate the Mg2+ ion cofactors 
required by the DNA polymerase, and the reaction will not work. 
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REAGENT PREPARATION: 
1. CTAB Buffer + 0.1% betamercaptoethanol 
a. Mix together: 
i. Sodium Chloride  1.4 M 
ii. EDTA, pH 8.0   0.05 M 
iii. CTAB    2% w/vol 
iv. Tris-HCl, pH 8.0  100 mM 
v. Deionized ultrapure water q.s. to 1 liter. 
b. Store at room temperature. 
2. 24:1 chloroform:isoamyl alcohol 
a. Mix together: 
i. 100% chloroform  24 mL 
ii. 100% isoamyl alcohol     1 mL 
iii. Store in the fume hood at room temperature. 
3. 70% ethanol 
a. Mix together: 
i. 100% ethyl alcohol   700 mL 
ii. Deionized water  300 mL 
b. Store at room temperature. 
4. 1X TE 
a. Mix together: 
i. 1 M Tris-HCl, pH 8.0  10 mL 
ii. 0.5 M EDTA      2 mL 
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b. Deionized water  q.s. to 1 liter 
c. Correct pH to 8.0. 
d. Autoclave. 
e. Store at room temperature. 
PROCEDURE: 
1. Prepare sample for DNA extraction. 
a. Place leaf in a microcentrifuge tube. 
b. Using clean scissors, mince as finely as possible. 
c. Add 600 uL of CTAB to each sample. Mix well. 
2. Incubate at 65 oC for 30 to 60 minutes, mixing occasionally. 
3. Remove cellular debris. 
a. Centrifuge samples for 10 minutes at 15,000 rcf. 
b. Collect supernatant and transfer to a new tube. 
c. Discard the cell debris pellet. 
4. Isolate DNA. 
a. Add one volume of 24:1 chloroform:isoamyl alcohol to each tube. 
b. Shake for 5 minutes at room temperature on an orbital shaker. 
c. Centrifuge samples for 10 minutes at 15,000 rcf. 
d. Collect aqueous layer on top and transfer to a new tube. 
i. Do not disturb the white intermediate protein layer, or green 
chloroform bottom layer while collecting the aqueous layer. 
e. Discard bottom layer in the chloroform waste container. 
f. Add 2/3 to one volume of 100% isopropanol. Invert to mix. 
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g. Store for at least one hour at -20 oC. 
h. Centrifuge for 5 minutes at 5000 rcf. 
i. Collect supernatant and discard. Retain the DNA pellet. 
5. Wash the DNA. 
a. Add 500 uL 70% ethanol, and mix to resuspend the DNA. 
b. Centrifuge for 5 minutes at 5,000 rcf. 
c. Repeat 3a and 3b once more. 
6. Dry the DNA for 15-60 minutes at room temperature. 
7. Prepare the DNA for use in PCR. 
a. Resuspend the DNA in 100 uL 1X TE buffer. 
b. Measure the quantity of DNA in 2 uL using a spectrophotometer. 
c. Dilute to 100 ng DNA uL-1 stock solution with 1X TE. 
d. Dilute stock solution to 25 ng uL-1 working solution with sterile deionized 
water. 
8. Store at 4 oC. 
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APPENDIX D. POINT MUTATION PCR PROCEDURE 
Source: Qi P. F., Wei Y. M., Chen G. Y., Jiang Q. T., Liu Y. X., Li W., Dai S. F., and 
Zheng Y. L. 2012. Development of chromosome 6D-specific markers for α-gliadin genes 
and their use in assessing dynamic changes at the Gli-2 loci. Molecular Breeding 29:199-
208. 
MATERIALS: 
 96-well PCR plate 
 1.5 mL microcentrifuge tubes 
 10 uL pipette tips 
 200 uL pipette tips 
 1 mL pipette tips 
 Silicon sealing mat 
 Centrifuge with plate rotor 
 Thermocycler 
REAGENTS: 
 5X PCR reaction buffer 
 Sterile deionized water 
 Tween-20, molecular biology grade 
 2.5 uM dNPT mixture 
 20 uM primer mixture 
 5U uL-1 DNA Taq polymerase in glycerol 
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PROCEDURE NOTES: 
1. Use 25 ng uL-1 genomic DNA template diluted in water.  
a. Too much EDTA in the reaction mix will chelate the Mg2+ ion cofactors 
needed by the polymerase, and the reaction won’t work. 
2. Change tips between reagents and samples. 
3. Wear gloves at all times. 
a. This is to protect the sample from the natural enzymes secreted from your 
skin as well as to protect you from the chemicals you are working with. 
4. Work quickly, and add the DNA polymerase last. 
a. Try to keep the enzyme cold for as long as possible, and keep in the 
benchtop cooler during use, as multiple exposures to room temperature 
will reduce the efficiency of the enzyme over time. 
5. Mix the reaction mix gently and thoroughly. 
a. Unnecessary roughness will damage the enzyme. 
b. The glycerol will not go into solution easily, and will sit on the bottom 
unless mixed well. 
6. Observe the melting temperatures of the primers. 
7. Use the minimum number of cycles required for effective amplification. 
a. Taq polymerase is most efficient between 25 and 30 cycles. Beyond 40, 
the enzyme is less efficient and mis-priming may occur. 
8. Difficult templates may be resolved using these technical tricks: 
a. Add adjuvant.  
b. 10% DMSO per reaction may lower the optimal annealing temperature by 
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as much as 5 oC. 
c. BSA or Betaine may help overcome PCR inhibitors or secondary 
structures in the genomic template. 
d. Check primer GC content. Increase denaturation temperature and/or time 
to provide adequate strand separation. 
e. Check primer Tm. If the primer Tm approaches 72 oC, increase the 
extension temperature 5 oC higher than the Tm to ensure proper 
amplification. 
REAGENT PREPARATION: 
1. 10 uM dNTP mixture 
a. Mix together: 
i. 100 mM dATP 0.25 mL 
ii. 100 mM dTTP 0.25 mL 
iii. 100 mM dCTP 0.25 mL 
iv. 100 mM dGTP 0.25 mL 
v. Sterile deionized water: q.s. to 10 mL. 
b. Aliquot into 1 mL portions. 
c. Store at -20 oC. 
2. 10 uM primer mixture 
a. Mix together: 
i. 100 uM stock solution primer   50 uL 
ii. Sterile deionized water q.s. to  450 uL 
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3. 1% Tween-20 in ultrapure water: 
a. Mix together: 
i. Tween-20, molecular biology grade   0.5 mL 
ii. Sterile ultrapure water 50.0 mL 
b. Store at room temperature 
PROCEDURE: 
1. Prepare PCR plate. 
a. Mark the first well, identify the marker used, etc. 
2. Pipette 4 uL DNA (25 ng uL-1) into each well. 
3. Prepare PCR reaction mix. 
a. See table below: 
Reagent 1 reaction 100 reactions 
5X PCR buffer   5.0 uL  500 uL 
2.5 mM dNTP   1.0 uL  100 uL 
10 uM Primers (each)   0.25 uL   25 uL 
5 U/uL Taq polymerase   0.15 uL   15 uL 
Sterile deionized water+1% Tween-20  12.85 uL 1285 uL 
 
b. Add 21 uL of PCR reaction mix to each well. 
4. Run PCR. 
a. Conditions: 
i. Initial denaturing: 94 oC, 4 min 
ii. Amplification cycle (35 times): 
iii. Denature: 94 oC, 45 seconds 
iv. Anneal: 54 oC, 1 min 
v. Extenstion: 72 oC, 1 minute 
vi. Final extension: 72 oC, 10 min. Hold at 4 oC until loaded on gel. 
305 
 
GLOSSARY 
Antibody A Y-shaped glycoprotein that is produced by the humoral 
immune system and is classified as an immunoglobulin. 
Antigen A molecule that can stimulate an immune cell response or 
interact with an antibody. 
Basophil White blood cells, characterized by lobed nuclei and 
“granular” cytoplasm, that initiate inflammatory reactions. 
Basophils are responsible for allergic responses such as 
rhinitis (hay fever) and anaphylaxis. 
Celiac disease An immune reaction within the intestine, triggered by 
consumption of wheat gliadin, or seed storage proteins of 
related cereals, in genetically-susceptible people. 
Cluster of Differentiation A cell surface molecule used to phenotype animal cells on 
the basis of its reaction with monoclonal antibodies. The 
numbering system is currently arbitrary. The designation 
‘+’ or ‘-’ indicates the presence or absence of the molecule 
on the cell surface. 
Cytokine A soluble protein that interacts with cell surface receptors 
and initiates a signal cascade to direct cell activities, such 
as differentiation or migration to the source of the cytokine 
signal. 
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Duodenum The first section of the intestine, proximal to the stomach. 
The duodenum is the site of iron absorption. 
Eosinophil A white blood cell, characterized by an avidity for red 
eosin dye and granular cytoplasm, that releases ROS, 
nucleases, lipid mediators, and cytotoxic cationic proteins 
in response to parasites and infections. Eosinophils are 
commonly found in the gastrointestinal tract. 
Epitope The portion of a molecule that is recognized by the immune 
system, which then organizes a response. Also known as an 
antigenic determinant. 
GEI Genotype-by-environment interaction in which phenotypic 
variation expressed by a genotype is a result of 
environmental variation. 
Human Leukocyte Antigen A receptor expressed on the surface of an antigen-
presenting cell. Specific Human Leukocyte Antigen (HLA) 
variants participate in the display of different pathogen-
derived antigens.  
HLA restriction T cell recognition of an antigen only when the antigen is 
bound to a specific Human Leukocyte Antigen. 
Hybridoma A hybridized cell generated from a B lymphocyte fused 
into a myeloma cell for the purpose of antibody production. 
Immunogenic Stimulates the immune response. 
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Immunoglobulin A family of proteins that participate in cell recognition, 
adhesion, and binding activities. Classification of proteins 
in this family is based on shared structural domains that are 
70-110 amino acids in size and contain a fold 
(Immunoglobulin-fold) that forms a hydrophobic pocket at 
one end to capture specific targets (epitopes). The other end 
of the domain contains a motif that modulates specificity 
for epitopes. 
Immunoglobulin A An isotype or class of monomeric or dimeric antibody 
produced by placental mammals. IgA can be secreted in 
dimeric form in the mucosa, in the blood serum in 
monomeric form, or deposited onto cell membranes in 
either form. 
Immunoglobulin D An isotype or class of dimeric antibody produced by 
placental mammals.  
Immunoglobulin E An isotype or class of monomeric antibody produced only 
by mammals. IgE participates in type I hypersensitivity, or 
allergic, responses and parasite recognition. IgE-mediated 
inflammation has been implicated in some autoimmune 
diseases.  
Immunoglobulin G An isotype or class of monomeric antibody produced by 
mammals, and the most-abundant class found in humans. 
IgG is produced after class-switching (class switch 
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recombination of antibody chain genetic loci). The IgG 
class is multifunctional; this class participates in 
recognition of pathogens, regulates allergic reactions, and 
cell-mediated immune responses. 
Immunoglobulin M An isotype or class of pentameric antibody produced by 
mammals in response to pathogens. IgM is the first class of 
antibody produced before class-switching occurs. 
Lectin Proteins that bind to sugar moieties with high affinity. 
Abundantly produced in legumes, cereals, and nuts, lectins 
are also produced by many other organisms, including 
animals. Lectins perform myriad physiological functions. 
Leukocyte White blood cells. 
Leukotriene Mediators of inflammation released by white blood cells.  
Lymphocyte The immune cells of the body that recognize antigenic 
epitopes. Specificity and memory of the adaptive immune 
response are the domain of this cell population. 
Mast cell Bone marrow-derived cells with a granular cytoplasm. IgE-
sensitized mast cells release histamines and vasoactive 
amines upon degranulation during the allergic response.  
Mucosa The membrane surrounding internal organs composed of 
epithelial cells. The three-layered gastrointestinal mucosa 
secretes mucus and acts as a barrier against pathogens. 
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Interactions with the microbiome and immune system 
occur on the mucosal surface. 
Myeloma cells A cell line, derived from cancerous plasma cells, with great 
capacity for proliferation. These cells are used to generate 
hybridomas in a process called immortalization.  
NCGS A non-celiac, non-allergic clinical entity, triggered by 
consumption of wheat gluten, that resolves with adherence 
to a gluten-free diet.  
 
 
